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ABSTRACT 
Traditional herbal medicine has been widely used in the treatment of various 
diseases.  A number of herbal medicines have been shown to have a favourable effect in 
treating cancer or cancer-related diseases. Phaleria macrocarpa (Scheff.) Boerl is one of 
the traditional herbal medicines that appear to be useful for treating patients who are 
hypertensive, diabetic and cancerous. This affect may be associated to its high 
antioxidant, antimicrobial, anti-inflammatory, and cytotoxic activities as well as other 
bioactivities present in its chemical constituents.  
The present study employed a bioassay - guided fractionation and purification of 
bioactive compounds from the P. macrocarpa plant. The methanol extract and fractions 
of the fruits and seeds of the plant were first screened for their cytotoxic potential using 
MTT cell proliferation assay. Chemical investigation of the bioactive ethyl acetate then 
led to the isolation and identification of several chemical constituents. Fractionation of 
the ethyl acetate fraction of P. macrocarpa seeds yielded palmitic acid, beta-sitosterol 
and (Z)-9, 17-octadecadienal. The ethyl acetate fraction of P. macrocarpa fruits yielded 
β-sitosterol, a mixture containing stigmast-4-en-3-one,  2, 4', 6-trihydroxy-4-
methoxybenzophenone, and 1-(2, 6-dihydroxy-4-methoxyphenyl)-2-(4-hydroxyphenyl) 
ethanone. 
The compounds 2, 4', 6-Trihydroxy-4-methoxybenzophenone, 1-(2, 6-dihydroxy-
4-methoxyphenyl)-2-(4-hydroxyphenyl) ethanone and 9, 17-octadecadienal were tested 
for cytotoxicity on the human colon carcinoma HT-29 cell line and normal human 
fibroblast lung MRC-5 cell line using the MTT assay. These compounds displayed 
cytotoxic effect on the HT-29 cell line in a dose- and time-dependent manner but 
exhibited very low cytotoxic effect on the normal MRC-5 cell line. Morphological 
features of apoptosis such as cell shrinkage, membrane blebbing, nuclear condensation 
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and DNA fragmentation under inverted, phase and fluorescence microscopy were then 
examined. 
The effects of the compounds on cells were further analysed using the Annexin 
V-FITC/PI assay. In this assay, the percentage of early apoptotic, late apoptotic, necrotic 
and live cells were determined and it was observed that cell death was induced in a dose- 
and time-dependent manner in HT-29 cells. Results of cell cycle analysis further 
confirmed that G0/G1 arrest and S-phase accumulation of HT-29 cells declined in a time-
dependent manner after treatment with the compounds. 
Taken together, these results suggested that the induced cell death resulting from 
treatment with the compounds were possibly associated with changes in the protein 
expression. The cell death also showed many characteristic of an apoptotic form of cell 
death. Thus, these compounds merit further investigation as potential anticancer agents.
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ABSTRAK 
Ubat-ubatan herba tradisional telah digunakan secara meluas dalam rawatan 
pelbagai penyakit. Kini, beberapa ubat-ubatan herba baik boleh merawat kanser atau 
penyakit yang berkaitan dengan kanser. Phaleria macrocarpa (Scheff.) Boerl adalah 
salah satu daripada ubat-ubatan herba tradisional Indonesia yang sangat berguna untuk 
merawat pesakit yang menghidapi penyakit seperti kencing manis atau kanser kerana ia 
mengandungi antioksidan yang tinggi, anti-mikrob, anti-radang, dan aktiviti sitotoksik 
serta bioaktiviti lain yang disebabkan oleh kandungan bioaktif kimianya.  
Eksperimen dalam kajian ini adalah berdasarkan bioesei yang berpandukan 
pemeringkatan. Pada mulanya, ekstrak metanol dan fraksi-fraksi dari buah-buahan dan 
biji P. macrocarpa saring keupayaan ketoksikannya menggunakan MTT. Kemudian, 
penyiasatan kimia etil asetat bioaktif yang membawa kepada pengasingan dan 
pengenalpastian beberapa juzuk kimia dijalankan. Dari esktrak etil asetat benih 
macrocarpa P. macrocarpa, terdapat asid palmitik, beta-sitosterol dan (Z) -9, 17-
oktadekadienal. Dari fraksi etil asetat yang dijalankan buah P. macrocarpa terdapat β-
sitosterol, campuran mengandungi stigmast-4-en-3-satu, 2, 4, 6-trihydroksi-4-
metoksibenzofenon dan 1 - (2, 6-dihidroksi-4-metoksifenil) -2 - (4-hidroksifenil) 
ethanon. 
2, 4, 6-Trihidroksi-4- metoksibenzofenon, 1 - (2, 6- dihidroksi-4-metoksifenil) -2 
- (4-hidroksifenil) ethanon dan 9, 17-oktadekadienal telah diuji ke atas sel kolon HT -29 
dan fibroblast paru-paru manusia normal MRC-5. Sebatian didapati mempunyai kesan 
mengikut dos dan masa tetapi menpunyai kesan sitotosik yang sangat rendah pada titsan 
sel normal (MRC-5). Seterusnya, ciri morfologi badan apoptotik seperti pengecutan sel, 
blebbing membran, pemeluwapan nuklear dan pemecahan DNA di bawah tertonggeng, 
fasa dan pendarfluor mikroskop turut dijalankan. 
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Dalam esei Annexin V-FITC/PI mendapati bahawa peratusan sel pada awal apoptotis, 
lewat apoptotis atau sel nekrotik sekunder dan sel-sel hidup boleh ditentukan dengan 
ketara mengikut perubahan dos dan cara. Selain itu, kajian ini juga mengesahkan bahawa 
keputusan analisis kitaran sel menunjukkan G0/G1 dan pengumpulan S-fasa HT-29 sel-
sel merosot adalah bergantung kepada masa selepas rawatan.Kesimpulannya, Oleh itu, 
keputusan dari kajian ini menujukkan bahawa biji Phaleria macrocarpa (Scheff.) Boerl 
berpotensi untuk digunakan sebagai perubatan moden pada masa akan datang.
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CHAPTER 1 
INTRODUCTION 
Today, herbal medicine plays a prominent role in our health and it has become 
almost as essential as modern medicine. However, traditional herbal medicine has not 
been standardized in its usage mainly because it has not been very much explored.  Herbal 
medicine is a traditional form of treatment performed by locals who gather raw 
ingredients from one or more plants and apply them as therapeutic treatments or as 
medication. 
Moreover, herbal medicine has contributed enormously to human healthcare and 
this has been increasingly acknowledged in medical practice for generations (Farnsworth 
et al., 1985). An estimate by the World Health Organization (WHO) indicated that up to 
80% of the world’s population still relied on traditional herbal medicine as their primary 
source of healthcare. Traditional herbal medicine has been used to maintain and promote 
human health, as well as to prevent or reduce symptomatic disorders and to date herbal 
medicine has made great contributions to healthcare in general. 
Furthermore, herbal medicine has played a key role in the world’s pharmaceutical 
products companies. Therefore, it follows that there is a high demand for natural or herbal 
medicine in the global market. Approximately 10,000 plants have been listed as medicinal 
plants but only 300 species are used commercially in traditional medicine. Several 
researchers are currently investigating their values scientifically in order to study their 
medicinal properties. In the current research, several classifications have been 
implemented in order to define and classify herbal medicine.  
Indonesia has an abundance of natural resources and one of its most important 
features has always been its abundant plant life (Jemal et al., 2007). Traditional herbal 
medicine has been used by the Indonesian society since ancient times where knowledge 
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has been passed down from generation to generation. Traditional herbal medicine has 
been a cultural mainstay in Indonesia for a good many centuries as it is believed to help 
locals maintain their health as well as to treat diseases. Despite the increasing awareness 
of modern medical treatments, traditional herbal medicine still remains as a popular 
choice in Indonesia.  
In this study, the focus was on a plant known as Phaleria macrocarpa which is 
renowned in Indonesia for its ability to treat a variety of ailments including cancer, 
diabetes mellitus, allergies, cardiac problems, hepatic diseases, kidney failure, 
hypertension, skin diseases, and many others (Harmanto et al., 2002; Jemal et al., 2007). 
The fruits and leaves of the P. macrocarpa are most commonly consumed in traditional 
medicine when mixed with other medicinal plants. Its seeds, however, are very toxic and 
they produce an unpleasant smell. It is, however, used in Indonesia to treat skin diseases. 
 The fruits and leaves of the Phaleria macrocarpa contain alkaloids, saponins, 
flavonoids, polyphenols, triterpenoids and many other components. The seeds on the 
other hand contain alkaloids, triterpenoids and coumarin groups (Hartani et al., 2005) as 
well as steroids (Susanthy et al., 2005). The major flavanoids present in the pericarp are 
kaempferol, myricetin, naringin and rutin and those found in the seeds and mesocarps are 
naringin and quercetin (Rudi et al., 2011). Ethyl acetate fractions derived from the flesh 
of the fruit contains flavonoids, triterpenoids and coumarin groups (Hartati et al., 2005). 
The major components of the flavonoids contained in the fruits of P. macrocarpa 
have been shown to be useful for blood circulation and in preventing blockages of blood 
vessels, the lowering of cholesterol levels, reducing fat collected in blood vessel walls, 
and also in lowering the risk of coronary heart disease. They also contain anti-
inflammatory agents and antioxidants, and help alleviate pain if there is bleeding or 
swelling. It is believed that the flesh of the P. macrocarpa (Mahkota Dewa) fruit contains 
anti-oxidative compounds that can fight cancer.  
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In addition, a powder derived from the dried flesh of the P. macrocarpa fruits has 
been used for medicinal purposes where it was reported to remedy dysentery, diabetes 
mellitus, hypertension, cancer and certain skin diseases (Harmanto et al., 2002). The fruit 
of the P. macrocarpa is potent in treating hypertension, diabetes, cancer and diuretic 
problems. It has a long history of pharmacological usage, and the lack of information 
about its biological activities has led to ongoing investigations (Hendra et al., 2011). 
Consumption of P. macrocarpa has a synergistic effect on Adriamycin-
cyclophosphamide treatment in decreasing the tumour growth and protects the kidney and 
liver from damage (Chong S.C al., 2011). Moreover, P. macrocarpa extract has been 
shown to reduce body weight, cholesterol, triglycerides and HDL LDL levels (Riwanto 
et al., 2011).     
The antibacterial, radical scavenging activities and cytotoxic properties of crude 
extracts from P. macrocarpa leaves have been reported by Andriani et al., (2011). Among 
the important sources of newer chemotherapeutic agents discovered were the chemicals 
derived from such herbal sources. Also, the use of complementary and alternative 
medicine such as botanical extracts is becoming increasingly popular among cancer 
patients (Harmanto, 2003 & Nahleh, 2003) while a number of phytochemicals have been 
proven to possess anticancer properties (Wong et al., 2005). 
With the various potential benefits reported for P. macrocarpa, the present study 
therefore was performed with the following main objectives:  
1. To examine the cytotoxicity of extracts and fractions from the fruits and seeds of 
P. macrocarpa in selected human cancer and non-cancer cell lines; 
2. To isolate bioactive compounds from the fruits and seeds of P. macrocarpa;  
3. To elucidate the structure(s) of the chemical components of the active extract by 
using spectroscopic and spectrometric methods (GC-MS, LC-MS/MS and NMR 
analysis);  
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4. To investigate the cytotoxic activity of bioactive compounds isolated from 
objectives (2) and (3) by determining the effects of the compounds on human 
colon cancer cells (HT-29) and human fibroblast cell line (MRC-5);  
5. To identify the molecular pathways of apoptosis effected/involved following 
treatment of cancer cell lines (HT-29 and MRC-5) with bioactive compounds 
from P. macrocarpa through cell cycle analysis and morphological examination 
of cancer cells.   
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Figure 1.1: Flow chart of research proje
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Figure 1.1: Flow chart of Experimental A proach.  
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CHAPTER 2 
LITERATURE REVIEW 
2.1. Cancer  
Cancer is a major public health problem all over the world. Cancer refers to a 
family of diseases in which tissues grow and spread uncontrollably throughout the body, 
and can gradually become fatal (Lewis, 2003). Cancer comes in the form of abnormal 
cells which multiply in an uncontrolled fashion and it can spread throughout the body. 
Such cells can emerge in a variety of tissues and organs, and each of these sites may carry 
different cell types that have been or are currently receiving the impact of the disease 
(Farnsworth et al., 1985).   The net result of this is more than a hundred types of cancer 
distinguishable from one another on the basis of their original location and the cell type 
that is involved (Farnsworth et al., 1985).   
Cancers are caused by multiple factors; namely genetic and environmental factors, 
diet and lifestyle factors, which include smoking, alcohol consumption, stress, lack of 
exercise and so on. Cancer brings about significant morbidity and mortality and poses a 
major public health problem worldwide (Lewis, 2003). The most common types of cancer 
are breast and prostate cancers followed by lung, colon, bladder, and lymphoma.  
2.2. Carcinogens 
The term carcinogen refers to a substance directly involved in causing cancer. A 
substance that elevates the risk of cancer, while not directly causing it, is called 
carcinogenic. While a great many substances are thought to cause cancer, a substance 
may only be called carcinogenic if ample evidence has been found to prove its 
carcinogenicity. Carcinogens react with DNA (deoxyribonucleic acid) by inciting deadly 
alterations or by causing the rate of cell division to escalate erratically. This alteration in 
the regularity of cell division may subsequently increase the probability of intrinsic 
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changes in DNA (Deorukhkar et al., 2007). Evidence of the correlation between exposure 
to alleged carcinogens and the advancement of cancer itself is worthy of consideration 
(Hanaha et al., 2000). Commonly known carcinogens include certain types of pesticides, 
radon, asbestos, arsenic, and cigarette smoke. Ironically, certain substances that are 
beneficial such as chlorine (used to disinfect water) may also be carcinogenic where its 
by-products have been found to cause a variety of diseases. 
It is interesting to note that one of the major known carcinogens emanates from 
an element necessary to life itself. The ultraviolet rays produced by the sun are 
carcinogenic as exposure to ultraviolet radiation has been found to cause an array of 
cancers affecting the skin. A substance cannot be said to be carcinogenic unless there has 
been prolonged and sustained human exposure to it. In addition to this, the breath taking 
number of substances said to be potential carcinogens is so immense that it has become 
increasingly difficult to ascertain exactly what is safe to use and consume. 
2.3. Carcinogenesis 
The process in which normal, healthy cells are mutated into cancer cells and thus 
contribute to the likely onset of cancer is known as carcinogenesis. Despite modern 
advances in cancer treatment as well as the increasing knowledge of its mechanisms, there 
is still a gap in understanding the molecular events preceding it. Twenty five years of 
scientific advancement in cancer research has resulted in a varied and detailed body of 
knowledge, where this deadly disease has been revealed to be the culmination of a number 
of dynamic alterations in the genome itself (Deorukhkar et al., 2007).   
Although carcinogenesis involves a complex interplay between genes, the 
environment and multiple cumulative mutational events are required for the progression 
from normal to a fully malignant phenotype. The quintessential traits of cancer cells are 
fundamental alterations in cell physiology that collectively dictate malignant growth 
(Hanaha et al., 2000).    
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2.4. Natural Products  
Natural products are derived from organic matters such as animals, plants, or 
microbes, and their pharmacological and biological potentials can be used to treat 
diseases. Natural products derived from plants in particular, have formed the very 
foundations of traditional medicine in many of the great civilizations of old, including 
Egypt, China, and India (Balandrin et al., 1993). The World health organization (WHO) 
has indicated that herbal medicine is still the primary choice for 80% of the world’s 
population. 
2.4.1. Bioactive natural products 
Each natural product has one or more bioactivity. Some may possess antioxidant, 
antimicrobial, antibacterial, antifungal, anti-cancer, anti-hypertensive and anti-diabetic 
activities.  
2.4.2. Natural products with anticancer activity  
The last 20 years has seen great strides in the never-ending battle to eliminate 
cancer. Our understanding of the various mechanisms of this disease has been greatly 
assisted by advances in cellular and molecular biology. Natural products have greatly 
contributed to the development of anti-cancer drugs and vaccines (Cooper. 1993).  
Most natural anticancer agents are secondary metabolites produced from one of 
the two protection mechanisms of the plant or from organisms which defend it from 
pathogens and growth regulations (Kintios & Barberaki, 2004).  These metabolites may 
constitute a compound cytotoxin or are capable of modulating tumor development 
(Kintios & Barberaki, 2004). These are just examples of the various natural compounds 
that have been found to have great potential in treating cancer through mechanism-based 
approaches which employ bioactive compounds.  
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2.5. Plants 
Although medicinal plants can be found worldwide, they are, however, most 
abundant in tropical regions. As such, classifying them systematically is important, in 
order to understand as well as to study them extensively and efficiently. The Phaleria 
macrocarpa (Scheff.) Boerl plant is one such medicinal plant and it originates from Irian 
Jaya, Indonesia. 
2.6. The P. macrocarpa plant  
P. macrocarpa belongs to the Thymelaeceae family and is called Mahkota Dewa 
in Indonesia which means 'God's Crown' in the Indonesian language. The name given to 
this fruit infers that it came from heaven, as a benediction from divinity to help mankind.  
The P. macrocarpa plant is perennial and is usually planted to provide shade. It 
is of medium size and its height can reach up to four meters. Its stem is full of sap and 
has a greenish brown bark, a white stem, taproots and also, flowers, leaves, fruits and 
seeds. Its small flowers are white and have a pleasant smell; physically, it resembles the 
clover. Moreover, all parts of the P. macrocarpa, namely the flesh of its fruits, seeds, 
leaves and stem, are beneficial components commonly used in herbal medicine.  
 
Figure 2.1: The P. macrocarpa (Scheff.) Boerl plant. 
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2.6.1. The Fruit of P. macrocarpa  
The fruit of the P. macrocarpa consists of a skin which is bright red, flesh, shell 
and seeds. It has white flesh, which is fibrous and watery (Figure 2.2). The flesh is round 
in shape, of orbicular to apple size (3-5cm), has a smooth surface, and dull green in color 
when young but becomes red when ripened. The fruits grow on the trunks and branches 
of the trees and has very short stalks making it look like it is attached to the branches.  
 
Figure 2. 2: The fruit of the  P. macrocarpa (Scheff.) Boerl  
(http://farmasi.ugm.ac.id). 
2.6.2. The Leaves of P. macrocarpa  
The leaves of the P. macrocarpa are long, thin and oval, with a long, sharp edge 
and are flat and smooth. The Indonesian people utilize them as tea leaves and as 
traditional medicine since ancient times (Figure 2.3). 
 
Figure 2.3: The leaves of the P. macrocarpa (Scheff.) Boerl 
 (http://farmasi.ugm.ac.id). 
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2.6.3. The Seeds of P. macrocarpa  
The seeds of the P. macrocarpa are oval with a diameter of about 1cm (Figure 
2.4). The outer part is brown and the inner part is white. The seeds are the most poisonous 
part but local people use them to treat skin diseases. 
 
Figure 2.4: The Seeds of P. macrocarpa (Scheff.) Boerl. 
 
2.7. Chemical components of P. marcrocapa  
The major chemical components of P. macrocarpa are flavonoids, alkaloids, 
saponins, tannins, and terpenoids. The n-hexane extract from the fruits of P. macrocarpa 
contains terpenoid compounds, whereas the ethanol extract of its fruits and seeds are 
composed of alkaloids, flavanoids and triterpenoids (Susanthy, 2005). The main 
flavonoid content in the pericarp, mesocarp, and seeds are  kaempferol, naringin, and rutin 
(Rudi et al., 2011). The bark contains alkaloids, terpenoids, flavonoids, polyphenols, 
saponins, resins, lignin and benzophenones (Harmanto, 2002). 2, 4’, 6-trihydroxy-4-
methoxybenzophenone 2-0-β-D-glucopyranoside has been isolated from the ethyl acetate 
extract of the bark (Winnarno, 2009).  
Wan-Joo Kim (Kim et al., 2010) reported that a mangiferin compound was 
extracted from the peel of the P. macrocarpa fruit by using subcritical water extraction. 
A new phenolic glycoside, mahkoside A, together with six known compounds including 
mangiferin, kaempferol-3-O-beta-D-glucoside, dodecanoic acid, palmitic acid, ethyl 
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stearate and sucrose have been isolated from the pit of the P. macrocarpa fruit (Oshimi 
et al., 2008). Also isolated were lignans pinoresinol, lariciresinol and matairesinol (Saufi 
et al., 2008). The chemical structures for these compounds are shown in Figure 2.5. 
 
Kaempferol 
 
Myricetin 
 
 
Mahkoside A 
 
Mangiferin 
Figure 2.5: Chemical structures of compounds reported present in P. marcrocarpa. 
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Quercetin 
 
Naringin 
 
 
Rutin 
Figure 2.5. Chemical structures of compounds reported present in P. marcrocarpa 
(Continued). 
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Kaempferol-3-O-beta-D-glucoside 
 
Sucrose 
 
Tamoxifen 
 
5-fluorourasil 
 
Dodecanoic acid 
Figure 2.5. Chemical structures of compounds reported present in P. marcrocarpa 
(Continued). 
O
O
OH O
OH
O
OH
OH
OH
OH
OH
O
O
O
OH
OH
OH
CH2OHHOH2C
CH2OHOH
OH
CH3
O
N
CH3
CH3
N
H
NH
OO
F
CH3
OH
O
15 
 
 
Palmitic acid 
 
Ethyl stearate 
Figure 2.5. Chemical structures of compounds reported present in P. marcrocarpa 
(Continued). 
2.7.1. Chemical components of P. macrocarpa leaves 
It has been reported that the leaves of the P. macrocarpa contain alkaloids, 
terpenoids, flavonoids, polyphenols, saponins, resins, lignins and benzophenones 
(Harmanto, 2002). Phalerin (4, 5-dihydroxy benzophenone-3-O-β-D-glucopiranoside has 
been obtained from the methanol extract of  P. macrocarpa leaves (Hartati et al., 2005). 
A more recent study reported that 2, 6’, 4-trihydroxy-4-methoxybenzophenone could also 
be obtained from the ethyl acetate extract of P. macrocarpa (Susilawati et al., 2011). 
Chemical structures of compounds extracted from P. macrocarpa leaves are shown in 
Figure 2.6. 
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2, 4’, 6 -Trihydroxy-4-methoxybenzophenone 
Figure 2.6: Chemical structures of compounds reported present in P. marcrocarpa 
leaves. 
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2, 4’, 6-Trihydroxy 4-methoxy benzophenone 3-O-β-D-glucoside  
Figure 2.7: Chemical structures of compounds reported present in P. marcrocarpa 
leaves. (continued) 
2.7.2. Chemical components of P. macrocarpa seeds 
The seeds of the P. macrocarpa fruit contain alkaloids, triterpenoids and coumarin 
groups (Hartati et al., 2005). Other studies have reported that the seeds also contain 
steroids (Susanthy, 2005) as well as quercetin and naringin (Hendra et al., 2011). The 
essential oils of the P. macrocarpa seeds contain heptadecane, octadecane, eiclosan, 
triclosan, vinyl laurate, and dioctyl ester (Wijayani, 2005).  
Prior studies have reported that mahkoside A and kaempferol 3-O-β-D-glucoside 
have been isolated from the seeds of P. macrocarpa (Zhang et al., 2006).  Other studies 
have shown that a new 29-norcucurbitacin, desacetylfevicordin A have been isolated from 
the ethyl acetate fraction of the P. macrocarpa seeds, together with three known 29-
norcucurbitacin derivatives, namely fevicordin A, fevicordin A glucoside and fevicordin 
D glucoside. (Kurnia et al., 2008). Chemical structures of compounds isolated form P. 
macrocarpa seeds are shown in Figure 2.7. 
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Figure 2.7: Chemical structures of compounds reported present in P.  macrocarpa seeds 
 
CH3
CH3
O
OHCl
Cl Cl
CH3
O CH2
O
O
OH
OOH
OH
OH
OH
18 
 
 
Desacetylfevicordin A 
 
Fevicordin A 
 
Fevicordin A glucoside 
 
Fevicordin D glucoside 
Figure 2.7: Chemical structures of compounds reported present in P.  macrocarpa seeds 
(Continued). 
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2.7.3. Chemical components of P. macrocarpa fruits 
The chemical components of the P. macrocarpa fruits include alkaloids, saponins, 
flavonoids, and polyphenols. Researches looking at the content of ethyl acetate fraction 
noted that flavonoids, triterpenoids and coumarin groups (Hartati et al., 2005) could be 
derived from the P. macrocarpa fruit. The essential oils identified in the fruits of P. 
macrocarpa include octadecane, triclosan, octacosane, dioctyl ester and tributyl ethyl 
citrate (Wijayani, 2005).  
6, 4’-Dihydroxy-4-methoxybenzophenone-2-0-α-D-glucoside was isolated from 
the butanol extract of the P. macrocarpa fruit (Tambunan & Simanjuntak, 2006). Gallic 
acid, with anticancer properties has also been isolated from the fruit (Faried et al., 2007). 
In addition, prior studies have reported that P. macrocarpa fruits contained icariside C3, 
phalerin, and mangiferin (Oshimi et al., 2008). 
Synthesis of the benzophenone glucopyranosides of P. macrocarpa has been 
successfully carried out and it was found to possess the same structure as 2, 4’, 6-
trihydroxy-4-methoxybenzophenone 2-0-β-D-glucopyranoside (Hendra et al., 2009). A 
more recent study reported that 2, 6’, 4-trihydroxy-4-methoxybenzophenone was derived 
from the ethyl acetate extract of the P. macrocarpa fruit (Aripin et al., 2011). All chemical 
structures of compounds isolated from P. macrocarpa fruits are shown in Figure 2.8. 
CH3CH3
 
Octadecane 
 
Triclosan 
Figure 2. 8: Chemical structures of compounds reported present in P. macrocarpa fruit. 
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Dioctyl ester, Hexanedioic acid 
 
Acetyl tributyl citrate 
 
Icariside C3 (sesquiterpene glucoside) 
Figure 2.8, Chemical structures of compounds reported present in P. macrocarpa fruit 
(Continued). 
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Phalerin (4, 6- Dihydroxy-4'-methoxybenzophenone-3-O-β-D-glucopiranoside) 
 
Mangiferin (Xanthone glycoside) 
 
2, 6, 4’-Dihydroxy-4-methoxybenzophenone 
 
 
4’, 6- Dihydroxy-4-methoxy benzophenone-2-O-β-D-glucoside 
 
4’, 6-Dihydroxy-4-methoxy benzophenone 2-0-β-D-glucopyranoside 
Figure 2.8, Chemical structures of compounds reported present in P. macrocarpa fruit 
(Continued). 
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4′, 6-Dihydroxy 4-methoxy benzophenone-2-O-β-D-glucoside 
 
Phalerin 
Figure 2.8, Chemical structures of compounds reported present in P. macrocarpa fruit 
(Continued). 
2.8. Bioactivity of P. macrocarpa  
The appreciable amount of phenolic and flavonoid compounds found in the 
pericarp and mesocarp of the P. macrocarpa fruit meant that they potentially possessed 
good antioxidant and anti-inflammatory activities. Extracts from the pericarp, mesocarp, 
and seeds have also been shown to display cytotoxic activity in HT-29, MCF-7 and HeLa 
cell lines (Hendra et al., 2011). 
2.8.1. Bioactivity in P. macrocarpa leaves 
The leaves of the P. macrocarpa are most commonly used as tea leaves in 
Indonesia. The leaves are reputedly said to be effective in increasing sexual drive and 
curing dysentery, allergies and tumors. Studies have shown that the chloroform extract of 
the P. macrocarpa leaves were toxic to the larvae of Artemia salina (Novetiana, 2002). 
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The methanol extract of the P. macrocarpa leaves displayed cytotoxic effect in Brine 
Shrimp Lethality assay and isolated phalerin is cytotxic to the NS-1 myeloma cell line 
(Kurnia et al., 2008)  
The crude methanolic extract of the P. macrocarpa leaf showed good activity 
against Pseudomonas aeroginosa, Bacillus cereus and Streptococcus aureus, and the 
ethyl acetate extract of the P. macrocarpa leaf showed strong activity against 
Pseudomonas aeroginosa, Bacillus cereus and Streptococcus aureus when using the 
Mueller Hinton agar well diffusion method (Andriani et al., 2011). The radical 
scavenging activity of four crude extracts obtained from the P. macrocarpa leaves and 
the active crude cytotoxic properties present in the HepG2 cells have also been 
investigated (Andriani et al., 2011). 
2.8.2. Bioactivity in P. macrocarpa seeds 
The seeds of P. macrocarpa are very toxic and they have an unpleasant taste but 
are nevertheless, used in Indonesia. It has been shown that the chloroform extract of P. 
macrocarpa seeds has an LC
50 
5.113.10
-4 
± 3.213.10
-5 
μg/mL (Sumarningsih, 2002). In 
addition, the ethanol extract of the P. macrocarpa seeds has higher cytotoxicity than 
extracts from the flesh of the fruit (Astuti et al., 2007). 
Ethanol extracts of the P. macrocarpa seed and fruit have been found to be non-
toxic to normal human peripheral blood mononuclear cells, but slightly toxic to the vero 
cell line (Astuti et al., 2007). The ethanol extract from the P. macrocarpa seeds and fruits 
have also been shown to be toxic towards the T47D breast cancer cell line through the 
inhibition of COX-2 expression with an LC
50 
15.12 ± 3.21 μg/mL (Bakhriansyah, 2004). 
The ethanol extract of the P. macrocarpa seeds and flesh of the fruit increased p53 gene 
expression but had no effect on Bcl-2 gene expression. The n-hexane extract from P. 
macrocarpa seeds was more effective in increasing p53 gene expression than the flesh of 
the fruit, but it had no effect on Bcl-2 gene expression (Wardani, 2005). 
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2.8.3. Bioactivity of P. macrocarpa fruits  
The edible fruits of P. macrocarpa are most commonly consumed in traditional 
medicine when mixed with other medicinal plants. The fruits of this plant are used as 
alternative medicine in curing cancer, diabetes, nerve pain, kidney failure and disorder, 
liver dysfunction and skin diseases. It is also said to help lower cholesterol level, increase 
stamina and is used as an anti-narcotic. The flavonoids contained in the P. macrocarpa 
fruits are useful for blood circulation throughout the body, for preventing blockages in 
blood vessels, lowering cholesterol levels, reducing the gathering of fat in blood vessel 
walls, and also reducing the risk of coronary heart disease. It contains anti-inflammatory 
agents and antioxidants, which helps alleviate pain when there is bleeding or swelling. It 
is believed that the flesh of the P. macrocarpa fruit contains antioxidant compounds that 
can fight cancer. 
It has been shown that n-butanol, ethyl acetate, and methanol extracts from the 
ripe fruit of P. macrocarpa contained inhibitory activities against the in vitro α-
glucosidase enzyme (Sugiwati et al., 2009). A related study by the same researchers 
indicated that, the ethyl acetate extract derived from old P. macrocarpa leaves displayed 
higher inhibition activity as compared to young leaves. This is based on the α-glucosidase 
inhibition test,   
Gallic acid which was isolated from the fruits of P. macrocarpa exhibited 
cytotoxic activity against human esophageal cancer cells (TE-2) but showed no cytotoxic 
effect on non-cancerous cells (CHEK-1) (Faried et al., 2007).  Isolated icariside C3 of  P. 
macrocarpa displayed a vasorelaxant effect on rat aorta (Oshimi et al., 2008). P. 
macrocarpa also increased antioxidant enzyme activities and SOD, GPx and CAT 
activities while   decreasing lipid peroxidation (Triastuti & Choi, 2008). 
It has been shown that oral treatments using P. macrocarpa lowered blood glucose 
levels, decreased kidney hypertrophy and diminished blood urea nitrogen in diabetic rats. 
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Therefore, the anti-hyperglycaemic and anti-nephropathic properties of P. macrocarpa 
may be correlated to increased renal antioxidative enzyme activity in the kidney (Triastuti 
et al., 2009).  
The butanol fraction of P. macrocarpa fruits have been shown to significantly 
prevent an alloxan-induced diabetic state by enhancing hepatic antioxidant activity in 
animals which were treated with the fraction (Triastuti et al., 2009). A study by the same 
researchers indicated that the methanol extract of P. macrocarpa displayed anti-
nephropathic effects, which may have a correlation with the increase of renal antioxidant 
enzyme activity in alloxan-induced diabetic rats.  
The major compound - phalerin - displayed inhibitory effects on the propagative, 
migrative, and insidious tendencies of  human breast adenocarcinoma cells (MDA-
MB231) in a dose-dependent manner and it was found to reduce phosphoinositide-3 
(PI3)-kinase/protein kinase B (AKT) thus signalling a significant decrease  of the PI3K 
transcript level. This consequently lowered AKT phosphorylation (Tandrasasmita et al., 
2010). 
Previous research has shown that the ethanol extract derived from the fruit of P. 
macrocarpa has high toxicity against the HeLa cell line. The major compound present in 
this extract- phalerin - possessed potent biological activity as an anticancer agent via the 
down-regulation of the PI3-KI/AKT signalling pathway. Phalerin caused the down-
regulation of the NFkB transcript followed by the reduction of eicosanoid-related genes, 
which in turn caused the increase of cell arrest (Tandrasasmita et al., 2010). P. 
macrocarpa has also been shown to reduce weight gain, overall cholesterol levels, 
triglycerides, HDL and LDL levels. It also up-regulated the hepatic LDL receptor and 
contains PCSK9 proteins found in hyper-cholesterolemic rats (Chong et al., 2011). 
2, 6’, 4-Trihydroxy-4-methoxybenzophenone and 4’, 6-dihydroxy-4-
methoxybenzophenone 2-0-β-D-glucopyranoside extracted from the P. macrocarpa fruit 
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showed anti proliferation activity against the breast cancer cell line MDA-MB231. It also 
been shown to possess apoptosis-inducing activity (Aripin et al., 2011). Another 
researcher reported that P. macrocarpa extracts showed good hypoglycaemic and anti-
hyperglycemic effects in normal and diabetic rates (Rabyah et al., 2012).   
2.9. Apoptosis and Cancer 
Apoptosis is central to cancer treatment as its mechanism may be manipulated to 
promote the cell death of tumors. This section will detail the genes that suppress tumor 
formation and the oncogenes that promote the propagation of cancer cells. It also looks 
at how these two factors are connected to the apoptotic pathway.  
(http://www.biooncology.com).  
2.10. Apoptosis 
Apoptosis is a form of programmed cell death, used by multi-cellular organisms 
to rid themselves of extraneous cells. It differs from necrosis in that the former tends to 
last a lifetime and is beneficial to the body, while the latter is a form of cell death caused 
by severe cellular damage (Potten, 2004). 
Plasma membrane blebbing, chromatin condensation, and DNA shrinkage are 
among the more remarkable morphological features of apoptosis. These are preceded by 
caspase proteases induced from a complex group of cysteine protease activating multi 
sub-units called apoptosomes. Apoptosis can occur, for instance, when irreversible cell 
damage takes place (Kumar Sharad, 1998).The decision to perform apoptosis comes from 
the cell itself, the surrounding tissue, or cells produced from the immune system (Kumar 
& Sharad, 1998). 
It is estimated that apoptosis causes up to 50 to 70 billion cells to die every day in 
human adults. The morphological changes undergone during apoptosis include cell 
shrinkage, alterations in cell shape, condensation of cytoplasm, changes to the nuclear, 
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envelope changes, nuclear fragmentation, loss of cell surface structure, apoptotic bodies, 
cell detachment and phagocytosis of remains, as may be seen in Figure 2.9 (Potten, 2004). 
 
Figure 2.9: Morphological changes of apoptosis (Potten, 2004). 
2.11. Apoptotic Pathway 
One of the most sophisticated pathways ever discovered in cells is the apoptotic 
pathway as its activity is monitored and organized by the cell itself (John & Douglas, 
2011). Increased understanding of the inner workings of this pathway has led to 
innovative treatments of cancer and other diseases. Nevertheless, the mechanisms of the 
apoptotic pathway have yet to be completely understood (Figure 2.10).  
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Figure 2.10: Apoptotic pathways (http://www.scq.ubc.ca/apoptosis). 
 
2.11.1. Intrinsic pathway 
The intrinsic pathway is caused by mitochondrial stress, including damage to 
DNA and heat shock (Adrain et al., 2002). After the stress signal is received, the pro-
apoptotic proteins in the cytoplasm, Bax and Bid, bind themselves to the mitochondrion’s 
outer membrane to initiate the release of its inner contents (Adrain et al., 2002). 
However, this signal is not enough to trigger a complete release of the contents. 
In addition to Bax and Bid, the pro-apoptotic protein Bak is also required in order to fully 
release cytochrome c and the mitochondrion’s intra-membranal content (Hague & 
Paraskeva, 2004). Upon release, the cytochrome c forms a complex with adenosine 
triphosphate (ATP) and the enzyme Apaf-1. The complex will then activate the initiator 
protein caspase-9 upon formation (Figure 2.11).   
The activated caspase-9 then combines with the complex to form an apoptosome, 
which subsequently activates caspase-3, the effector protein that triggers degradation 
(Hague & Paraskeva, 2004). The intra-membrane content of the mitochondrion also 
contains apoptosis-inducing factor (AIF), which encourages DNA fragmentation, and 
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Smac/Diablo proteins which deter inhibitors of apoptosis (IAP) (Hague & Paraskeva, 
2004). 
 
Figure 2.11: Intrinsic pathway of apoptosis (http://www.biooncology.com). 
2.11.2. Extrinsic Pathway 
In the extrinsic pathway, apoptosis is induced by ligands (signal molecules), 
which bind themselves to trans-membrane death receptors on the target cell. An example 
of this would be the binding of FasL to Fas receptors (a death receptor) on the target cell 
which will trigger the aggregation of multiple receptors on the target cell’s surface (Figure 
2.12). 
The result of this receptor aggregation is the recruitment of the adaptor protein 
called the Fas-associated death domain protein (FADD) on the cytoplasmic side of the 
receptors (Csipo et al., 1998). Subsequently, FADD recruits caspase-8 to form the death-
inducing signal complex (DISC). Caspase-8 is activated via its recruitment to DISC, the 
result of which is that it is now able to directly trigger the activation of caspase-3, which 
will in turn, trigger the cell’s degradation. Active caspase-8 can also bind BID protein to 
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BID, which releases a signal for the release of cytochrome c in the intrinsic pathway 
(Adrain et al., 2002). 
 
Figure 2.82: Extrinsic Pathway of Apoptosis (http://wiki.geneontology.org). 
2.12. Cell Cycle 
The cell cycles, as well as the proteins linked to it, play an important part in the 
fate of a cell, including a cell’s death, function, and replication. Cell division refers to the 
equal distribution of DNA into two daughter cells. The normal amount of DNA is referred 
to as diploid or 2n, in reference to the two homologous chromosomes representing each 
chromosome type. 
The cell cycle consists of five stages: the S phase, during which DNA replication 
and synthesis occurs; the G1 phase, which is preceded by mitosis, and the level of DNA 
content is 2n; the G2 phase, which is when cells prepare for entry into mitosis, and the 
level of DNA content is 4n; the M phase, during which  the cell splits to produce two 
daughter cells; and the G0 phase gap, which is when cells reversibly retreated from cell 
division high cells due to high cell density or a lack of nitrogen (Figure 2.13). 
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Figure 2.13: Cell cycle analysis and cell cycle check point control 
(http://www.scq.ubc.ca). 
In addition, the G1, G2, and M phase also contain checkpoints. The G1 checkpoint 
or the point of restriction, guarantees that the cell is of a large enough size for division. It 
ensures that there are sufficient nutrients to support the daughter cells.  The G2 checkpoint 
checks that the DNA replication (which takes place during the S phase) is completed 
without incident. The final checkpoint, the metaphase checkpoint, guarantees that all 
chromosomes are firmly attached to a mitotic spindle by a kinetochore.  
2.13. Cell cycle in flow cytometry analysis 
Cell cycle arrest is one of the most important mechanisms in cancer treatment 
(Call et al., 2008; Dickson & Schwartz, 2009). It can be measured by DNA content levels. 
In addition to containing important genetic information, DNA is vital to the reproduction 
and the life and death of cells. DNA consists of two chromosome sets. While 2n DNA is 
present in the G0 and G1 phase, 4n DNA is present in the G2 and M phase, twice as much 
of the 2n number of chromosomes. The synthesized DNA in the S phase is replicated by 
using a flow cytometer.  
Measuring DNA content in cells is one of the first applications of flow cytometry, 
which is the first rapid phase identification of the cell cycle, aside from mitosis. Flow 
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cytometry analysis is reliant on the stoichiometric ability to stain DNA at the cellular 
level (as is indicated by the amount of DNA within the cell being directly proportionate 
to the amount of stain used) (www.phoenixflow.com). 
A variety of dyes with high binding tendencies to DNA are available for this very 
purpose. The type of dye determines where the dyes will bind on the DNA molecule. The 
blue-excited propidium iodide (PI), or ethidium bromide, and the UV-excited dyes 
diamidino-phenylindole (DAPI) and Hoescht 33342 and 33258 are most commonly used 
to stain DNA. Propidium iodide is an intercalating dye which binds itself to DNA and 
double-stranded RNA; this is why it is usually used together with RNase to eradicate 
RNA. DAPI and the Hoescht dyes bind themselves to the grooves of the DNA helix and 
have no binding affinity to RNA (www.phoenixflow.com).
33 
 
CHAPTER 3 
MATERIAL AND METHODS 
3.1. Plant Material 
The seeds and fruits of the Phaleria macrocarpa (Scheff.) Boerl were collected 
from Yogyakarta, Indonesia between July 2009 and 2011.   
3.2. Extraction and Fractionation of P. macrocarpa  
Dried samples (fruits without seeds: 1000g and seeds: 1660g) were ground into 
powder using an electric blender. The dried, ground samples were weighed and then 
soaked in 80% methanol for three days at room temperature. The resulting methanol 
extract was filtered with filter paper. The filtrate obtained was then poured into a beaker 
and anhydrous sodium sulphate was added to remove traces of water in the filtrate. The 
filtrate was then re-filtered and poured into a round bottomed flask to be evaporated at 
low pressure at 60 rpm to remove excess methanol. The result was a dark-brown, 
concentrated crude methanol extract. This extract was removed by using a spatula and 
placed into a vial and then kept in the refrigerator. 
The crude methanol extract was initially fractionated with hexane in a round 
bottomed flask. The hexane-containing extract was then poured into a beaker and 
anhydrous sodium sulphate was added. The mixture was filtered with filter paper. The 
filtrate was poured into another round bottomed flask and the solvent was evaporated by 
using a rotary evaporator to produce the hexane fraction. The sticky dark hexane fraction 
was taken out with a spatula and placed in a vial and then placed in the refrigerator. The 
hexane-insoluble residue was then extracted with chloroform to produce a chloroform-
soluble fraction and a chloroform-insoluble residue. It was then filtered with filter paper 
and subjected to evaporation under pressure to remove excess solvent. The chloroform 
extract was taken out, placed in a vial and kept in the refrigerator. 
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The chloroform-insoluble fraction was partitioned between ethyl acetate and 
water. A mixture of ethyl acetate and water (1:1) was prepared and poured into the round 
bottomed flask containing the hexane-insoluble extract. The flask was shaken vigorously 
and separation was carried out in a separating funnel. The funnel was slightly shaken and 
the mixture was allowed to settle into the two layers. The top layer consisted of ethyl 
acetate whereas the bottom layer consisted of water. The water layer was separated by 
opening the tap of the funnel. The water layer was then collected in a beaker. 
 The ethyl acetate layer was poured into an Erlenmeyer flask. The water layer was 
returned to the separating funnel and the extraction of the components in the water layer 
was repeated using fresh ethyl acetate until the ethyl acetate part became colourless. It 
was then filtered using filter paper and subjected to evaporation under pressure to remove 
excess solvent. The ethyl acetate extract was taken out, placed in a vial and then kept in 
the refrigerator. The water fraction was dried through rotary evaporation and the hard 
sticky extract was put in a vial and then kept in the refrigerator for further bioactivity 
assay. 
3.3. In vitro cytotoxicity assay 
3.3.1. Cell lines and culture medium 
MCF-7 (hormone-dependent breast carcinoma cell line), HT-29 (colon carcinoma 
cell line), Ca Ski (cervical carcinoma cell line), A549 (human lung carcinoma cell line), 
SKOV-3 (human ovarian carcinoma cell line) and MRC-5 (non-cancerous human 
fibroblast lung cell line) were purchased from the American Tissue Culture Collection 
(ATCC, USA).  
MCF-7, HT-29, Ca Ski and A549 cells were maintained in RPMI 1640 medium 
(Sigma), SKOV-3 cells in Dulbecco’s Modified Eagle’s Medium (DMEM; Sigma) and 
MRC-5 cells in Eagle Minimum Essential Medium (EMEM; Sigma), supplemented with 
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10% Fetal bovine serum (FBS), 100μg/ml penicillin or streptomycin (P/S) and 50μg/ml 
of kanamycin/amphotecerin B.  
3.3.2. Trypan blue exclusion test 
Trypan blue is a stain that only enters across the membrane of non-viable/dead 
cells. After detaching cells from the tissue culture flask by trypsinization, the cell 
suspension was mixed with trypan blue solution. Three to five minutes later, the colored 
(non-viable) and dye-excluding (viable) cells were counted and the percentage of viable 
cells determined. 
3.3.3. Selectivity Index  
The selectivity index (SI) value was determined according to Mahavorasirikul et 
al., 2010. “The selectivity index (SI) value indicates cytotoxic selectivity of the sample 
to the cell lines tested. The methanol extract and all fractions with a selectivity index of 
more than three were considered to have high selectivity” (Mahavorasirikul et al., 2010).  
The selectivity index (SI) was calculated according to the following formula:  
Selectivity Index (SI) =
IC50 value of normal fibroblast cell line
IC50 value of cancerous cells 
 
3.3.4. In vitro neutral red cytotoxicity assay 
The cell’s sensitivity to the P. macrocarpa seed extracts was determined by the 
neutral red assay by using the Borenfreund and Puerner method with some modifications 
as previously described (Borenfreund, 1984; Malek et al., 2011). In brief, “the cells were 
detached from the tissue culture flask (Nunc.Wiesbaden, Germany) with 0.25% of 
trypsin-EDTA solution and phosphate buffered saline (PBS) solution and then washed in 
culture medium. The cell pellet was obtained by centrifugation for 5min at 1000rpm. 
After trypsinization, the total cell count from the culture flask was estimated by 
using a haemocytometer. The individual wells of a 96-well plate (Nunc. Wiesbaden, 
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Germany) were inoculated with 200µl medium containing 3 x 103 cells. The plate was 
incubated in a CO2 incubator at 37
●C for 24h to allow the cells to adhere and achieve 60-
70% confluence. After 24h of incubation, the cells were treated with different 
concentrations (1 µg/mL, 10 µg/mL, 50 µg/mL and 100 µg/mL) of the test extracts in 
three replicate tests. The plate was incubated for 72h at 37●C in a 5%CO2 incubator. 
After 72h, the media were replaced with a medium containing 50 µg/mL of neutral 
red. The plate was then incubated for another 3h to allow for uptake of vital dye into the 
lysosomes of viable and injured cells. The media was removed after incubation (3h) and 
the cells were washed with 200 µL of the neutral red washing solution and the dye was 
eluted from the cells by adding 200 µL of neutral red resorb solution. The plate was 
incubated for 30 minutes at room temperature with rapid agitation on a microtiter plate 
shaker (LT BioMax 500). Dye absorbance was measured at 540 nm by using an ELISA 
Microplate Reader (E-max Microplate Reader of Molecular Devices, USA). The 
cytotoxic effect of each test as determined from the three replicates was then evaluated 
based on the percentage of inhibition values. 
The percentage of inhibition (%) was calculated according to the following formula: 
Percentage of inhibition (%) =
OD control − OD sample 
OD control
x100% 
 
The cytotoxicity of each sample was expressed as ±IC50 value. The IC50 value is 
the concentration of test compounds that causes 50% inhibition or cell death, the average 
for three experiments was obtained by plotting the percentage of inhibition versus the 
concentration of test compounds. The extract that gave IC50 of 20 µg/mL or less was 
considered active (Swanson & Pezzuto, 1990). 
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3.3.5. In vitro MTT assay 
The MTT (3, 4, 5-dimethylthiazol-2-yl)-2-5-diphenyltetrazolium bromide) cell 
proliferation assay was performed as described by Mosmann (Mosmann, 1983).  In brief, 
the cells from a confluent tissue culture flask was spun at 1,000 rpm for 5 minutes and re-
suspended with 1.0 ml of growth medium. The density of the viable cells was counted 
using 0.4% of trypan blue exclusion dye in a haemocytometer with a microscope. The 
cells were seeded into each well on the microtiter plate and incubated in a CO2 incubator 
at 37C for 24h to allow the cells to adhere and achieve 70-80% confluence. After 24h, 
the media was removed and each extract, at varying concentrations of 1, 10, 25, 50 and 
100g/mL with 200l of 10% media, were added into the respective wells containing the 
cells. The assay was carried out in triplicates. Wells containing untreated cells were used 
as a negative control. After 24h, 48h, and 72h, each well was added with 10L MTT stock 
solution via the mitochondrial dehydrogenase of intact cells into a purple formazan. The 
amount of formazon was determined by measuring the absorbance at 540nm by using an 
ELISA plate reader. The cytotoxicity of each sample is expressed as ±IC50 value.  
The percentage of inhibition (%) was calculated according to the following formula: 
Percentage of inhibition (%) =
OD control − OD sample 
OD control
x 100% 
3.4. Instrumentation 
3.4.1. Column chromatography 
All solvents except those used for the seed and fruit extractions are of AR grade. 
Silica gel 60 (70-230 mesh) was used for column chromatography. The ratio of silica gel 
to the sample was approximately 30:1. The gel was made into a slurry with a suitable 
solvent before being packed into glass columns. The glass columns used were of various 
dimensions; a 7cm x 60cm dimension column was utilized for the fractionation of the 
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crude extract, and a 3cm x 60cm and 2cm x 60 cm dimension columns were used for the 
separation of compounds from partially purified fractions. 
3.4.2. Thin layer chromatography (TLC) 
Glass-supported silica gel 60 F254 plates were used for thin layer chromatography 
(TLC). TLC spots or bands were visualized or examined under ultraviolet light (254nm 
and 365nm).  
3.4.3. Preparative Thin Layer Chromatography (Prep-TLC)  
Silica gel 60 F254 was used in preparative thin layer chromatography on 20cm x 
20cm plates, with a layer thickness ranging from 0.25mm to 1mm, depending on the 
amount of sample to be worked upon. 
3.4.4. Gas Chromatography-Mass Spectrophotometry (GC-MS) 
GC-MS was performed as described by Malek et al., (2011). Briefly, GC-MS was 
used to determine the molecular weight of the components collected and the purity of the 
collected compounds. The oven temperature was programmed with an initial temperature 
of 100 ̊C, which was then increased at a ramp rate of 5 ̊C/min; culminating in a final 
temperature of 300 ̊C. The carrier gas or mobile phase being used was helium which was 
programmed at a flow rate of 1 mL/min. The mass spectrometry mode used was the 
electron ionization (EI) mode with a current of 70eV. The injection mode was 
programmed with the sample injection volume of 1μL via a split mode with a ratio of 
1:20. The injection port temperature was set to 230 ̊C and the detector/interface 
temperature was set to 250 ̊C.  
3.4.5. Nuclear Magnetic Resonance (NMR) 
NMR was used in the study to obtain the 1D NMR 1H and NMR 13C with a 
frequency of 270MHz and 67MHz, respectively. The spectrum obtained was compared 
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with the literature. The structure of the compounds was then determined. The physical 
data of the isolated compounds were obtained from the following instruments: 
NMR analysis was carried out on the JEOL JNM-LA FT-NMR system with 
deuterated chloroform (CDCl3) or deuterated methanol as solvents. Chemical shifts were 
reported in ppm on scales and coupling constants were given in Hz.  
3.5. Extraction, isolation and identification of chemical constituents from 
bioactive extracts of P. macrocarpa  
3.5.1. Separation of Compounds using Column Chromatography  
A glass column with a height of 60cm and an internal diameter of 6.5cm was 
cleaned and prepared. The silica gel was soaked in hexane. Bubbles were removed and 
the silica gel was allowed to soak overnight, after which it will be referred to henceforth 
as slurry. The packing of the column was done when the slurry was ready for use. A small 
piece of cotton was inserted into the tubing area. Next, a layer of sea sand was added to 
create a smooth straight layer so that when silica gel slurry is added to the column, it 
would not be affected by the impact of the added silica gel, and would have a straight and 
stable level. Some solvent was added into the column with a quantity of around 20% of 
the column length.  
The slurry was poured into the column little by little until it reached about 65-70% 
of the column height. The slurry was left to settle and the column was packed until a 
stable elution rate was obtained. Samples were prepared by diluting them in a polar 
solvent and the silica gel was then mixed with the sample to facilitate application to the 
column. The ratio of silica gel to sample was 1:50g. Another layer of sand was poured on 
top of the sample to avoid any contamination of the sample. The eluent was slowly passed 
through the column. The silica gel should always be submerged in solvent. This is because 
if the column lacks solvent, the silica gel would affect the separation of the compounds.  
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The flow rate of column can accelerated by adding more solvent on top of the 
column and it could be decreased by adjusting the tap at the base of the column. A conical 
flask is placed at the bottom of the column to collect the eluent in the form of fractions 
and the eluent is then transferred into a round bottomed flask to be evaporated before 
obtaining the eluted component.  
After evaporation, the eluted component/components was dissolved with a small 
volume of chloroform and transferred into a small vial and covered with aluminium foil 
which has a few holes in it. It was then left overnight so that any remaining solvent would 
evaporate. The elution of components from the column was monitored by TLC. Polarity 
is added by adding an ethyl acetate solvent. Hence, from this investigation, the solvent 
that was used for pouring into the column was prepared accordingly with increasing 
polarity.  
3.5.2. Combining eluent fractions obtained from column chromatography 
Fractions were collected concurrently from the column. Thin layer 
chromatography (TLC) was performed. Spots that appear in each fraction were compared. 
The fraction which showed approximately the same spots between the neighbouring 
fractions were identified and grouped together. The fractions with a similar pattern of 
spots in the TLC plates were combined. 
3.5.3. Isolation of bioactive compound(s)  
Active fractions from the column were tested for bioactivity using cytotoxicity 
assay. If the extracts produced positive results, the chemical components present in the 
active fraction/fractions were identified by using spectroscopic and spectrometric 
methods.  
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3.6. Morphological changes associated with apoptosis  
3.6.1. Inverted and phase-contrast microscopy 
The induction of apoptotic death of selected cell lines by P. macrocarpa can be 
investigated for morphological features typical to apoptotic cells. This was performed 
using an inverted and a phase contrast microscope. HT-29 cells were placed in a petri dish 
(30mm) at a density of 1 x 105 cells/well plate and grown for 24h. A test compound was 
then added at the IC50 value and the cells were further incubated for 24h, 48h and 72h, 
respectively. After the various incubation periods, morphological changes in the apoptotic 
bodies of the HT-29 cells were examined by an inverted and phase-contrast microscopy 
(Leica, Germany) and photographed. 
3.6.2. Fluorescence microscopy   
HT-29 cells at a density of 1 x 105 cells/mL were cultured in the petri dishes 
(30mm) for 24h. The next day, the cells were treated with compound and incubated for 
72h. After the incubation, the cells were detached with 0.25% accutase and phosphate 
buffered saline (PBS). The supernatant was then discarded and the cells were re-
suspended in 1mL of PBS. 100µLof the cells were incubated with 5µl of acridine orange 
(AO) and 5µl of propidium iodide (PI) for 10 min at room temperature in a dark place. A 
total of 10µl of stained cells were placed into three wells of coated glass slides with 20µL 
of mounting media. They were stored at -20°C before analysis. These double stained cells 
were photographed under a fluorescent microscope (Leica, Germany). All experiments 
were performed in triplicates.  
3.7. Annexin V staining assay 
The quantification of cell death was determined by flow cytometry analysis using 
the Annexin V-FITC Apoptosis Detection Kit according to the manufacturer’s 
instructions (BD PharmingenTM, BD Bioscience, USA). In brief, 1x 106 of the HT-29 
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cells were seeded into each petri dish (30mm) and after 24h incubation, various 
concentrations of the test compound were added to different petri dishes and then 
incubated for 24h, 48h, and 72h, respectively. The cells were then washed with PBS, 
suspended in Annexin V binding buffer and then added to the Annexin V-FITC solution 
and propidium iodide (PI) for 10 minutes at room temperature. The samples were then 
analyzed by FACScalibur (BD Bioscience, USA) by using the CellQuest Pro Analysis 
software (Becton Dickinson, USA). 
3.8. Cell cycle analysis 
The cells were detached from the tissue culture flask with 0.25% of trypsin-EDTA 
solution and PBS solution and washed in a culture medium. The cell pellets were obtained 
by centrifugation at 1000rpm for 5 min. The density of the viable cells was counted with 
0.4% of trypan blue exclusion in a haemocytometer. A total of 5 × 105 of the cells were 
then seeded into 1ml of 10% medium  per petri dish in a 60cm3 petri dish (SPL). The dish 
was incubated in a CO2 incubator at 37°C for 24h to allow the cells to adhere and to 
achieve 60-70% confluence. After 24h, the cells were treated with an IC50 value of each 
test agent and the dishes were then incubated for 24h, 48h, and 78h respectively at 37°C 
in a 5% CO2 incubator. 
After the incubation period, each dish was washed with PBS and the cells were 
then centrifuged at 2000rpm for five minutes. The cells were then re-suspended, mixed 
with PBS and the cell concentration was adjusted to 1×106 per mL and centrifuged at 
2000rpm for five minutes. The supernatant was then discarded. After centrifugation, the 
cells were fixed into each falcon tube by using 70% ethanol heated at 4°C for two hours 
or overnight.  
The cells were then washed with PBS in order to remove the fixing solution. 
Where necessary, the cell suspension was filtered once by using a 200 mesh sieve. Next, 
100uL of RNase was added to the cell suspension and the cells were incubated at 37°C 
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for 30 minutes. Then 400 µL of propidium iodide was added for staining and the cells 
were incubated at 4°C for 30min and protected from the light. Finally, the results were 
observed at 488nm of excitation wavelength by flow cytometry according to the Cycle 
TESTTM PLUS DNA Reagent Kit (Becton Dickinson, USA) protocol.  
The cells were sorted in a FACScalibur flow cytometer (BD, USA) by using the 
CellQuest Pro software (Becton Dickinson, USA) and a quantitative analysis of the cell 
cycle distribution was then conducted by using  a trial version of the ModFit LT software 
(version 4.0). The significance of the differences was analyzed by Student's t-test and the 
p value stated to be less than 0.5 was applied by using version 16.0 of the SPSS program. 
3.9. Data analysis 
The numbers of viable cells were counted by using a haemocytometer with trypan 
blue exclusion. The MTT tests were carried out in triplicates and were repeated at least 
three times. The data of the cytotoxicity assay were expressed as the mean ± standard 
derivations (SD) by using Microsoft Excel software. The mean ± standard derivations 
(SD) in each cell cycle phase as well as the Annexin V assay were also calculated. The 
results from the treated and untreated control cells were analysed by Student’s t-test. The 
statistical significance was considered when the p value is 0.05 by using version 16.0 of 
the SPSS program. 
3.10. Statistical analaysis 
Data from cytotoxicity assay, Annexin V assay and cells cycle analysis were 
analysed   using Microsoft excel software to determine standard deviation.  Statistical 
analysis was then performed on data from Annexin V assay and cell cycle analysis using 
SPSS 16.0 software.
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CHAPTER 4 
RESULTS AND DISCUSSIONS 
PART A: Extraction, Fractionations, Isolations and Identification of bioactive 
compounds from P. macrocarpa Seeds and Fruits 
4.1. Extraction and Fractionations 
The seeds and fruits of P. macrocarpa were collected in Yogyakarta, Indonesia in 
July 2009 and 2011. Both samples were extracted through a systematic procedure as 
shown in Figure 4.1. 
 
Figure 4.1: Procedure of extraction of P. macrocarpa seeds and fruits. 
 The collected materials were washed, dried in the oven and ground to a fine 
powder by using a blender. The air-dried and finely milled sample (1660 g of seeds and 
1000g of fruits without seeds) were exhaustively soaked in 80% aqueous methanol for 
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three days at room temperature. The dry methanol extracts were obtained after removing 
the solvent by evaporation under reduced pressure to produce a dark brown crude 
methanol extract (198.72g, 11.99% of seeds and 47.23g, 4.70% of fruits without seeds). 
The methanol extract was further extracted with hexane to give a hexane-soluble fraction 
(158.69g, 9.47% of seeds and 2.11g, 0.21% of fruits without seeds) and a hexane-
insoluble residue, which had been  extracted with chloroform in order to produce a 
chloroform-soluble fraction (7.28g, 0.43% of seeds and 3.12g, 0.31% of fruits without 
seeds). The chloroform-insoluble was then partitioned between ethyl acetate and distilled 
water (1:1, 500ml: 500ml) so as to produce an ethyl acetate soluble fraction (6.23g, 0.37% 
of seeds and 12.20g, 1.22% of fruits without seeds) and a water soluble fraction by using 
freeze drying. The extracts and all the fractions were concentrated by using a rotary 
evaporator (Buchi, USA) under reduced pressure at 45°C. The dried extracts were kept at 
-4°C for further tests. The yield of the extract from the seeds and fruits are shown in Table 
4.1.  
Table 4.1: Yield of extracts and fractions from P. macrocarpa seeds and fruits. 
 
 Material (g) Yield (g) % of yield 
From Seeds 1660   
Methanol extract   198.72 11.99 
Hexane fraction   158.69 9.47 
Chloroform fraction   7.28 0.43 
Ethyl acetate fraction   6.23 0.37 
Water fraction   26.62 1.60 
From fruits without seeds 1000   
Methanol extract   47.23 4.70 
Hexane fraction   2.11 0.21 
Chloroform fraction   3.12 0.31 
Ethyl acetate fraction   12.20 1.22 
Water fraction   29.8 2.90 
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The percentage yield of crude methanol extract was based on the weight of the 
dried and ground plant material. The yield of the crude methanol extract of P. macrocarpa 
seeds (11.99%) was higher than that of the extract from the fruits without seeds (4.7%). 
The highest yield was the hexane extract of the seeds (9.47%) and the lowest yield was 
the hexane extract of the fruits without seeds (0.20%). The chloroform extract had the 
lowest yield from the seeds (0.43%).  
4.2. Characterization and Identification of P. macrocarpa seeds 
4.2.1. Characterization and Identification of hexane fraction  
Six compounds were identified from the hexane fraction of P. macrocarpa seeds 
by using GC-MS, namely methyl stearate, oleic acid, methyl oleate, linoleic acid, methyl 
linolenate, palmitic acid and other minor components, as shown in Table 4.2.  
Table 4.2: Characterization and Identification of compounds from hexane fraction of   
P. macrocarpa seeds using GC-MS. 
No Chemical components Molecular 
weight 
(g/mol) 
% of area 
1 n-Hexadecanoic acid 
(Palmitic acid) 
256.42 8.46 
2 Octadecanoic acid, methyl ester 
(Methyl stearate) 
298.50 1.02 
3 9-octadecenoic acid (z)-, 
methyl ester (Methyl Oleate) 
296.27 17.76 
4 9,12-octadecadienoic acid, 
methyl ester  (Methyl linoleate) 
292.46 17.87 
5 9,12,Octadecatenoic acid, (z,z) 
–  (Linoleic acid) 
280.45 23.13 
6 Oleic acid 282.46 31.76 
 Total percentage of identified 
chemical components 
 95.66 
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4.2.2. Characterization and Identification of chloroform fraction 
A GC/MS analysis of the chloroform fraction of P. macrocarpa seeds showed the 
presence of methyl myristate, palmitic acid, methyl oleate, methyl linoleate, oleic acid, 
(z)- and 9,17-octadecadienal as shown in the Table 4.3. The total number detected 
components were only 92.43%. The rest were probably very polar and could not be 
resolved in the GC-MS analysis. 
Table 4.3: Characterization and Identification of compounds from chloroform fraction 
of P. macrocarpa seeds using GC-MS. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.2.3. Isolation of  chemical components in the  ethyl acetate fraction of P. 
macrocarpa seeds  
According to the results of the preliminary cytotoxicity screening of the MTT cell 
proliferation assay and the neutral red assay, the ethyl acetate extract of the P. 
No Chemical components 
 
Molecular weight 
(g/mol) 
% of area 
1 Methyl myristate 242.39 3.31 
3 n-Hexadecanoic acid 
(Palmitic acid) 
256.42 22.17 
4 9,12-Octadecadienoic acid, 
methyl ester (methyl linoleate) 
292.46 5.29 
5 9-Octadecenoic acid (z)-, 
methyl ester 
( Methyl oleate) 
296.27 6.21 
6 9,12-Octadecadienoic acid, (z, 
z)- (Linolenic acid) 
280.44 15.03 
7 Oleic acid 282.46 14.93 
8 9,17-Octadecadienal,(z)- 264.44 9.06 
 Other minor components  26.43 
 Total percentage of chemical 
detected components 
 92.43 
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macrocarpa seeds was identified as the bioactive extract. The ethyl acetate extract 
showed excellent cytotoxic activity in selected cancer cell lines, namely the human 
cervical epithelioid carcinoma cell line (Ca Ski),  the human hormone-dependent breast 
carcinoma cell line (MCF-7), the human colon epithelioid carcinoma cell line (HT-29), 
the human lung epithelioid carcinoma cell line (A549), the human ovarian carcinoma cell 
line (SKOV-3), the human hormone-independent breast carcinoma cell line (MDA-
MB231) and the non-cancer human fibroblast cell line (MRC-5). With these positive 
results, further chemical investigations were directed to the ethyl acetate extract of the P. 
macrocarpa seeds. 
The ethyl acetate fraction (5.60g) was subjected to silica gel column 
chromatography (300g) over Merck Kieselgel 60 (0.063-0.200 mm mesh size): initial 
elution with chloroform was followed by chloroform enriched with increasing 
percentages of acetone, and then monitored with TLC, to give several main fractions: 
SEF1 (1.3g) , SEF2 (0.92g), SEF3 (0.013g), SEF4 (0.28g), SEF5 (0.59g), SEF6 (0.42g), 
SEF7 (0.61g) and SEF8 (1.54g). β-sitosterol was obtained from fraction 3 and a mixture 
was obtained from fraction 4. Preparative TLC on fraction 4 using chloroform and ethyl 
acetate as developing solvent yielded (z)-9, 17-octadecadienal (6.2 mg) and n-
hexadecanoic acid (32 mg). These compounds were identified using GC-MS analysis and 
NMR techniques, where necessary (Figure 4.2). 
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Figure 4.2: Column chromatography separation for ethyl acetate fraction of P. 
macrocarpa seeds. 
Table 4.4 shows the chemical components detected in the ethyl acetate fraction of 
the P. macroacarpa seeds which comprise the 6.87% of the total ethyl acetate extract.  
The components identified were palmitic acid, β-sitosterol and (z)-9, 17-octadecadienal. 
These three compounds were identified based on the results of the GC-MS analysis. Only 
a small percentage of components were detected in the ethyl acetate extract by GC-MS 
analysis. The rest maybe polar and thus could be resolved under the condition of the GC-
MS analysis. 
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Table 4.4: Characterization and Identification of isolated compounds from ethyl acetate 
fraction of P. macrocarpa seeds using GC-MS. 
No Chemical components Molecular weight 
(g/mol) 
% Area 
1 n-hexadecanoic acid 
(Palmitic acid) 
256.42 12.32 
2 (z)-9,17-octadecadienal 264.44 6.87 
3 β-sitosterol 414.71 11.65 
 Total % of components 
detected 
 30.84 
4.2.4. Identification of chemical components in hexane and chloroform    
fractions of P. macrocarpa  
The mass-spectral data of the identified compounds in the hexane and chloroform 
fractions of the P. macrocarpa seeds and fruits are as follows. 
Methyl linoleate  
 
 
EI-MS m/z (%) : 
294 (3, [M] +, 263(2, [M-OCH3]
+, C18H31O1
+), 220 (1), 178 (2), 164(6), 150 (10), 
135 (11), 123 (12), 109 (25), 95 (58), 81 (82), 67 (100), 55 (86). The mass spectrum gave 
the molecular ion peak at m/z =294, which suggested that the molecular formula was 
C19H34O2 and this is consistent with methyl linoleate. A comparison with the NIST mass 
spectral library (NIST 05 MS library, 2002) and Adams (2001) confirmed this compound.  
 
CH3
O
CH3
O
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Methyl Stearate  
 
 
EI-MS M/Z (%): 
298 (5, [M+]), 267 (2), 255 (9), 213 (2), 199 (7), 185 (4), 157 (4), 143 (19), 129 
(8), 111 (4), 97 (9), 87 (77), 74 (100, C3H6O2
+), 55 (45). The mass spectrum gave the 
molecular ion peak, which suggested that the molecular formula was C20H40O2 of methyl 
stearate. A comparison with the NIST mass spectral library (NIST 05 MS library, 2002) 
and Adams (2001) confirmed this compound.  
Palmitic acid  
 
EI-MS M/Z (%): 
256 ([M]+,12), 227([M-CHO]+,2), 213 ([M-CHO-CH2]
+,10),199 ([M-CHO-
(CH2)2]
+,4), 185 ([M-CHO-(CH2 )3]
+,5), 171 ([M-CHO-(CH2 )4]
+,5), 157 ([M-CHO-
(CH2)5]
+,7), 143 ([M-CHO-(CH2)6]
+,3), 129 ([M-CHO-(CH2)7]
+,50), 73 
([(CH2)2COOH]
+,100), 60 (C2H4O2
+, 100). The mass spectrum gave the molecular ion 
peak, which suggested that the molecular formula was C16H32O2 of palmitic acid. A 
comparison with the NIST mass spectral library (NIST 05 MS library, 2002) and Adams 
(2001) confirmed this compound.  
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Oleic acid  
 
CH3 O
OH
 
EI-MS M/Z (%): 
282 (M+, 3), 264 ([M- H20]
+, 8), 256, 235 ([M- H20- C2H5]
+, 3), 222, 207, 193 
([M- H20- C2H5- C3H6]
+, 3), 180, 165, 151, 137, 123, 111, 97, 83, 69,55(100). The mass 
spectrum gave the molecular ion peak, which suggested that the molecular formula was 
C18H34O2 of oleic acid. A comparison with the NIST mass spectral library (NIST 05 MS 
library, 2002) and Adams (2001) confirmed this compound.  
Methyl myristate  
 
  
EI-MS M/Z (%): 
242 (M+, 30), 225 ([M-OH]+, 5), 213, 199 (15), 185 (10), 171 (8), 157 ( 8), 143 
(16), 129 (50), 73 ( 100). The mass spectrum gave the molecular ion peak, which 
suggested that the molecular formula was C1H30O2 of methyl myristate. A comparison 
with the NIST mass spectral library (NIST 05 MS library, 2002) and Adams (2001) 
confirmed this compound.  
Linoleic acid  
CH3 OH
O
 
EI-MS M/Z (%): 
         280 ([M]+ ,6), 195, 182,123, 109, 95, 81, 67 (100), 5.The mass spectrum gave the 
molecular ion peak, which suggested that the molecular formula was C18H32O2 of linoleic 
acid. A comparison with the NIST mass spectral library (NIST 05 MS library, 2002) and 
Adams (2001) confirmed this compound. 
O
O
CH3
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Methyl oleate  
 
O
CH3
O
CH3
 
EI-MS M/Z (%): 
296 (2, [M+]), 264 (7), 222(6), 180 (6), 166 (5), 151 (5), 137 (8), 123 (16), 111 
(18), 97 (40), 83 (43), 69 (58), 55 (100).The mass spectrum gave the molecular ion peak, 
which suggested that the molecular formula was C19H36O2 of methyl oleate. A 
comparison with the NIST mass spectral library (NIST 05 MS library, 2002) and Adams 
(2001) confirmed this compound.  
4.3. Characterization and Identification of components in the P. macrocarpa fruit 
extract and its fractions of P. macrocarpa 
4.3.1. Characterization and Identification of components in the hexane 
fraction of P. macrocarpa fruits 
Table 4.5 showed that the components identified present in the hexane fractions 
of the P. macrocarpa fruits using GC-MS analysis. Methyl myristate, palmitic acid, β-
sitosterol, methyl oleate, oleic acid, methyl linoleate and other minor components were 
identified. 
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Table 4.5: Characterization and Identification of compounds from the hexane fraction of 
P. macrocarpa fruits using GC-MS. 
No Chemical components Molecular 
weight (g/mol) 
% of 
area 
1 Methyl myristate 242.39 16.37 
2 n-Hexadecanoic acid 
(Palmitic acid) 
256.42 15.04 
3 9,12-Octadecadienoic acid, methyl 
ester   (methyl linoleate) 
292.46 5.59 
4 9-Octadecenoic acid (z)-, methyl 
ester 
(Methyl oleate) 
296.27 15.08 
5 Octadecenoic acid ,  (Oleic acid) 282.46 1.79 
6 β-Sitosterol 414.71 29.35 
7 Other minor components  3.00 
 Total percentage of chemical 
components detected 
 86.22 
 
4.3.2. Characterization and Identification of components in the chloroform 
fraction of P. macrocarpa fruits 
Table 4.6 showed that the chloroform fraction of the P. macrocarpa fruits yielded 
three chemical components, namely methyl myristate, oleic acid, beta-sitosterol and other 
minor components. These compounds were also identified by using the GC-MS 
technique. The total number detected components were only 79.80%. The rest were 
probably very polar and could not be resolved in the GC-MS analysis.  
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Table 4.6:  Characterization and Identification of compounds from chloroform fraction 
of P. macrocarpa fruits using GC-MS. 
No Chemical components Molecular 
weight 
(g/mol) 
% of area 
1 Methyl myristate 242.39 5.42 
2 9-Octadecenoic acid (z)-, 
(Oleic acid) 
282.46 10.29 
3 β-Sitosterol 414.71 14.38 
4 Other minor components  49.71 
 Total percentage of detected 
chemical components 
 79.80 
 
4.3.3. Separation and Isolation of components in the ethyl acetate fraction 
of P. macrocarpa fruits 
The results of the preliminary cytotoxicity screening of the MTT cell proliferation 
assay and the neutral red assay indicated that the ethyl acetate extract of the P. 
macrocarpa fruits were identified as containing bioactive compounds. The ethyl acetate 
extract showed cytotoxic activity in selected cancer cell lines, namely the human 
hormone-dependent breast carcinoma cell line (MCF-7), the human lung epithelioid 
carcinoma cell line (A549), the human ovarian carcinoma cell line (SKOV-3), the human 
hormone-dependent breast carcinoma (MDA-MB231) and the non-cancer human 
fibroblast cell line (MRC-5). Therefore, further chemical investigations were directed to 
the ethyl acetate extracts of the P. macrocarpa fruits. 
The ethyl acetate fraction (9.8g) was subjected to silica gel column 
chromatography (400g) over Merck Kieselgel 60 (0.063-0.200 mm mesh size): initial 
elution with hexane  was followed by ethyl acetate that was enriched with increasing 
percentages of acetone and monitored with TLC to give several major fractions: 
FF1(0.7g), FF2(0.79g), FF3(0.42g), FF4(0.7g), FF5 (0.5g), FF6(0.8), FF7(1.5g), 
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FF8(1.8g), and FF9 (2.3g) as shown in Figure 4.3. All the above compounds were 
identified by using GC-MS analysis, LC-MS/MS and NMR techniques where necessary.  
Figure 4.3: Column chromatography separation for ethyl acetate fraction of the P. 
macrocarpa fruits. 
The results of the ethyl acetate fraction conducted on  the P. macrocarpa fruits 
showed that this fraction contained palmitic acid, methyl palmitate, methyl oleate, oleic 
acid, methyl myristate, methyl linoleate, β-sitosterol, stigmast-4-en-3-one, flamenol, 
phenol, 2,4',6-Trihydroxy-4-methoxybenzophenone, 1-(2, 6-dihydroxy-4-
methoxyphenyl)-2-(4-hydroxyphenyl) ethanone, mixture containing Stigmast-4-en-3-
one and other unknown components as shown in Table 4.7. All compounds were using 
GC-MS analysis except compound which are 2, 4’, 6-trihydroxy-4-
methoxybenzophenone, 1-(2, 6-dihydroxy-4-methoxyphenyl)-2-(4-hydroxyphenyl) 
ethanone were also identified by using the NMR analysis. NMR spectra are included in 
appendix section. 
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Table 4.7: Characterization and Identification of compounds from ethyl acetate fraction 
of P. macrocarpa fruits using GC-MS, NMR techniques. 
No Components Molecular 
weight (g/mol) 
% of  area 
1 Phenol 94.11 7.10 
2 2,6-Dimethoxy phenol 154.16 3.09 
3 2-Methoxy phenol 124.14 2.45 
4 Methyl 3-phenyl 2-propenoic  acid 162.18 7.11 
5 Flamenol 140.14 5.10 
8 n-Hexadecanoic acid,(palmitic acid) 256.42 5.46 
9 Oleic acid 282.46 3.02 
10 β-Sitosterol 414.71 8.23 
12 2,4',6-Trihydroxy-4-methoxybenzophenone 260.24 5.89 
13 1-(2, 6-Dihydroxy-4-methoxyphenyl)-2-(4-
hydroxyphenyl) ethanone 
274.26 2.48 
14 mixture containing Stigmast-4-en-3-one 412.69  
 Other unknown and minor  components  29.67 
 Total percentage of chemical components  79.60 
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4.3.4. Identification of chemical components in the Hexane and 
Chloroform fractions of P. macrocarpa fruits from GC-MS analysis 
The mass-spectral data of the identified compounds in the hexane and chloroform 
fractions of the P. macrocarpa fruits are as follows. 
Palmitic acid  
 
EI-MS M/Z (%) : 
256 ([M]+,12), 227([M-CHO]+,2), 213 ([M-CHO-CH2]
+,10),199 ([M-CHO-
(CH2)2]
+,4), 185 ([M-CHO-(CH2 )3]
+,5), 171 ([M-CHO-(CH2 )4]
+,5), 157 ([M-CHO-
(CH2)5]
+,7), 143 ([M-CHO-(CH2)6]
+,3), 129 ([M-CHO-(CH2)7]
+,50), 73 
([(CH2)2COOH]
+,100), 60 (C2H4O2
+, 100). The mass spectrum gave the molecular ion 
peak, which suggested that the molecular formula was C16H32O2 of palmitic acid. A 
comparison with the NIST mass spectral library (NIST 05 MS library, 2002) and Adams 
(2001) confirmed this compound.  
Oleic acid  
CH3 O
OH
 
EI-MS M/Z (%): 
282 (M+, 3), 264 ([M- H20]
+, 8), 256, 235 ([M- H20- C2H5]
+, 3), 222, 207, 193 
([M- H20- C2H5- C3H6]
+, 3), 180, 165, 151, 137, 123, 111, 97, 83, 69,55(100). The mass 
spectrum gave the molecular ion peak, which suggested that a molecular formula was 
C18H34O2 of oleic acid. A comparison with the NIST mass spectral library (NIST 05 MS 
library, 2002) and Adams (2001) confirmed this compound.  
 
 
CH3 OH
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Methyl myristate  
  
EI-MS M/Z (%): 
242 (M+, 30), 225 ([M-OH]+, 5), 213, 199 (15), 185 (10), 171 (8), 157 ( 8), 143 
(16), 129 (50), 73 ( 100). The mass spectrum gave a molecular ion peak, which suggested 
that a molecular formula C15H30O2 of methyl myristate. A comparison with the NIST 
mass spectral library (NIST 05 MS library, 2002) and Adams (2001) confirmed this 
compound.  
Methyl oleate  
 
O
CH3
O
CH3
 
EI-MS M/Z (%): 
296 (2, [M+]), 264 (7), 222(6), 180 (6), 166 (5), 151 (5), 137 (8), 123 (16), 111 
(18), 97 (40), 83 (43), 69 (58), 55 (100).The mass spectrum gave a molecular ion peak at 
m/z 296, which suggested the molecular formula was C19H36O2 of methyl oleate. A 
comparison with the NIST mass spectral library (NIST 05 MS library, 2002) and Adams 
(2001) confirmed this compound. 
O
O
CH3
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4.4. Characterization and identification of isolated compounds from P. 
macrocarpa seeds and fruits  
4.4.1. Stigmast-4-en-3-one  
The P. macrocarpa seeds and fruits contained β-sitosterol as a major component. 
This compound was obtained from fraction 2 (FF 2) from P. macrocarpa fruits and this 
compound was identified using GC-MS analysis. 
 
EI-MS M/Z (%): 412 (M+), 398 (14), 370 (30), 355 (7), 327 (42), 314, 289, 271 (22), 257 
(32), 245, 229 (16), 215, 201, 187, 175, 161(36), 149, 137, 124, 107, 95 (12), 81 (38), 69 
(24), 55 (48), 43, 29. The mass spectrum gave the molecular ion peak at m/z 414, which 
was consistent with the molecular formula C29H48O for stigmast-4-en-3-one. A 
comparison with the fragmentation data from the NIST mass spectral library (NIST 05 
MS library, 2002) and Adams (2001) confirmed this compound.  
4.4.2. β-Sitosterol 
The P. macrocarpa seeds and fruits contained β-sitosterol as a major component. 
This compound was obtained from fraction 2 (FF 2) from P. macrocarpa fruits and 
fraction 3(SEF 3) from P. macrocarpa seeds. This compound was identified using GC-
MS analysis. 
 
CH3
CH2
CH3
CH3
CH3
CH3
CH3
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EI-MS M/Z (%): 414 (100, [M]+) 381 (40), 354 (8), 329 (44), 303 (40), 273 (20), 255 
(30), 231 (14), 159 (34), 273 (20), 255 (30), 231 (14), 159 (34), 145 (54), 133 (34), 119 
(32), 105 (46), 81 (38), 105 (46), 81 (38), 69 (24), 55 (48).The mass spectrum gave the 
molecular ion peak, which suggested that the molecular formula was C29H50O of β-
sitosterol. A comparison with the NIST mass spectral library (NIST 05 MS library, 2002) 
and Adams (2001) confirmed this compound.  
4.4.3. Palmitic acid 
The P. macrocarpa seeds contained palmitic acid as a major component and as a 
minor components in P.macrocarpa fruits. This compound was obtained from fraction 2 
(FF 2) from P. macrocarpa fruits and fraction 2(SEF 2) from P. macrocarpa seeds. This 
compound was identified using GC-MS analysis. 
  
The palmitic acid from the P. macrocarpa extract (C16H32O2; Mol.Wt: 256 m/z) 
spectroscopy displayed the molecular ion peaks at 256 that corresponded to the molecular 
formula C16H32O2. Ion peaks were also observed at m/z (%): 256 ([M]
+,12), 227([M-
CHO]+,2), 213 ([M-CHO-CH2]
+,10),199 ([M-CHO-(CH2)2]
+,4), 185 ([M-CHO-(CH2 
)3]
+,5), 171 ([M-CHO-(CH2 )4]
+,5), 157 ([M-CHO-(CH2)5]
+,7), 143 ([M-CHO-
(CH2)6]
+,3), 129 ([M-CHO-(CH2)7]
+,50), 73 ([(CH2)2COOH]
+,100), 60 (C2H4O2
+, 100). 
CH3CH3
HH
OH
CH3 H
CH3
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A comparison with the NIST mass-spectral library (NIST 05 MS library, 2002) and 
Adams (2001) confirmed this compound to be palmitic acid or hexadecanoic acid. 
4.4.4. (Z)-9, 17-Octadecadienal  
9, 17-Octadecadienal (Z) was isolated from the ethyl acetate fraction of 
P.macrocarpa fruits using column chromatography. Firstly, this mixture with compound 
was obtained from fraction 4 (SEF 4) and then isolated from preparative thin layer 
chromatography. The compound gave a peak at RT 36.815 min, giving a mass spectrum 
that has  a 97% quality match to that of the accompanying mass-spectral library (NIST 
05 MS library, 2002) for 9, 17-octadecadienal. 
  
The molecular ion peak at m/z 164 corresponded to the molecular formula 
C18H32O. A fragment peak at M-1 at m/z 163 due to the loss of an aldehydic proton was 
also observed. There was also an M-28 peak (loss of ethylene) at m/z 236 and M-43 (loss 
of CH2=CH-O·) at m/z 221 for aldehydes. Prominent CnH2n-2 and CnH2n-3 peaks 
characterizing a long chain hydrocarbon containing two double bonds which also 
appeared, respectively, at m/z 54, 68, 82, 96, 110, 124, 138, 152, 166, 180, 194, 208, 222, 
236 and m/z 53, 67, 81,95, 109, 123, 137, 151, 165, 179, 193, 207, 221, 235. 
 
CH2
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4.4.5. 2, 4’, 6-Trihydroxy-4-methoxy-benzophenone  
2, 2,4',6-Trihydroxy-4-methoxybenzophenone (or) (2,6-dihydroxy-4-
methoxyphenyl)(4-hydroxyphenyl) methanone was isolated from the ethyl acetate 
fraction of P.macrocarpa fruits using column chromatography. This yellow color 
crystalline compound was obtained from fraction 4 (FF 4) after recrystallization and was 
identified as 2,4',6-trihydroxy-4-methoxybenzophenone using NMR and GC-MS 
analysis. The compound which was eluted at retention time 43.93 min in the total ion 
chromatogram of fraction FF7P-HP.D was identified as 2,4',6-trihydroxy-4-
methoxybenzophenone (or) (2,6-dihydroxy-4-methoxyphenyl)(4-hydroxyphenyl) 
methanone from its NMR and mass spectra. The two pairs of equivalent aromatic 
hydrogens, H2'/H6' and H3'/H5', produced in the p-disubstituted benzene and a pair of 
equivalent aromatic hydrogens in the 2, 6-dihydroxy-4-methoxyphenyl group, H3/H5, was 
observed at  7.59 (d), 6.75 (d), and 5.95 (s), respectively, in the 1H NMR spectrum 
(CDCl3/CD3OD, 400 Mz). The corresponding three equivalent pairs of aromatic carbons, 
C2'/C6', C3'/C5', and C3/C5, appeared at  134.05, 116.58, and 95.35 in the 13C NMR 
spectrum (CDCl3/CD3OD, 100 Mz) respectively. An aromatic methoxy group was also 
shown by the signals at  3.74 and 55.86, respectively, in the 1H and 13C NMR spectra of 
the compound. The ketone carbonyl signal appeared at  199.59. Together with the 
chemical shifts of the remaining carbons, the assignments of all the NMR signals were 
summarized in Figure 4.4. The assignment of 1H and 13C NMR signals were also 
summarized together with the 1H-13C HMBC and HMQC data in the Table 4.8.  The H-
NMR, C13-NMR and the HMQC and HMBC spectra are attached in the Appendix 
section 10 to 15. 
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Figure 4.4: Structure analysis of 2, 4', 6-trihydroxy-4-methoxybenzophenone in 1H 
and 13C NMR spectra 
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Table 4.8: 1H NMR (CDCl3/CD3OD, 400 MHz), 
13C NMR (CDCl3/CD3OD, 100 MHz), 
HMQC and HMBC Data of Isolated 2, 4’, 6-trihydroxy-4-methoxybenzophenone. 
Position/ 
Group 
C 
H 
(mult, J in Hz) 
1H-13C HMBC 
1 109.05 - - 
2/6 162.16 - - 
3/5   95.35 5.95 (s) C-1, C-2/C-6, C-4 
4 166.58 - - 
1' 133.77 - - 
2'/6' 134.05 7.59 (d, 8.8) C-1', C-3'/C-5', C-4', C=O 
3'/5' 116.58 6.75 (d, 8.8) C-1', C-2'/C-6', C-4' 
4' 164.07 - - 
C=O 199.59 - - 
OCH3   55.86 3.74 (s) C-4 
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The mass spectrum of the compound supports the assigned structure: M+ peak 
appeared at m/z 260; ions resulting from the cleavage on each side of the carbonyl group 
were also observed. One fragment ion series, m/z 167, 166, 138, and 95 supported the 2, 
6-dihydroxy-4-methoxyphenyl moiety on one side, and the fragment ion series, m/z 121, 
93, 65, and 64 supported the 4'-hydroxyphenyl moiety on the other side of the carbonyl 
group. The M-1 peak at m/z 259 may be justified by cleavage  to the oxygen atom of 
the methoxy group (Figure 4.5). 
 
Figure 4.5: Structure analysis of 2, 4', 6-trihydroxy-4-methoxybenzophenone in mass 
spectrum data using gas-chromatography and mass-spectrometry technique. 
 
4.4.6. 1-(2, 6-Dihydroxy-4-methoxyphenyl)-2-(4-hydroxyphenyl) ethanone  
1-(2, 6-dihydroxy-4-methoxyphenyl)-2-(4-hydroxyphenyl) ethanone was also 
isolated from the ethyl acetate fraction of P.macrocarpa fruits using column 
chromatography. This white fined powder compound was obtained from fraction 5 (FF 
5) after wash with chloroform solution and was identified as 1-(2, 6-dihydroxy-4-
methoxyphenyl)-2-(4-hydroxyphenyl) ethanone using NMR and GC-MS analysis. The 
compound in the sample which eluted at retention time 30.13 minutes in total ion 
chromatogram gave a molecular ion peak at m/z 274 in its mass spectrum. This compound 
was identified as 1-(2, 6-dihydroxy-4-methoxyphenyl)-2-(4-hydroxyphenyl) ethanone 
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from the fragment ion peaks in the mass spectrum. The justification for this assignment 
of structure is summarized in the following fragmentation pathway. The ion pairs 
primarily given by the cleavage on each side of the carbonyl group can be observed at 
m/z 135, 166, 108, and 77. The M-1 peak at m/z 273 supported the presence of benzyl 
moiety, where easy loss of H by benzylic cleavage is a possible process. The peaks at m/z 
108 and 77 on the one hand, and the peaks at m/z 92, 64, and 63 on the other hand, 
justified the presence of a p-hydroxybenzyl moiety on one side of the carbonyl group; 
while the peaks at m/z 166, 138, 108, 123, and 95 justified the presence of a 2, 6-
dihydroxy-4-methoxyphenyl moiety on the other side of the carbonyl group. 
Justifications for the presence of a methoxy group were in the form of the prominent 
peaks set at at m/z 259 and 243. Most of the proton transfers can be made through six-
membered cyclic transition states that are possible in the molecule.  
The two pairs of equivalent aromatic hydrogens, H2'/H6' and H3'/H5', in the di-
substituted benzene and a pair of equivalent aromatic hydrogens in the 2, 6-dihydroxy-4-
methoxyphenyl group, H3/H5, can be seen at  7.54 (d, 8.6 Hz), 6.74 (d, 8.6 Hz), and 5.93 
(s), respectively, in the 1H NMR spectrum (CDCl3/CD3OD, 270 MHz). The 
corresponding three equivalent pairs of aromatic carbons, C2'/C6', C3'/C5', and C3/C5, can 
also be seen at  131.41, 114.65, and 93.90 in the 13C NMR spectrum (CDCl3/CD3OD, 
67.5 MHz). An aromatic methoxy group was also shown by the signals at  3.73 and 
55.24, respectively, in 1H and 13C NMR spectra of the compound. In the 1H NMR 
spectrum, the signal for the two benzylic hydrogens was not observed as it must have 
fallen under the strong solvent (methanol) peak at  3.45. However, from the normal and 
DEPT 13C NMR, methylene carbon at  55.25 justified one benzylic methylene group 
that is connected to a carbonyl group. The ketone carbonyl signal appeared at  198.14. 
Together with the chemical shifts for the remaining carbons, the assignments of all the 
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NMR signals are summarized in the structural Figure 4.6, Figure 4.7, Appendix 16 and 
Appendix 17. 
 
Figure 4.6: Structure analysis of 1-(2, 6-dihydroxy-4-methoxyphenyl)-2-(4-
hydroxyphenyl) ethanone. 
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Figure 4.7: Structure analysis of 1-(2, 6-dihydroxy-4-methoxyphenyl)-2-(4-
hydroxyphenyl) ethanone in 1H and 13C NMR spectra. 
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PART B: SCREENING OF CYTOTOXIC ACTIVITY OF P.  MACROCARPA  
4.5. In vitro Neutral Assay  
In this study, the cytotoxicity activities of the methanolic extract and fractionated 
extracts of hexane and ethyl acetate from the P. macrocarpa seeds and fruits were 
screened using the neutral red cytotoxicity assay on the following selected cell lines: 
1. human cervical epithelioid carcinoma cell (Cas Ki), 
2. human hormone-dependent breast carcinoma (MCF-7), 
3. human epithelioid colon carcinoma cell (HT-29),  
4. human epithelioid lung carcinoma cell(A549), 
5. human ovarian carcinoma cell (SKOV-3),  
6. Non-cancer human fibroblast cell line (MRC-5). 
The cytotoxicity study was performed on MRC-5, Ca Ski, MCF-7, HT-29, A549 
and SKOV-3 cells according to describe protocols (Borenfreund, 1984). The stock 
materials of the test extracts were dissolved in 100% DMSO. The maximum amount of 
DMSO present in the wells (0.5%) was found to have no effect on the cells. To determine 
the effectiveness of the inhibition concentration of cell proliferation, the cell lines were 
incubated with various concentrations of the extract. The amount of neutral red dye 
accumulated may be extracted from the lysosomes of viable cells. The cytotoxic activities 
of the methanolic and fractionated extracts were determined by reading the spectrometric 
absorbance at 540 nm using an ELISA Reader. The results were expressed as IC50 values 
which correspond to the mean of three replicate experiment.   
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4.5.1. Screening of cytotoxic activity of P. macrocarpa seed extract and its 
fractions 
4.5.1.1. Human cervical carcinoma cell line (Ca Ski) 
The growth inhibition effect of P. macrocarpa (Scheff.) Boerl seed extracts on 
the Ca Ski cell line is shown in Table 4.9. The inhibition percentage of the Ca Ski cells 
increased as the concentrations increased. The ethyl acetate fraction possessed the highest 
cyototoxic activity when tested at the highest concentration (1.90±1.79µg/mL), followed 
by the methanol extract and the hexane fraction. However, the hexane fraction of P. 
macrocarpa seeds showed mild cytotoxicity with an IC50 value of 26.50±2.66 µg/mL but 
the methanol extract displayed excellent cytotoxic effect on the Ca Ski cell line with an 
IC50 value of 3.50±1.14 µg/mL, as shown in Figure 4.8. The water extract showed less 
than 50% inhibition activity when tested at the highest concentration (100.00 µg/mL). 
Each value is expressed as the mean ± standard deviation of three measurements. 
Table 4.9: The IC50 values of the cytotoxic activity of P. macrocarpa seed extract and 
its fractions against the Ca Ski cell line. 
Extract/ Fractions IC50 values (µg/mL) 
Methanol (SMF) 3.50±1.14 
Hexane (SHF) 26.50±2.66 
Ethyl acetate (SEF) 1.90±1.79 
Water (SWF) ≥100.00 
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Figure 4.8: In vitro, growth inhibition of Ca Ski cells by P. macrocarpa seed extract and 
its fractions were determined by neutral red cytotoxitiy assay. 
 
4.5.1.2. Hormone-dependent breast carcinoma cell line (MCF-7) 
The cytotoxic activity of the P. macrocarpa seed extract and its fractions against 
the MCF-7 cell line are summarized in Table 4.10. The crude methanol extract exhibited 
strong cytotoxicity with an IC50 value of 2.25±1.23 µg/mL. The hexane fraction also 
showed high cytotoxic activity with an IC50 value of 9.80±0.50 µg/mL. On the other hand, 
the ethyl acetate fraction was less cytotoxic with an IC50 value of 19.50±1.71 µg/mL 
(Figure 4.9). In contrast, the water fraction was not active in the MCF-7 cell line (IC50 
≥100.00 µg/mL). Each value is expressed as the mean ± standard deviation of three 
measurements. 
Table 4.10: The IC50 values of cytotoxic activity of P. macrocarpa seed extract and its 
fractions against the MCF-7 cell line. 
Extract/ Fractions IC50 values (µg/mL ) 
Methanol (SMF) 2.25±1.23 
Hexane (SHF) 9.80±0.50 
Ethyl acetate (SEF) 19.50±1.71 
Water (SWF) ≥100.00 
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Figure 4.9: In vitro, growth inhibition of MCF-7 cells by P. macrocarpa Boerl seed 
extract and its fractions were determined by neutral red cytotoxicity assay. 
 
4.5.1.3. Human colon carcinoma cell line (HT-29) 
The cytotoxic activity of the P. macrocarpa seed extract and its fractions against 
the HT-29 cell line is shown in Figure 4.10 and the IC50 value of the hexane fraction 
(5.20±1.81 µg/mL ), the ethyl acetate fraction (6.00±1.64 µg/mL ) and the methanol 
extract (6.55±2.11 µg/mL ), are as shown in Table 4.11. However, the water fraction of 
the P. macrocarpa seeds was not active on the HT-29 cell line (IC50 value ≥100.00 
µg/mL). Each value is expressed as the mean ± standard deviation of three measurements. 
Table 4.11: The IC50 values of cytotoxic activity of P. macrocarpa seed extract and its 
fractions against the HT-29 cell line. 
Extract/Fractions IC50 values (µg/mL ) 
Methanol (SMF) 6.55±2.11 
Hexane (SHF) 5.20±1.81 
Ethyl acetate (SEF) 6.00±1.64 
Water (SWF) ≥100.00 
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Figure 4.10: In vitro, growth inhibition of HT-29 cells by P. macrocarpa seed extract 
and its fractions were determined by neutral red cytotoxicity assay. 
 
4.5.1.4. Human lung carcinoma cell line (A-549) 
The in vitro growth inhibition of the P. macrocarpa seed extracts and fractions on 
A549 cells is shown in Figure 4.11. The percentage of inhibition increased as the extract 
concentrations increased. The highest cytotoxic activity on A-549 was with the ethyl 
acetate fraction of the P. macrocarpa seeds, with an IC50 value of 1.00±2.35µg/mL. This 
was followed by the crude methanol extract, with an IC50 value of 5.75±2.47 µg/mL. The 
hexane fraction had a cytotoxic effect on the A-549 cell line, with an IC50 value of 
25.00±1.57 µg/mL. However, the IC50 value of the water fraction were above 100.00 
µg/mL, as shown in Table 4.12. Each value is expressed as the mean ± standard deviation 
of three measurements. 
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Table 4.12: The IC50 values of cytotoxic activity of P. macrocarpa seed extract and its 
fractions against the A549 cell line. 
Extract/Fractions IC50 values (µg/mL ) 
Methanol (SMF) 5.75±2.47 
Hexane (SHF) 25.00±1.57 
Ethyl acetate (SEF) 1.00±2.35 
Water (SWF) ≥100.00 
 
 
Figure 4.11: In vitro, growth inhibition of A549 cells by P. macrocarpa seed extract 
and its fractions were determined by neutral red cytoxicity assay. 
 
4.5.1.5. Human ovarian carcinoma cell line (SKOV-3) 
The in vitro growth inhibition of SKOV-3 cells by the extract and fractions from 
the seeds of P. macrocarpa is shown in Figure 4.12. The percentage of inhibition 
increased with extract concentration. The ethyl acetate fraction possessed the strongest 
cytotoxic activity with an IC50 value of 2.75±1.00 µg/mL, followed by the methanol 
extract with an IC50 value of 7.00±1.00 µg/mL. The hexane fraction of the P. macrocarpa 
seeds exhibited a lower cytotoxic effect with an IC50 value of 25.90±1.19 µg/mL.  
However, the IC50 value of the water fraction as above 100.00 µg/mL, as shown in Table 
4.13.  Each value is expressed as the mean ± standard deviation of three measurements. 
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Table 4.13: The IC50 values of cytotoxic activity of P. macrocarpa seed extract and 
fractions against the SKOV-3 cell line. 
Extract/Fractions IC50 values (µg/mL ) 
Methanol (SMF) 7.00±1.00 
Hexane (SHF) 25.9±1.19 
Ethyl acetate (SEF) 2.75±1.00 
Water (SWF) ≥100.00 
 
 
Figure 4.12: In vitro, growth inhibition of SKOV-3 cells by P. macrocarpa seed extract 
and fractions were determined by neutral red cytotoxicity assay. 
 
4.5.1.6. Human fibroblast cell line (MRC-5) 
The IC50 values (µg/mL) of the P. macrocarpa seed extracts in the MRC-5 cell 
line are summarized in Table 4.14. The methanol extract, hexane and water fractions 
exhibited low cytotoxicity towards the MRC-5 cell line. The IC50 values of the hexane 
and water fractions were above 100.00 µg/mL and the methanol extract showed a low 
cytotoxic effect on the MRC-5 cell line, with an IC50 value of 85.00±2.23µg/mL. 
However, the ethyl acetate fraction exhibited cytotoxicity against the normal cell MRC-
5 with an IC50 value of 23.00±1.54 µg/mL (Figure 4.13). Each value is expressed as the 
mean ± standard deviation of three measurements. 
76 
 
Table 4.14: The IC50 values of cytotoxic activity of the P. macrocarpa seed extract and 
fractions against the MRC-5 cell line. 
Extract/ Fractions IC50 values (µg/mL ) 
Methanol (SMF) 85.00±2.23 
Hexane (SHF) ≥100.00 
Ethyl acetate (SEF) 23.00±1.54 
Water (SWF) ≥100.00 
 
Figure 4.13: In vitro, growth inhibition of MRC-5 cells by P. macrocarpa seed extract 
and fractions were determined by neutral red cytotoxicity assay. 
 
4.5.1.7. Discussion  
The crude methanol extract and its fractions from the P. macrocarpa seeds were 
evaluated for cytotoxic activities against six (6) human cell lines (MRC-5, Ca Ski, MCF-
7, HT-29, A549 and SKOV-3) by using the neutral red cytotoxicity assay. The IC50 values 
of the extract are in µg/mL and they are summarised in Table 4.15. Each value is 
expressed as the mean ± standard deviation of three measurements. 
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Table 4.15: IC50 values of Methanol Extract and Fractions of P. macrocarpa seeds.  
    IC50 (µg/mL )     
CELL LINES METHANOL 
ETHYL 
ACETATE  
HEXANE  WATER 
MCF-7 2.25±1.27 19.50±1.64 9.80±0.50 ≥100.00 
Ca Ski 3.50±0.93 1.90±0.33 26.50±2.48 ≥100.00 
A549 5.75±1.25 1.00±1.23 25.00±0.46 ≥100.00 
HT-29 6.55±2.05 6.00±1.41 5.20±1.04 ≥100.00 
SKOV-3 7.00±0.60 2.75±0.38 25.90±1.10 ≥100.00 
MRC-5 85.00±1.03 23.00±1.54 100.00±0.52 ≥100.00 
 
Table 4.15 shows the comparison between the IC50 values of the methanol extract 
and the fractions of the P. macrocarpa seeds against various cancer and non-cancer cell 
lines. The IC50 values of the methanol extract, the ethyl acetate fraction, the hexane 
fraction and the water fraction were less than 20.00 µg/mL and thus were considered 
highly active. IC50 values of plant extracts and fractions greater than 20.00 µg/mL are 
considered inactive (Swanson and Pezzuto, 1990; Geran et al., 1972).  
The crude methanol extract showed excellent cytotoxic activity with IC50 values 
of 3.50±0.93, 2.25±1.27, 6.55±2.05, 5.75±1.25 and 7.00±0.60 µg/mL on Ca Ski, MCF-7, 
HT-29, A549 and SKOV-3, respectively.  In contrast, the methanol extracts displayed 
only mild toxicity on the normal cell line MRC-5, with an IC50 value of 85.00±1.03 
µg/mL. It is of interest that the extract showed much lower cytotoxicity against the normal 
cell line, and, if this also true in vivo, the use of this plant by locals would have some 
scientific support. The ethyl acetate fraction exhibited remarkable cytotoxic activity, with 
IC50 values of 1.90±0.33, 6.00±1.41, 1.00±1.23 and 2.75±0.38 µg/mL in Ca Ski, HT-29, 
A549 and SKOV-3 cells, respectively. However, this extract displayed lower cytotoxic 
activity in MCF-7 cells with an IC50 value of 19.50±1.64µg/mL. This gives some supports 
to the use of P. macrocarpa in folk medicine for treating cancer. The hexane fraction 
displayed cytotoxic activity against the Ca Ski, MCF-7, HT-29, A549 and SKOV-3 cell 
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lines, with IC50 values of 26.50±2.48, 9.80±0.50, 5.20±1.04, 25.00±0.46 and 25.90±1.10 
µg/mL, respectively. This hexane extract has no apparent cytotoxic effect against MRC-
5 cells with and IC50 100.00 µg/mL.  
In summary, the results of the present work indicated that the methanol extract 
and ethyl acetate fraction of the P. macrocarpa seeds possessed remarkable cytotoxicity 
against selected cancer cells and mild toxicity against normal cells (based on the neutral 
red cytotoxicity assay). The methanol extract and the ethyl acetate fraction had a 
selectivity index (SI) value of less than three and were thus considered to have high 
selectivity. Moreover, the hexane fraction of the P. macrocarpa seeds showed high 
cytotoxicity against MCF-7 and HT-29 cells and also was not toxic to normal cells (MRC-
5). Bioassay guided fractionation was then performed to identify the bioactive 
compound(s).  
4.5.2. Screening of cytotoxic activity of P. macrocarpa fruits extract and its 
fractions 
The cytotoxicity (IC50 value in µg/mL) of the P. macrocarpa fruit extract towards 
selected cell lines is summarized in Table 4.16. The percentage of inhibition of selected 
cell lines increased as the extract concentrations increased. The cytotoxic effect of the 
crude extracts and fractionated extracts of the P. macrocarpa fruits was evaluated using 
the neutral red cytotoxicity assay against five human carcinoma cell lines (MCF-7, Ca 
Ski, A 549, HT-29 and SKOV-3) and the non-cancer human fibroblast cell line (MRC-
5). The crude methanol extract, and the hexane and water fraction had no cytotoxic effect 
on all cancer cell lines and normal cells MRC-5, with IC50100.00 µg/mL. However, 
ethyl acetate fraction showed mild toxicity on the normal cell line MRC-5 and the human 
carcinoma cell line SKOV-3, with IC50 values of 62.50±3.25 µg/mL. Each value is 
expressed as the mean ± standard deviation of three measurements. 
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Table 4.16: IC50 values of methanol extract and its fractions of the P. macrocarpa fruits 
after 72 hours incubation. 
    IC50 (µg/mL )      
Cell Line 
Methanol 
Extract 
Ethyl Acetate 
Fraction  
Hexane Fraction  
Water 
Fraction 
MCF-7 54.40±1.20 48.30±2.90 ≥100.00 ≥100.00 
Ca Ski ≥100.00 ≥100.00 ≥100.00 ≥100.00 
A549 91.50±3.30 52.90±1.70 ≥100.00 ≥100.00 
HT-29 ≥100.00 ≥100.00 ≥100.00 ≥100.00 
SKOV-3 88.60±1.80 62.00±2.48 ≥100.00 ≥100.00 
MRC-5 ≥100.00 62.50±3.25 ≥100.00 ≥100.00 
4.6. In vitro MTT cell proliferation assay 
In addition, the neutral red cytotoxicity assay, the MTT assay was also used in 
this study in order to determine the cytotoxic effect of the P. macrocarpa seed and fruit 
extracts and isolated compounds against selected human cell lines - the human cervical 
carcinoma cell line (Ca Ski), the human colon carcinoma cell line (HT-29), the hormone-
dependent breast carcinoma cell line (MCF-7), human ovarian carcinoma cell line 
(SKOV-3) and the hormone-independent breast carcinoma cell line (MDA-MB231). 
To determine the effective concentration of inhibition of cell proliferation, the cell 
lines were incubated with the extract at various concentrations. The amount of MTT dye 
accumulated can be extracted from the mitochondria and quantified by comparing it with 
the MTT dye recovered from an untreated control cell culture. The results were expressed 
as IC50 values which can be obtained from control concentration-response curves. The 
IC50 value is the effective concentration (µg/mL ) of a test extract or compound that cause 
50% inhibition or cell dead (Borenfreund et al., 1988).  
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4.6.1. Screening for cytotoxic activity of P.macrocarpa seeds  
4.6.1.1. Human cervical carcinoma cell line (Ca Ski) 
In Table 4.17, the cytotoxic activity of the extract and fractions of P. macrocarpa 
seeds was investigated. The hexane, chloroform, ethyl acetate, and water fractions 
prepared from the seeds were tested on Ca Ski cells for cytotoxic activity using the MTT 
assay.  
The hexane extracts of P. macrocarpa were not cytotoxic with IC50 values of 
≥100.00, as shown in the Table 4.17. Both the methanol extract and the chloroform 
fraction exhibited cytotoxic activity with IC50 values of 8.20±4.66 µg/mL (24h), 
19.70±0.92µg/mL (48h), 40.70±2.26 µg/mL (72h) for the methanol extract, and 
10.00±1.31 µg/mL (24h), 8.20±1.04 µg/mL (48h), 22.00±1.86 µg/mL (72h) for the 
chloroform fraction. The ethyl acetate fractions showed stronger cytotoxic activity with 
IC50 values of 5.60±1.17 µg/mL (24h), 7.70±1.85 µg/mL (48h), 6.00±3.22 µg/mL (72h). 
However, the IC50 value of the water fraction was more than 100.00 µg/mL at 24h, 48h 
and 72h. All data were shown in Figure 4.14 and Figure 4.15. Each value is expressed as 
the mean ± standard deviation of three measurements. 
Table 4.17: The IC50 values of cytotoxic activity of P. macrocarpa seed extract and its 
fractions against the Ca Ski cell line. 
Extract/ Fractions 24h  (µg/mL ) 48h  (µg/mL ) 72h  (µg/mL ) 
Methanolic extract (SME) 8.20±4.66 19.70±0.92 40.70±2.26 
Hexane fraction (SHF) ≥100.00 ≥100.00 ≥100.00 
Chloroform fraction (SCF) 10.00±1.31 8.20±1.04 22.00±1.86 
Ethyl acetate fraction (SEAF) 5.60±1.17 7.70±1.85 6.00±3.22 
Water fraction (SWF) ≥100.00 ≥100.00 ≥100.00 
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Figure 4.14: In vitro, growth inhibitions of Ca Ski cells by seeds of P. macrocarpa 
methanol extract determined by MTT assay. 
 
 
 
Figure 4.15: In vitro, growth inhibition of Ca Ski cells by the chloroform extract of the 
P. macrocarpa seeds determined by MTT assay. 
 
4.6.1.2. Human hormone-dependent breast carcinoma cell line (MCF-7)  
In Table 4.18, the cytotoxic activity of the extract and its fractions of P. 
macrocarpa seeds were investigated. The hexane, chloroform, ethyl acetate, and water 
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fractions prepared from the seeds of P. macrocarpa were tested for cytotoxic activity on 
MCF-7 cells using the MTT assay.  
Table 4.18: The IC50 values of cytotoxic activity of P. macrocarpa seed extract and its 
fractions against the MCF-7 cell line. 
Extracts/ Fractions 24h  (µg/mL ) 48h  (µg/mL ) 72h (µg/mL ) 
Methanolic extract (SMF) 12.00±2.20 8.50±1.68 ≥100.00 
Hexane fraction (SHF) 45.20±1.49 55.50±1.97 ≥100.00 
Chloroform fraction (SCF) 57.50±2.64 40.00±1.48 46.50±3.45 
Ethyl acetate fraction (SEAF) 22.30±1.58 16.80±1.70 8.40±1.71 
Water fraction (SWF) ≥100.00 ≥100.00 ≥100.00 
 
The hexane fractions of P. macrocarpa displayed weak cytotoxic activity with 
IC50 values of 45.20±1.49 µg/mL (24h), 55.50±1.97 µg/mL (48h), ≥100.00 µg/mL (72h). 
Both the methanol extract and the ethyl acetate fraction exhibited cytotoxic activity with 
IC50 values of 12.00±2.20 µg/mL (24h), 8.50±1.68 µg/mL (48h), ≥100.00 µg/mL (72h) 
for the methanol extract, and 22.30±1.58 µg/mL (24h), 16.80±1.70 µg/mL (48h), 
8.40±1.71 µg/mL (72h) for the ethyl acetate fraction. The chloroform fraction showed 
cytotoxic activity with IC50 values of 57.50±2.64 µg/mL (24h), 40.00±1.48 µg/mL (48h), 
46.50±3.45 µg/mL (72h). However, the IC50 values of the water fraction were more than 
100.00 µg/mL at 24h, 48h and 72h respectively as shown in Figures 4.16 - 4.19. Each 
value is expressed as the mean ± standard deviation of three measurements. 
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Figure 4.16: In vitro, growth inhibitions of MCF-7 cells by methanol extract of P. 
macrocarpa seeds determined by MTT assay. 
 
 
Figure 4.17: In vitro, growth inhibition of MCF-7 cells by hexane fraction of P. 
macrocarpa seeds determined by MTT assay. 
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Figure 4.18: In vitro, growth inhibition of MCF-7 cells by chloroform fraction of P. 
macrocarpa seeds determined by MTT assay. 
 
 
Figure 4.19: In vitro, growth inhibition of MCF-7 cells ethyl acetate fraction of P. 
macrocarpa seeds determined by MTT assay. 
 
4.6.1.3. Human colon carcinoma cell line (HT-29) 
In Table 4.19, the cytotoxic activity of the extract and fractions of the P. 
macrocarpa seeds were investigated. The hexane, chloroform, ethyl acetate, and water 
fractions prepared from the seeds of P. macrocarpa were tested for cytotoxic activity on 
HT-29 cells using the MTT assay.  
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Table 4.19: The IC50 values of cytotoxic activity of P. macrocarpa seed extract and its 
fractions against the HT-29 cell line. 
Extract / Fractions 24h (µg/mL ) 48h (µg/mL ) 72h (µg/mL ) 
Methanolic extract (SMF) 29.30±2.26 25.00±1.35 21.50±3.30 
Hexane fraction (SHF) 40.00±3.15 64.00±2.03 75.00±3.14 
Chloroform fraction (SCF) 9.50±2.95 8.70±1.59 21.00±1.98 
Ethyl acetate fraction (SEAF) 1.10±1.20 3.50±2.00 12.00±2.28 
Water fraction (SWF) ≥100.00 ≥100.00 ≥100.00 
 
The hexane extracts of P. macrocarpa displayed weak cytotoxic activity with IC50 
values of 40.00±3.15 µg/mL (24h), 64.00±2.03 µg/mL (48h), and 75.00±3.14 µg/mL 
(72h). Both the methanol extract and the chloroform fraction exhibited cytotoxic activity 
with IC50 values of 29.30±2.26 µg/mL (24h), 25.00±1.35 µg/mL (48h), and 21.50±3.30 
µg/mL (72h) for the methanol extract and 9.50±2.95 µg/mL (24h), 8.70±1.59 µg/mL 
(48h), and 21.00±1.98 µg/mL (72h) for chloroform fraction. The ethyl acetate fraction 
displayed stronger cytotoxic activity with IC50 values of 1.10±1.20 µg/mL (24h), 
3.50±2.00 µg/mL (48h), and 12.00±2.28 µg/mL (72h). However, the IC50 values of the 
water fraction were above 100.00 µg/mL at 24h, 48h and 72h respectively (Figures 4.20 
- 4.23). Each value is expressed as mean ±standard deviation of three measurements. 
 
Figure 4.20: In vitro, growth inhibition of HT-29 cells by methanol extract of P. 
macrocarpa seeds determined by MTT assay. 
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Figure 4.21: In vitro, growth inhibition of HT-29 cells by ethyl acetate extract of P. 
macrocarpa seeds determined by MTT assay. 
 
 
Figure 4.22: In vitro, growth inhibition of HT-29 cells by chloroform fraction of P. 
macrocarpa seeds determined by MTT assay. 
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Figure 4.23: In vitro, growth inhibition of HT-29 cells by hexane fraction of  P. 
macrocarpa seeds determined by MTT assay. 
 
4.6.1.4. Human ovarian carcinoma cell line (SKOV-3) 
The cytotoxic activity of the extract and fractions of the P. macrocarpa seeds was 
investigated and the results were as shown in Table 4.20. The hexane, chloroform, ethyl 
acetate and water fractions prepared from the seeds of P. macrocarpa were tested for 
cytotoxic activity on SKOV-3 cells by using the MTT assay.  
Table 4.20: IC50 values of cytotoxic activity of P. macrocarpa seed extract and its 
fractions against the SKOV-3 cell line. 
Extract/ Fractions 24h (µg/mL ) 48h (µg/mL ) 72h (µg/mL ) 
Methanolic extract (SMF) 16.50±2.52 22.10±2.47 36.00±3.55 
Hexane fraction (SHF) 40.50±3.52 50.00±3.02 70.30±3.53 
Chloroform fraction (SCF) 24.80±2.06 16.50±3.21 9.00±2.60 
Ethyl acetate fraction (SEAF) 6.80±1.80 6.50±2.30 3.20±2.81 
Water fraction (SWF) ≥100.00 ≥100.00 ≥100.00 
 
The hexane extracts of P. macrocarpa exhibited weak cytotoxic activity with IC50 
values of 40.50±3.52 µg/mL (24h), 50.00±3.02 µg/mL (48h), and 70.30±3.53 µg/mL 
(72h). Both the methanol extracts and chloroform fraction exhibited cytotoxic activity 
with IC50 values of 16.50±2.52 µg/mL (24h), 22.10±2.47 µg/mL (48h), and 36.00±3.55 
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µg/mL (72h) for the methanol extract, and 24.8±2.06 µg/mL (24h), 16.5±3.21 µg/mL 
(48h), 9.00±2.60 µg/mL (72h) for the chloroform fraction. The ethyl acetate fraction 
displayed stronger cytotoxic activity with IC50 values of 6.80±1.80 µg/mL (24h), 
6.50±2.30 µg/mL (48h), and 3.20±2.81 µg/mL (72h). However, the IC50 values of the 
water fraction were above 100.00 µg/mL at 24h, 48h and 72h respectively as shown in 
Figures 4.24 - 4.27. Each value is expressed as mean ±standard deviation of three 
measurements. 
 
Figure 4.24: In vitro, growth inhibition of SKOV-3 cells by methanol extract of P. 
macrocarpa seeds determined by MTT assay. 
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Figure 4.25: In vitro, growth inhibition of SKOV-3 cells by hexane fraction of P. 
macrocarpa seeds determined by MTT assay. 
 
 
Figure 4.26: In vitro, growth inhibition of SKOV-3 cells by chloroform extract of P. 
macrocarpa seeds determined by MTT assay. 
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Figure 4.27: In vitro, growth inhibition of SKOV-3 cells by ethyl acetate fraction of P. 
macrocarpa seeds determined by MTT assay.   
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4.6.1.5. Human hormone-independent breast carcinoma cell line 
(MDA-MB231) 
In Table 4.21, the cytotoxic activity of the extract and fractions of the P. 
macrocarpa seeds is presented. The hexane, chloroform, ethyl acetate and water fractions 
prepared from the seeds of P. macrocarpa were tested for cytotoxic activity on MDA-
MB231 cells using the MTT assay.  
Table 4.21: IC50 values of cytotoxic activity of P. macrocarpa seed extract and fractions 
against the MDA-MB231 cell line. 
Extract/ Fractions 24h (µg/mL ) 48h (µg/mL ) 72h (µg/mL ) 
Methanolic extract (SMF) ≥100.00 ≥100.00 ≥100.00 
Hexane fraction (SHF) ≥100.00 ≥100.00 ≥100.00 
Chloroform fraction (SCF) ≥100.00 ≥100.00 ≥100.00 
Ethyl acetate fraction (SEAF) 6.50±2.30 15.00±3.43 18.60±1.26 
Water fraction (SWF) ≥100.00 ≥100.00 ≥100.00 
The hexane extracts of P. macrocarpa displayed no cytotoxic activity with IC50 
values more than 100.00 µg/mL. The ethyl acetate fraction possessed high cytotoxic 
activity with IC50 values of 6.50±2.30 µg/mL (24h), 15.00±3.43 µg/mL (48h), and 
18.60±1.26 µg/mL (72h). However, the IC50 values of the methanol extract and the water 
and chloroform fractions were above 100.00 µg/mL at 24h, 48h and 72h respectively as 
shown in Figure 4.28. Each value is expressed as the mean ± standard deviation of three 
measurements. 
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Figure 4.28: In vitro, growth inhibition of MDA-MB231 cells by ethyl acetate fraction 
of P. macrocarpa seeds determined by MTT assay. 
 
4.6.1.6. Discussions  
The methanol extract and hexane, chloroform, ethyl acetate and water fractions of 
the P. macrocarpa seeds were investigated for their cytotoxic effect in human epithelioid 
cervical carcinoma cells (Ca Ski), human hormone-dependent breast carcinoma cells 
(MCF-7), human epithelioid colon carcinoma cells (HT-29), human ovarian carcinoma 
cells (SKOV-3), human hormone-independent breast carcinoma cells (MDA-MB231) 
and normal cells (MRC-5) using the MTT cell proliferation assay at 24h, 48h and 72h, 
respectively. 
The methanolic extract from the P. macrocarpa seeds showed excellent cytotoxic 
activity, with IC50 values of 8.20±4.66 µg/mL in Ca Ski cells at 24h, and 12.00±2.20, 
8.50±1.68 and 3.00±2.50 µg/mL in MCF-7 cells at 24h, 48h and 72h, respectively. 
Moreover, the methanol extract displayed good cytotoxic effects in HT-29 cells with IC50 
values of 29.30±2.26, 25.00±1.35 and 21.50±3.30 µg/mL at 24h, 48h and 72hrs, in Ca 
Ski cells with IC50 values of 19.70±0.92 µg/mL and in SKOV-3 cells with IC50 values of 
16.50±2.52, 22.10±2.47 and 36.00±3.55 µg/mL at 24h, 48h and 72h. However, this 
extract had no cytotoxic effect on MDA-MB231 cells displaying IC50 100.00 µg/mL. 
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The extract also exhibited a low cytotoxic effect on the MRC-5 cells with an IC50 values 
of more than 50.00 µg/mL.  
The hexane fraction of the P. macrocarpa seeds showed moderate cytotoxic 
effects with IC50 values of 45.20±1.49 and 55.50±1.97 µg/mL at 24h and 48h on MCF-7, 
40.00±3.15 µg/mL in HT-29 cells at 24h, and 40.50±3.52 and 50.00±3.02 µg/mL in 
SKOV-3 at 24h and 48h. The hexane fraction also displayed low cytotoxic effect in MCF-
7 at 72h, HT-29 at 48h and 72h, and in SKOV-3 at 72h. The IC50 value of treatment with 
the hexane fraction in MCF-7 was 72.50±1.52 µg/mL for 72h. In this respect, the IC50 
values of treatment in HT-29 were 64.00±2.03, 75.00±3.14 µg/mL at 48h and 72h, while 
the IC50 value of treatment in SKOV-3 was 70.30±3.53 µg/mL at 72h. In contrast, the 
hexane fraction had no cytotoxic effect in MDA-MB231 cells or MRC- 5 cells. 
The chloroform fraction of the P. macrocarpa seeds exhibited the highest 
cytotoxic effect with IC50 values of 10.00±1.31, 8.20±1.04 and 22.00±1.86 µg/mL at 24h, 
48h and 72h in Ca Ski cells, 9.50±2.95, 8.70±1.59 and 21.00±1.98 µg/mL at 24h, 48h and 
72h on HT-29 cells, and 24.80±2.06, 16.50±3.21 and 9.00±2.60 µg/mL in SKOV-3 cells.  
The chloroform fraction exhibited a moderate cytotoxic effect in MCF-7 cells with IC50 
values of 57.50±2.64, 40.00±1.48 and 46.50±3.45 µg/mL for 24h, 48h and 72h. In 
contrast, the chloroform fraction had no cytotoxic effect against the MDA-MB231 cells 
with IC50 values of more than 100.00 µg/mL and it also had no cytotoxic activity in 
normal MRC-5 cells with IC50 values of more than 100.00 µg/mL. 
The ethyl acetate fraction of the P. macrocarpa seeds exhibited the highest 
cytotoxic effect, with IC50 values of less than 25.00 µg/mL in the SKOV-3 cells, MDA-
MB 231 cells, MCF-7 cells and Ca Ski cells. On the other hand, the fraction displayed a 
low cytotoxic effect in MRC-5 normal cells with IC50 values of 35.00 µg/mL. Therefore, 
the ethyl acetate fraction gave the highest cytotoxic effect in all the selected cells which 
were Ca Ski, MCF-7, HT-29 and MDA-MB231 cells. The water extract had no cytotoxic 
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effect on the all selected cancer cell lines, namely Ca Ski, MCF-7, HT-29, SKOV-3 and 
MDA-MB 231 cells, with IC50 >100.00 µg/mL  had mild cytotoxic effects against MRC-
5 cells. A summary of the above data are shown in Table 4.22 and Figures 4.29 – 4.33. 
Each value is expressed as mean ±standard deviation of three measurements. 
Table 4.22: In vitro cytotoxic effects of methanol extract and its fractions of P. 
macrocarpa seeds on Ca Ski, MCF-7, HT29, SKOV3 and MDA-MB231 cancer cells 
lines. Cells were treated with various concentrations of the extract and fractions for 24h, 
48h and 72h prior to determine cytotoxicity by using MTT cell proliferation assay. 
Cell line Hr MEF HF CF EAF 
 24 8.20±4.66 ≥100.00 10.00±1.31 5.60±1.17 
Ca Ski 48 19.70±0.92 ≥100.00 8.20±1.04 7.70±1.85 
 72 40.70±2.26 ≥100.00 22.00±1.86 6.00±3.22 
      
 24 12.00±2.20 45.20±1.49 57.50±2.64 22.30±1.58 
MCF-7 48 8.50±1.68 55.50±1.97 40.00±1.48 16.80±1.70 
 72 6.30±2.50 72.50±1.52 46.50±3.45 8.40±1.71 
      
 24 29.30±2.26 40.00±3.15 9.50±2.95 1.10±1.20 
HT-29 48 25.00±1.35 64.00±2.03 8.70±1.59 3.50±2.00 
 72 21.50±3.30 75.00±3.14 21.00±1.98 12.00±2.28 
      
 24 16.50±2.52 40.50±3.52 24.80±2.06 6.80±1.80 
SKOV-3 48 22.10±2.47 50.00±3.02 16.50±3.21 6.50±2.30 
 72 36.00±3.55 70.30±3.53 9.00±2.60 3.20±2.81 
      
 24 ≥100.00 ≥100.00 ≥100.00 6.50±2.30 
MDA-MB231 48 ≥100.00 ≥100.00 ≥100.00 15.00±3.43 
  72 ≥100.00 ≥100.00 ≥100.00 18.60±1.26 
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Figure 4.29: In vitro, cytotoxic effects of methanol extract and its fractions of P. 
macrocarpa seeds on Ca Ski cervical cancer cells line. Cells were treated with various 
concentrations of extract and all fractions for 24h, 48h and 72h prior to the 
determination of cytotoxicity by MTT cell proliferation assay. 
 
 
Figure 4.30: In vitro, cytotoxic effects of methanol extract and its fraction of P. 
macrocarpa seeds on MCF-7 breast cancer cells line. Cells were treated with various 
concentrations of extract and all fractions for 24h, 48h and 72h prior to the 
determination of cytotoxicity by MTT cell proliferation assay. 
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Figure 4.31: In vitro, cytotoxic effects of methanol extract and its fractions of P. 
macrocarpa seeds on HT29 colon cancer cells line. Cells were treated with various 
concerntrations of extract and all fractions for 24h, 48h and 72h prior to the 
determination of cytotoxicity by using MTT cell proliferation assay. 
 
 
Figure 4.32: In vitro, cytotoxic effects of methanol extract and its fractions of P. 
macrocarpa seeds on SKOV-3 ovarian cancer cells line. Cells were treated with various 
concentrations of extract and all fractions for 24h, 48h and 72h prior to the 
determination of cytotoxicity by using MTT cell proliferation assay. 
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Figure 4.33: In vitro, cytotoxic effects of methanol extract and its fractions of P. 
macrocarpa seeds on MDA-MB231 breast cancer cells line. Cells were treated with 
various concentrations of extract and all fractions for 24h, 48h and 72h prior to the 
determination of cytotoxicity by using MTT cell proliferation assay. 
 
The MTT assay is a sensitive and reliable colorimetric assay. It uses quantitative 
measurements to calculate the viability, proliferation and activation of cells. This method 
is commonly applied in order to screen anticancer agents (Petty et al., 1995). The most 
well-known methods used to calculate cytotoxicity are the neutral red (NR) uptake and 
dimethylthiazole-diphenyl tetrazolium bromide (MTT) metabolism (Mosmann, 1983; 
Sellers et al., 1994). It has previously been shown that the ethanol extract of the P. 
macrocarpa seed and fruit were not toxic to normal human peripheral blood mononuclear 
cells, but slightly toxic to the vero cell line (Astuti et al., 2007). The ethanol extract of the 
P. macrocarpa seeds and fruits also reported to display toxicity towards the T47D breast 
cancer cell line through the inhibition of COX-2 expression (Bakhriansyah, 2004). This 
study  has shown that the methanolic extract of the P. macrocarpa seeds have cytotoxic 
effect on the HT-29, MCF-7, HeLa and Chang cell lines (Hendra et al., 2011). In these 
cytotoxic studies, the results showed that there was a significant cytotoxic effect on 
selected cell lines in a time and dose-dependent manner due to the presence of cyanogenic 
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glycosides. Therefore, Phaleria macrocarpa extract and its fraction appear to be potent 
anticancer agents according to the best of my knowledge and results. 
4.6.2. Screening of cytotoxic activity of Extract and Fractions of P. 
macrocarpa fruits  
4.6.2.1. Human cervical carcinoma cell line (Ca Ski) 
The cytotoxic activity of the extract and fractions of P. macrocarpa fruits was 
investigated and the results are shown in Table 4.23. The hexane, chloroform, ethyl 
acetate and water fractions prepared from the fruit of P. macrocarpa were tested for its 
cytotoxic activity on Ca Ski cells by using the MTT assay. These extracts (methanol, 
hexane, chloroform, ethyl acetate, and water) were shown to have no cytotoxic effect with 
IC50 values of more than 100.00 µg/mL at 24h, 48h and 72h respectively. Each value is 
expressed as the mean ± standard deviation of three measurements. 
Table 4.23: IC50 values of cytotoxic activity of P. macrocarpa fruit extract and fractions 
against the Ca Ski cell line. 
Extract/ Fractions  Ca Ski  
 24h (µg/mL ) 48h (µg/mL) 72h (µg/mL ) 
Methanol extract (FMF) ≥100.00 ≥100.00 ≥100.00 
Hexane Fraction (FHF) ≥100.00 ≥100.00 65.20±2.41 
Chloroform Fraction (FCF) ≥100.00 ≥100.00 85.70±2.85 
Ethyl Acetate Fraction (FEAF) ≥100.00 ≥100.00 ≥100.00 
Water Fraction (FWF) ≥100.00 ≥100.00 ≥100.00 
 
4.6.2.2. Human hormone-dependent breast carcinoma cell line (MCF-7) 
The cytotoxic activity of the extract and fractions of the P. macrocarpa fruit was 
investigated and the results are shown in Table 4.24. The hexane, chloroform, ethyl 
acetate and water fractions prepared from the fruit of P. macrocarpa were tested for 
cytotoxic activity on MCF-7 cells by using the MTT assay.  
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Table 4.24: IC50 values of cytotoxic activity of P. macrocarpa fruit extract and fractions 
against the MCF-7 cell line. 
Extract/ Fractions 24h (µg/mL ) 48h (µg/mL ) 72h (µg/mL ) 
Methanol extract (FMF) ≥100.00 ≥100.00 ≥100.00 
Hexane Fraction (FHF) ≥100.00 44.10±2.38 ≥100.00 
Chloroform Fraction (FCF) 36.30±2.76 85.50±1.76 ≥100.00 
Ethyl Acetate Fraction (FEAF) 16.50±2.45 23.00±3.44 43.50±4.03 
Water Fraction (FWF) ≥100.00 ≥100.00 ≥100.00 
 
The methanol extract and hexane fraction of the P. macrocarpa fruit displayed no 
cytotoxic activity, with IC50 values of more than 100 µg/mL at 24h, 48h and 72h 
respectively. Both the chloroform and ethyl acetate fractions exhibited cytotoxic activity 
with IC50 values of 36.30±2.76 µg/mL (24h), 85.50±1.76 µg/mL (48h), ≥100.00 µg/mL 
(72h) for the methanol extract, and with IC50 values of 16.50±2.45 µg/mL (24h), 
23.00±3.44 µg/mL (48h), 43.50±4.03 µg/mL (72h) for the chloroform fraction as shown 
in Figures 4. 34 - 4.37. Each value is expressed as the mean ± standard deviation of three 
measurements.  
 
Figure 4.34: In vitro, growth inhibition of MCF-7 cells by methanol extract of P. 
macrocarpa fruit determined by MTT assay. 
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Figure 4.35: In vitro, growth inhibition of MCF-7 cells by hexane fraction of P. 
macrocarpa fruit determined by MTT assay. 
 
 
Figure 4.36: In vitro, growth inhibition of MCF-7 cells by chloroform fraction of P. 
macrocarpa fruit determined by MTT assay. 
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Figure 4.37: In vitro, growth inhibition of MCF-7 cells by ethyl acetate fraction of P. 
macrocarpa fruit determined by MTT assay. 
 
4.6.2.3. Human colon carcinoma cell line (HT-29) 
The cytotoxic activity of the extract and fractions of the P. macrocarpa fruit was 
investigated and the results were shown in Table 4.25. The hexane, chloroform, ethyl 
acetate and water fractions prepared from the fruit of P. macrocarpa were tested for 
cytotoxic activity on HT-29 cells by using the MTT assay.  
Table 4.25: IC50 values of cytotoxic activity of P. macrocarpa fruit extract and its 
fractions against the HT-29 cell line. 
Extract/ Fractions 24h(µg/mL ) 48h(µg/mL ) 72h(µg/mL ) 
Methanol extract (FME) 96.00±2.92 83.50±2.52 38.40±1.82 
Hexan fraction (FHF) 81.50±3.00 60.00±2.33 68.10±3.75 
Chloroform fraction (FCF) 41.20±3.66 44.00±3.76 37.00±2.65 
Ethyl acetate fraction (FEAF) 32.10±2.32 44.50±1.29 83.50±2.52 
Water fraction (FWF) ≥100.00 ≥100.00 ≥100.00 
 
Both the methanol extract and the hexane fraction of P. macrocarpa exhibited 
weak cytotoxic activity with IC50 values of 96.00±2.92 µg/mL  (24h), 83.50±2.52 µg/mL  
(48h), 38.40±1.82 µg/mL  (72h) for the methanol extract and 81.50±3.00 µg/mL  (24h), 
60.00±2.33 µg/mL  (48h), 68.10±3.75 µg/mL  (72h) for the hexane fraction. The 
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chloroform and ethyl acetate fractions displayed cytotoxic activity with IC50 values of 
41.20±3.66 µg/mL (24h), 44.00±3.76 µg/mL (48h), 37.00±2.65 µg/mL (72h) for the 
chloroform fraction, and 32.10±2.32 µg/mL (24h), 44.50±1.29 µg/mL (48h), 83.50±2.52 
µg/mL (72h) for the ethyl acetate fraction. However, the IC50 value of water fraction was 
above 100.00 µg/mL at 24h, 48h and 72h, respectively. All data were shown in Figures 
4.38 - 4.41. Each value is expressed as the mean ± standard deviation of three 
measurements. 
 
Figure 4.38: In vitro, growth inhibition of HT-29 cells by methanol extract of P. 
macrocarpa fruit determined by MTT assay. 
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Figure 4.39: In vitro, growth inhibition of HT-29 cells by hexane fraction of P. 
macrocarpa fruit determined by MTT assay. 
 
 
Figure 4.40: In vitro, growth inhibition of HT-29 cells by chloroform fraction of P. 
macrocarpa fruit determined by MTT assay. 
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Figure 4.41: In vitro, growth inhibition of HT-29 cells by ethyl acetate fraction of P. 
macrocarpa fruit determined by MTT assay. 
 
4.6.2.4. Human ovarian carcinoma cell line (SKOV-3) 
In this study, the cytotoxic activity of the extract and fractions of the P. 
macrocarpa seeds was investigated and the results were shown in Table 4.26. The hexane, 
chloroform, ethyl acetate and water fractions prepared from the seeds of P. macrocarpa 
were tested for cytotoxic activity on SKOV-3 cells by using the MTT assay.  
Table 4.26: IC50 values of cytotoxic activity of P. macrocarpa fruit extracts against the 
SKOV-3 cell line. 
Extract/Fractions 24h (µg/mL ) 48h (µg/mL ) 72h (µg/mL ) 
Methanol extract (FME) 80.00±2.44 68.10±1.81 7.70±2.56 
Hexan fraction (FHF) 10.10±2.71 69.00±2.56 72.50±3.13 
Chloroform fraction (FCF) 35.00±1.11 37.50±1.62 80.00±4.56 
Ethyl acetate fraction (FEAF) 46.00±1.14 21.80±2.58 8.10±1.81 
Water fraction (FWF) ≥100.00 ≥100.00 ≥100.00 
 
The methanol extract and chloroform fraction of P. macrocarpa Boerl displayed 
mild cytotoxic activity with IC50 values of 80.00±2.44 µg/mL  (24h), 68.10±1.81 µg/mL  
(48h), 7.70±2.56 µg/mL  (72h) for the former and 35.00±1.11 µg/mL  (24h), 37.50±1.62 
µg/mL  (48h), and 80.00±4.56 µg/mL  (72h) for the latter. The hexane fraction exhibited 
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cytotoxic activity with IC50 values of 10.10±2.71 µg/mL (24h), 69.00±2.56 µg/mL (48h), 
and 72.50±3.13 µg/mL (72h). The ethyl acetate fraction exhibited stronger cytotoxic 
activity with IC50 values of 46.00±1.14 µg/mL (24h), 21.80±2.58 µg/mL (48h), and 
8.10±1.81 µg/mL (72h). However, the IC50 value of the water fraction was more than 
100.00 µg/mL for 24h, 48h and 72h, respectively. All data are shown in Figure 4.42 – 
4.45. Each value is expressed as the mean ± standard deviation of three measurements. 
 
Figure 4.42: In vitro, growth inhibition of SKOV-3 cells by methanol extract of P. 
macrocarpa fruit determined by MTT assay. 
 
 
Figure 4.43: In vitro, growth inhibition of SKOV-3 cells by hexane fraction of P. 
macrocarpa fruit determined by MTT assay. 
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Figure 4.44: In vitro, growth inhibition of SKOV-3 cells by chloroform fraction of P. 
macrocarpa fruit determined by MTT assay. 
 
 
 
Figure 4.45: In vitro, growth inhibition of SKOV-3 cells by ethyl acetate fraction of P. 
macrocarpa fruit determined by MTT assay. 
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4.6.2.5. Human hormone-independent breast carcinoma cell line 
(MDA-MB231) 
The cytotoxic activity of the extract and fractions of the P. macrocarpa seeds was 
investigated and the results were shown in Table 4.27. The hexane, chloroform, ethyl 
acetate and water fractions prepared from the seeds of P. macrocarpa were tested for 
cytotoxic activity on SKOV-3 cells by using the MTT assay.  
Table 4.27: IC50 values of cytotoxic activity of P. macrocarpa fruit methanol extract 
and fractions against the MDA-MB231 cell line 
Extract/ Fractions 24h (µg/mL )  48h (µg/mL ) 72h (µg/mL ) 
Methanol extract (FME) 20.30±3.71 34.60±1.83 95.00±2.11 
Hexane fraction (FHF) 5.80±2.15 4.60±1.32 34.30±2.19 
Chloroform fraction (FCF) 14.60±1.45 7.80±1.57 15.30±1.72 
Ethyl acetate fraction (FEAF) 6.80±2.08 6.40±1.09 16.20±2.40 
Water fraction (FWF) ≥100.00 ≥100.00 ≥100.00 
 
The methanol extract of the P. macrocarpa fruits displayed mild cytotoxic activity 
with IC50 values of 20.3±3.71 µg/mL (24h), 34.6±1.83 µg/mL (48h), and 95.00±2.11 
µg/mL (72h). Both the hexane and chloroform fractions inhibited cytotoxic activity with 
IC50 values of 5.80±2.15 µg/mL (24h), 4.60±1.32 µg/mL (48h), and 34.30±2.19 µg/mL 
(72h) for the hexane fraction and 14.60±1.45 µg/mL (24h), 7.80±1.57 µg/mL  (48h), and 
15.30±1.72 µg/mL  (72h) for the chloroform fraction. The ethyl acetate fraction exhibited 
stronger cytotoxic activity with IC50 values of 6.80±2.08 µg/mL (24h), 6.40±1.09 µg/mL 
(48h), and 16.20±2.40 µg/mL (72h). However, the IC50 value of the water fraction was 
more than 100.00 µg/mL at 24h, 48h and 72h, respectively. All data are shown in Figures 
4.46 - 4.49. Each value is expressed as the mean ± standard deviation of three 
measurements. 
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Figure 4.46: In vitro, growth inhibition of MDA-MB231 cells by methanol extract of P. 
macrocarpa fruit determined by MTT assay. 
 
 
Figure 4.47: In vitro, growth inhibition of MDA-MB231 cells by hexane fraction of P. 
macrocarpa fruit determined by MTT assay. 
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Figure 4.48: In vitro, growth inhibition of MDA-MB231 cells by chloroform fraction of 
P. macrocarpa fruit determined by MTT assay. 
 
 
 
Figure 4.49: In vitro, growth inhibition of MDA-MB231 cells by ethyl acetate fraction 
of P. macrocarpa fruit determined by MTT assay. 
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4.6.2.6. Discussion  
The methanol extract, and the hexane, chloroform, ethyl acetate, and water 
fractions of the P. macrocarpa fruits were investigated for cytotoxic effects in human 
epithelioid cervical carcinoma cells (Ca Ski), human hormone-dependent breast 
carcinoma cells (MCF-7), human epithelioid colon carcinoma cells (HT-29), human 
ovarian carcinoma cells (SKOV-3), human hormone-independent breast carcinoma cells 
(MDA-MB231) and normal cells (MRC-5) by using the MTT cell proliferation assay at 
24h, 48hand 72h, respectively.  
In the breast cancer cell (MDA-MB231), the methanol extract of P. macrocarpa 
fruits displayed good IC50 values of 20.30±3.71 µg/mL at 24h. The IC50 values measured 
at 48h and 72h of treatment with the methanol extract in MDA-MB231 were 34.60±1.83 
and 95.00±2.11 µg/mL, respectively. The MTT cell proliferation assay showed the 
highest value of IC50 in the ovarian cancer cells (SKOV-3) treated with methanolic extract 
for 72h. The IC50 values of the SKOV-3 cells were 7.70±2.56 µg/mL at 72h, but the low 
IC50 values of the methanol extract in SKOV-3 were 80.00±2.44 and 68.10±1.81 µg/mL 
at 24h and 48h, respectively. The methanolic extract displayed moderate cytotoxic 
activity in HT-29 cells with IC50 values of 38.50±1.82 µg/mL at 72h and very low 
cytotoxic activity with IC50 values of 83.50±2.52 and 68.10±1.81 µg/mL at 24h and 48h. 
However, the methanol extract had no cytotoxic effect against the Ca Ski and MCF-7 
cells with IC50 100.00 µg/mL. Furthermore, this extract also did not show any cytotoxic 
effect on normal MRC-5 cells with IC50 100.00 µg/mL. Therefore, the methanol extract 
revealed a highly cytotoxic effect in SKOV-3 at 72h and MDA-MB231 at 24h, a moderate 
cytotoxic effect at 48h in MDA-MB-231 and HT-29 at 72h, a very low cytotoxic effect 
in HT-29 at 24h and 48h and SKOV-3 at 24h and 48h, and had absolutely no cyctotoxic 
effect in the MCF-7, Ca Ski and MRC-5 cells. 
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The hexane fraction of the P. macrocarpa fruits exhibited a good cytotoxic effect 
with IC50 values of 10.15±2.71 µg/mL at 24h in SKOV-3, 5.80±2.15 and 4.60±1.32 
µg/mL at 24h and 48h in MDA-MB 231. The IC50 values of treatment with the hexane 
fraction in MDA-MB231 were 34.30±2.19 µg/mL at 72h and the IC50 values of treatment 
in SKOV-3 were 69.00±2.56, 72.50±3.13 µg/mL at 24h and 48h. Additionally, the hexane 
fraction displayed a moderate cytotoxic effect on HT-29 cells with IC50 values of 
81.50±3.0, 60.00±2.33 and 68.10±3.75 µg/mL at 24h, 48h and 72h respectively. 
Furthermore, there was no cytotoxic effect in either the Ca Ski or MCF-7 cells except 
MCF-7, with IC50 values of 44.10±2.38 µg/mL at 48h. Therefore, the hexane fraction 
revealed a high cytotoxic effect in SKOV-3 and MDA-MB231 at 24h, a moderate 
cytotoxic effect at 48h in MDA-MB231 at 48h and HT-29 at 72h, a very low cytotoxic 
effect in HT-29 at 24h and 48h, a very low cytotoxic effect in SKOV-3 at 24h and 48h, 
and no cyctotoxic effect in MCF-7, Ca Ski and MRC-5. Therefore, the hexane fraction 
revealed a high cytotoxic effect in SKOV-3 for 72h and MDA-MB231 for 24h and 48h, 
a moderate cytotoxic effect in MDA-MB231 at 48h and MCF-7 at 48h, a low cytotoxic 
effect in SKOV-3 at 48h and 72h, a low cytotoxic effect in HT-29 at 24h, 48h and 72h, 
and no cytotoxic effect in Ca Ski at 24h, 48h and 72h, as well as in MCF-7 at 24h and 
72h. 
The chloroform fraction of the P. macrocarpa fruit exhibited the highest cytotoxic 
effect with IC50 values of 14.60±1.45, 7.80±1.57 and 15.30±1.72 µg/mL  at 24h, 48hand 
72h in MDA-MB 231. In HT-29, the chloroform fraction displayed a moderate cytotoxic 
effect with IC50 values of 41.20±3.66, 44.00±3.76, 37.00±2.65 µg/mL at 24h, 48h and 
72h. Also, this chloroform fraction showed a moderate cytotoxic effect in SKOV-3 with 
IC50 values of 35.00±1.11, 37.50±1.62, 37.00±2.65 µg/mL at 24h and 48h, but had a low 
cytotoxic effect in SKOV-3 at 72h. The IC50 values for MCF-7 were 36.30±2.76 µg/mL 
at 24h but it had a low cytotoxic effect with IC50 values of 85.50±1.76 µg/mL at 48h and 
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no cytotoxic effect on MCF-7 cells with IC50 100.00 µg/mL. In contrast, the chloroform 
fraction had no cytotoxic effect against Ca Ski cells with IC50 100.00 µg/mL and also 
no cytotoxic activity on normal MRC-5 with IC50 100.00 µg/mL. To conclude, the 
chloroform fraction only showed the highest cytotoxic effect in MDA-MB 231 cells at 
24h, 48h and 72h, a moderate cytotoxic effect in MCF-7 at 24h, a moderate cytotoxic 
effect in HT-29 cells for 24h, 48h and 72h, and SKOV-3 cells at 24h and 48h, a low 
cytotoxic effect in MCF-7 at 48h and SKOV-3 cells at 72h, and no cytotoxic effect in Ca 
Ski at 24h, 48h and 72h, and also MCF-7 at 72h. 
The ethyl acetate fraction of the P. macrocarpa fruit exhibited a good cytotoxic 
effect with IC50 values of 21.85±2.58, 8.10±1.81 µg/mL at 48h and 72h in the SKOV-3 
cells, 6.80±2.08, 6.40±1.09, 16.20±2.40 µg/mL at 24h, 48h and 72h in the MDA-MB 231 
cells, 16.50±2.45, 23.00±3.44 µg/mL at 24h and 48h in the MCF-7 cells. In addition, the 
ethyl acetate fraction displayed a moderate cytotoxic effect in MCF-7 with IC50 values of 
43.50±4.03 µg/mL at 72h, and IC50 values of 46.00±1.14 µg/mL for 24h in SKOV-3. 
There was a low cytotoxic effect in the HT-29 cells with IC50 values of 83.50±2.52 µg/mL 
at 72h. On the other hand, the ethyl acetate fraction revealed no cytotoxic effect in the Ca 
Ski and MRC-5 normal cells. Therefore, the ethyl acetate fraction gave highest cytotoxic 
effect in SKOV-3 at 48h and 72h, MDA-MB 231 at 24h, 48h and 72h, MCF-7 for 24h 
and 48h.  
The water extract has no cytotoxic effect against all of the selected cancer cell 
lines namely Ca Ski, MCF-7, HT-29, SKOV-3, and MDA-MB 231 cells with IC50 
100.00 µg/mL, and also had no cytotoxic effect against MRC-5 cells with IC50 100 
µg/mL. All these results are shown in Table 4.28 and Figures 4.50 - 4.53.  
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Table 4.28: In vitro cytotoxic effects of methanolic extract, ethyl acetate fraction, 
hexane fraction and chloroform fraction of the P. macrocarpa fruits on Ca Ski, MCF-7, 
HT-29, SKOV-3 and MDA-MB231 cancer cell lines and normal human fibroblast lung 
cell line MRC-5. The cells were treated with various concentrations of the extract and 
all fractions for 24h, 48h and 72h prior to determining cytotoxicity by the MTT cell 
proliferation assay. 
Cell line  hr FME FHF FCF FEAF FWF 
 24 ≥100.00 ≥100.00 ≥100.00 ≥100.00 ≥100.00 
Ca Ski 48 ≥100.00 ≥100.00 ≥100.00 ≥100.00 ≥100.00 
 72 ≥100.00 ≥100.00 ≥100.00 ≥100.00 ≥100.00 
       
 24 ≥100.00 ≥100.00 36.30±2.76 16.50±2.45 ≥100.00 
MCF-7 48 ≥100.00 44.10±2.38 85.50±1.76 23.00±3.44 ≥100.00 
 72 ≥100.00 ≥100.00 ≥100.00 43.50±4.03 ≥100.00 
       
 24 96.00±2.92 81.50±3.0 41.20±3.66 32.10±2.32 ≥100.00 
HT-29 48 83.50±2.52 60.00±2.33 44.00±3.76 44.50±1.29 ≥100.00 
 72 38.50±1.82 68.10±3.75 37.00±2.65 83.50±2.52 ≥100.00 
       
 24 80.00±2.44 10.15±2.71 35.00±1.11 46.0±1.14 ≥100.00 
SKOV-3 48 68.10±1.81 69.00±2.56 37.50±1.62 21.85±2.58 ≥100.00 
 72 7.750±2.56 72.50±3.13 80.00±4.56 8.10±1.81 ≥100.00 
       
 24 20.30±3.71 5.80±2.15 14.60±1.45 6.80±2.08 ≥100.00 
MDA- 48 34.60±1.83 4.60±1.32 7.80±1.57 6.40±1.09 ≥100.00 
 MB231 72 95.00±2.11 34.30±2.19 15.30±1.72 16.20±2.4 ≥100.00 
Each value is expressed as the mean ±standard deviation of three measurements. 
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Figure 4.50: In vitro, cytotoxic effects of the methanolic extract, ethyl acetate fraction, 
hexane fraction, chloroform fraction and water fraction of P. macrocarpa fruit on MCF-
7 breast cancer cell line. Cells were treated with various concentrations of the extract 
and all fractions for 24h, 48h and 72h prior to determining the cytotoxicity by MTT cell 
proliferation assay. 
 
 
Figure 4.51: In vitro, cytotoxic effects of methanolic extract, ethyl acetate fraction, 
hexane fraction, chloroform fraction and water fraction of P. macrocarpa fruit on HT-
29 colon cancer cell line. Cells were treated with various concentrations of extract and 
all fractions for 24h, 48h and 72h prior to determining the cytotoxicity by MTT cell 
proliferation assay. 
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Figure 4.52: In vitro, cytotoxic effects of methanolic extract, ethyl acetate fraction, 
hexane fraction, chloroform fraction and water fraction of P. macrocarpa fruit on 
SKOV-3 ovarian cancer cell line. Cells were treated with various concentrations of 
extract and all fractions for 24h, 48h and 72h prior to determining the cytotoxicity by 
MTT cell proliferation assay. 
Figure 4.53: In vitro, cytotoxic effects of methanolic extract, ethyl acetate fraction, 
hexane fraction, chloroform fraction and water fraction of P. macrocarpa fruits on 
MDA-MB231 breast cancer cell line. Cells were treated with various concentrations of 
extract and all fractions for 24h, 48h and 72h prior to determining the cytotoxicity by 
MTT cell proliferation assay. 
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4.7. Cytotoxicity Screening of Bioactive Compounds  
The preliminary cytotoxicity screening of the different crude extracts and its 
fractions from P. macrocarpa seeds and fruits was conducted using Neutral Red assay 
and MTT cell proliferation assay. Evaluation of cytotoxic activity showed that crude 
extract and all its fractions of P. macrocarpa  possessed excellent anti-proliferative 
activity against MDA-MB231 cells line and good cytotoxic effect on HT-29 cells line and 
SKOV-3 cells but no cytotoxic activity on Ca Ski cell line after treatment in a time 
dependent and a dose dependent manner. Previous researcher revealed that 2, 4’, 6-
trihydroxy-4-methoxy-benzophenone possessed very cytotxic effect on MDA-MB231 
(US patent Ref). In my study, these compounds of P. macrocarpa also exhibited good 
cytotoxic effects on HT-29 cells and non-cytotoxic effect on normal human lung cells 
line (MRC-5) base on MTT cell proliferation assay. Therefore, HT-29 cells were selected 
for further investigation. 
4.7.1. 2, 4’, 6-Trihydroxy-4-methoxy-benzophenone  
In this study, the cytotoxicity screening of the 2, 4’, 6-trihydroxy-4-methoxy-
benzophenone on the human colon carcinoma cell line (HT-29) was performed by using 
the MTT cell proliferation assay and the cell viability of HT-29 cells was counted by 
using the trypan blue exclusion assay. The HT-29 cells were treated with varying 
concentrations (1, 10, 25, 50 and 100 µg/mL) for 24h, 48h and 72h, respectively. The 
results showed that cell growth inhibitory of HT-29 cells significantly declined in a dose- 
and time-dependent manner when the cells were treated with 50 and 100 µg/mL of the 2, 
4’, 6-trihydroxy-4-methoxy-benzophenone for 48h and 72h except with 25 µg/mL for 
24h, as shown in Figure 4.54 and Figure 4.55. The IC50 values of the compound against 
the HT-29 cells were 45.00±2.21, 37.50±2.66 and 31.80±1.69 µg/mL for 24h, 48h and 
72h. In contrast, the 2, 4’, 6-trihydroxy-4-methoxy-benzophenone mildly exhibited 
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cytotoxic effect on normal human fibroblast lung cells (MRC-5), with an IC50 value of 
100.00 µg/mL.  
 
Figure 4.54: In vitro, cytotoxic effects of the 2, 4', 6-trihydroxy-4-
methoxybenzophenone on HT-29 colon cancer cells. Cells were treated with various 
concentrations of the compound derived from the ethyl acetate fraction of P. 
macrocarpa fruit for 24h, 48h and 72h prior to determining the cytotoxicity by MTT 
cell proliferation assay. 
 
Figure 4.55: In vitro, cytotoxic effects of the 2, 4', 6-Trihydroxy-4-
methoxybenzophenone on normal fibroblast lung cells. Cells were treated with various 
concentrations of the compound derived from the ethyl acetate fraction of P. 
macrocarpa fruit for 24h, 48h and 72h prior to determining the cytotoxicity by MTT 
cell proliferation assay. 
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4.7.2. 1-(2, 6-Dihydroxy-4-methoxyphenyl)-2-(4-hydroxyphenyl) ethanone  
Cytotoxicity determining, a common method used to evaluate the biological 
activity of natural products, is useful in confirming whether plant extracts have potential 
bioactive properties (Itharat et al., 2004). A common method of cytotoxicity 
determination is by examining the bioactivity of natural products, which is very useful in 
discovering new drugs. 
In this study, the cytotoxicity screening of the 1-(2, 6-dihydroxy-4-
methoxyphenyl)-2-(4-hydroxyphenyl) ethanone on a human colon adenocarcinoma cell 
line (HT-29) was examined by using the MTT cell proliferation method and the cell 
viability of the HT-29 cells was counted by using the trypan blue exclusion assay. The 
HT-29 cells were treated with various concentrations (1, 10, 25, 50 and 100 µg/mL) of 
the compound for 24h, 48h and 72h, respectively.  
The results showed that cell growth inhibitory of HT-29 cells significantly 
decreased in a dose- and time-dependent manner when the HT-29 cells were treated with 
the compound at 50 and 100 µg/mL  for 48h and 72h, except with 25µg/mL  for 24h as 
shown in Figure 4.56 and Figure 4.57. The IC50 values of the 1-(2, 6-Dihydroxy-4-
methoxyphenyl)-2-(4-hydroxyphenyl) ethanone against HT-29 cells were 38.80±1.64, 
17.20±2.29 and 25.30±0.99 µg/mL  for 24h, 48h and 72h. In contrast, the proliferation of 
the normal human fibroblast breast cell line MRC-5 was very lowly affected by treatment 
with the 1-(2, 6-dihydroxy-4-methoxyphenyl)-2-(4-hydroxyphenyl) ethanone with IC50 
value .  
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Figure 4.57: In vitro, cytotoxic effects of 1-(2, 6-Dihydroxy-4-methoxyphenyl)-2-(4-
hydroxyphenyl) ethanone on normal fibroblast lung cells. Cells were treated with 
various concentrations the 1-(2, 6-Dihydroxy-4-methoxyphenyl)-2-(4-hydroxyphenyl) 
ethanone compound derived from the ethyl acetate fraction of the P. macrocarpa fruit 
for 24h, 48h and 72h, prior to determining cytotoxicity by MTT cell proliferation assay. 
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Figure 4.56: In vitro, cytotoxic effects of 1-(2, 6-Dihydroxy-4-methoxyphenyl)-2-(4-
hydroxyphenyl) ethanone on HT-29 colon cancer cells. Cells were treated with various 
concentrations the 1-(2, 6-Dihydroxy-4-methoxyphenyl)-2-(4-hydroxyphenyl) ethanone 
compound derived from the ethyl acetate fraction of the P. macrocarpa fruit for 24h, 48h 
and 72h, prior to determining cytotoxicity by MTT cell proliferation assay. 
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4.7.3. (Z)-9, 17-Octadecadienal  
In this study, the cytotoxicity screening of the compound on the human colon 
carcinoma cell line (HT-29) was examined by using the MTT cell proliferation method 
and the cell viability of the HT-29 cells were counted by using the trypan blue exclusion 
assay. HT-29 cells were treated with various concentrations (1, 10, 25, 50 and 100 µg/mL) 
of the 9, 17-octadecadienal for 24h, 48h and 72h, respectively.  The results showed that 
cell growth inhibitory of HT-29 cells decreased in a dose- and time- dependent manner 
when they were treated with the compound at 1, 10, 25, 50 and 100 µg/mL for 24h, 48h 
and 72h, except with 25µg/mL for 24h, as is shown in Figure 4.58 and Figure 4.59. The 
IC50 values of the compound against HT-29 cells were 19.10±1.26, 16.20±0.70 and 
3.20±0.13 µg/mL for 24h, 48h and 72h. In contrast, the proliferation of the normal human 
fibroblast lung cell line MRC-5 was very lowly affected by treatment with the compound 
with IC50 value in a time- and dose-dependent manner.  
 
Figure 4.58: In vitro, cytotoxic effects of 9, 17-octadecadienal on HT-29 colon cancer 
cells. Cells were treated with various concentrations of 9, 17-octadecadienal (z) from 
ethyl acetate fraction of P. macrocarpa fruit for 24h, 48h and 72h prior to determining 
cytotoxicity by MTT cell proliferation assay. 
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Figure 4.59: In vitro cytotoxic effects of 9, 17-octadecadienal (z) on normal fibroblast 
lung cells. Cells were treated with various concentrations of 9, 17-octadecadienal (z) 
from ethyl acetate fraction of P. macrocarpa fruit for 24h, 48h and 72h prior to 
determining cytotoxicity by MTT cell proliferation assay. Each value is expressed as the 
mean ±standard deviation of three measurements.
0
10
20
30
40
50
60
70
80
90
100
1 10 25 50 100
24 h 48 h 72 h
MRC-5
P
er
ce
n
ta
ge
o
f 
In
h
ib
it
io
n
 (
%
)
Concentration (µM)
122 
 
PART C: APOPTOSIS STUDIES ON ISOLATED BIOACTIVE COMPOUNDS 
FROM PHALERIA MACROCARPA (SCHEFF.) BOERL 
4.8. Apoptosis Studies  
Apoptosis plays an important role in cancer prevention, and therapeutics can 
manipulate apoptosis to promote tumour cell death. Apoptosis is a form of programmed 
cell death, used by multi-cellular organisms to rid themselves of extraneous cells (Potten, 
2004). 
4.8.1. 2, 4', 6-Trihydroxy-4-methoxybenzophenone  
4.8.1.1. Inverted and Phase contrast microscopic examination 
HT-29 cells were treated with 2, 4', 6-trihydroxy-4-methoxybenzophenone at IC50 
value of concentrations (30.00 µg/mL) with the isolated bioactive compound for an 
incubation period of 24h, 48h and 72h respectively. After these incubation periods, the 
morphological changes in the cells were examined by using inverted and phase-contrast 
microscopy. The cells displayed changes that were known to be associated with apoptosis 
including membrane blebbings, cell shrinkage, chromatin condensation, apoptotic nuclei 
and DNA fragmentation, based on the respective time increase. As such, the compound 
has been shown to trigger morphological changes in the apoptotic bodies in HT-29 cells 
(Figure 4.60 and 4.61). 
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Figure 4.60: HT-29 cells treated with the compound (30 µg/mL) for 24h, 48h and 72h 
were shown to undergo morphological changes typical of apoptosis. Control or treated 
cells were observed under inverted microscope and photographed. 
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Figure 4.61: Treatment with 2, 4', 6-trihydroxy-4-methoxybenzophenone for 24h, 48h 
and 72h induced morphological changes typical of apoptosis in HT-29 colon cancer 
cells. Control or treated cells were observed under phase contrast microscopy and 
photographed. 
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4.8.1.2. Fluorescence microscopic examination 
The cells were observed under a fluorescent microscope at different excitations 
after staining with acridine orange and propidium iodide (AO/PI) for nuclei containing 
DNA. The results showed that the viable cells revealed green nuclei, dead cells, late 
apoptotic and the necrotic cells displayed red nuclei and early apoptotic cells displayed 
orange nuclei as shown in Figure 4.62. Thus, AO/PI staining of HT-29 showed that the 
cells had undergone morphological changes associated to apoptosis. Apoptosis is 
evidenced by AO/PI double staining. Morphological study of HT-29 cells cultryed in 3 
wells Lab-Tek II chamber slide and treated with 30.00 µg/mL for 72h. After incubation, 
cells were stained with AO/PI to detect apoptosis. Images were captured at different 
settings, AO: Acridine Orange, PI: propidium iodide. Viable cells excluded propidium 
iodide and their nuclei were bright green with intact structure, while apoptotic cells were 
organge to red color with highly condensed nuclei. 
 
Figure 4.62: Treatment with IC50 value (30 µg/mL) of 2, 4', 6-trihydroxy-4-
methoxybenzophenone for 48h induces morphological changes typical of apoptosis in 
HT-29 colon cancer cells. After being stained with acridine orange and propidium 
iodide, treated cells were observed under fluorescence microscopy for live cells stained 
(green colour), apoptotic cells (orange colour) and necrotic cells or dead cells (red 
colour). All images used different filters without using overlay.  
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4.8.1.3. Annexin V staining assay 
The most often exploited important molecular mechanism used in the treatment 
of anti-cancer drugs is programmed cell death or apoptosis as seen in chemotherapeutic 
approach (Call et al., 2008; Dickson & Schwartz, 2009).  In this report, staining with 
Annexin V-FITC and propidium iodide (PI) will allow the distinction between intact cells 
or early apoptosis cells from late apoptosis or dead cells (Cheng et al., 2004).  Single 
staining was also used with only Annexin V-FITC or PI was used to distinguish between 
live cells and dead cells. However, single staining could not distinguish between early 
apoptotic cells, late apoptotic cells or dead cells, or necrotic and live cells.  
Cells were treated with various concentrations (25 µg/mL, 50 µg/mL and 75 
µg/mL) of the compound for 24h, 48h and 72h. They were then harvested with accutase 
and phosphate buffer saline solution and centrifuged, after which they were stained with 
Annexin V-FITC and propidium iodide and analysed in FACScalibur with CellQuest Pro 
software. The number of early apoptotic cells, late apoptotic cells, live cells and necrotic 
cells were counted in every 10,000 cells for each treatment (Yuan et al., 2012).  All data 
were expressed as the mean ± SD (standard deviation). The standard deviation was 
calculated for the treated and untreated cells. The SPSS program (version 16.0) found a 
significant difference between the treated and untreated cells (p <0.05).  
During the flow cytometry analysis in Annexin V/PI double staining, late or 
secondary necrotic apoptotic cells were visible in the upper right (UR) and early apoptotic 
cells were visible in the lower right (LR) quadrants while primary necrotic cells were 
visible in the upper left (UL) and live cells were visible in the lower left (LL) quadrants 
respectively. In untreated HT-29 cells, 92.28% of the cells were viable, 1.85% was in 
early apoptosis and 3.21% cells were in late apoptosis or secondary necrotic stage.  
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Table 29: Total cells percentage of viable cells (LL), early apoptotic cells (LR), necrotic 
dead cells (UL) and late apoptotic/secondary necrotic cells (UR) of HT-29 treatment 
with different concentration of compound for 24h, 48h and 72h. Most results showed 
that a statistical significant difference in a time dependent manner and in a dose 
dependent manner (* shown that statistical significant). 
 Concentratio
n (µg/mL) 
viable cells 
(LL) 
early 
apoptotic 
cells (LR) 
necrotic 
dead cells 
(UL) 
late 
apoptotic/ 
secondary 
necrotic cells 
(UR) 
Hour
s 
Untreated 92.28±1.25* 2.66±0.24* 1.85±1.23 3.21±1.25* 
 25 69.26±2.86* 2.96±0.17* 15.49±1.35* 12.28±1.40* 
24 50 35.16±1.11 8.46±2.67 30.40±1.66* 25.98±1.14 
 75 22.85±1.61* 6.71±2.17* 19.63±1.06* 50.81±2.39* 
 25 49.00±1.21 10.87±1.77* 8.04±0.91 32.48±2.89* 
48 50 34.22±2.86* 4.74±1.17* 35.05±1.61* 25.99±1.14 
 75 26.80±1.91* 8.51±3.17* 10.02±1.26 54.67±2.59* 
 25 52.21±3.06* 1.33±0.83 30.69±2.50* 15.77±1.40* 
72 50 12.73±2.91* 14.34±1.67* 13.96±1.58 58.97±2.79* 
 75 54.64±2.76* 0.28±1.33* 36.63±2.65* 8.45±2.40* 
 
When the HT-29 cells were treated with 25 µg/mL, 50 µg/mL and 75 µg/mL of 
the compound for 24h, the viable cells were 69.26%, 35.16% and 23.83%, the primary 
necrotic cells were 15.49%, 30.40% and 19.63%, the early apoptotic cells were 2.96%, 
8.46% and 6.71% and, late apoptotic cells were 12.28%, 25.98% and 50.81% 
respectively. After 48h incubation, live cells were at 49.61%, 34.22% and 26.80%, 
primary necrotic cells were at 8.04%, 35.05% and 10.02%, early apoptotic cells were at 
10.87%, 4.74% and 8.51% and late apoptotic cells were at 31.48%, 25.55% and 54.67%, 
respectively. After 72h incubation, live cells were at 52.21%, 12.73% and 54.64%, 
primary necrotic cells were at 30.69%, 13.96% and 36.63%, early apoptotic cells were at 
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1.33%, 14.34% and 0.28%, and late apoptotic or secondary necrotic cells were at 15.77%, 
58.97% and 8.45% respectively. All these data are shown in Table 4.29, Figure 4.63 and 
Figure 4.64. 
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Figure 4.63: Effects of 2, 4', 6-Trihydroxy-4-methoxybenzophenone on induction of 
apoptosis in HT-29 cells. The cells were treated with different concentration of 
compounds (25 µg/mL , 50 µg/mL  and 75 µg/mL ) in a time dependent manner (24h, 
48h and 72h), labelled with FITC Annexin V and PI. Viable cells = LL; Early apoptotic 
cells = LR; Late or secondary necrotic cells = UR; primary necrotic cells = UL. 
 
During apoptosis there is a lag period between PS positivity and PI positivity 
while in necrotic cells both events coincide (Krysko et al, 2008). The results in this study 
showed very low percentage of cells were in the early apoptotic stage (LR quadrant). For 
example, when cells were treated with compound at a concentration of 50 µg/mL after 
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72hours of incubation, 58.97% cells were in the late secondary necrotic stage whilst only 
14.34% were in the early apoptotic stage. This situation was also observed after 24 h and 
48 h of treatment. After 24h and 48h of treatment, 61.48% and 25.99% were at late 
apoptotic stage respectively. Only a small percentage of cells were at the early apoptotic 
stage i.e 8.46% and 4.74% respectively for the period mentioned. A similar situation was 
also observed when cells were treated with 75 µg/mL of compound for 24, 48 and 72h. 
These strongly suggested that the compound induced necrotic cell death coupled with low 
level apoptotic cell death in HT-29 cells. Further confirmation of necrotic and apoptotic 
cell death need to be conducted using other bioassays.  
 
 
Figure 4.64: Histogram representation of the quantitative percentage of viable cells 
(LL), early apoptotic cells (LR), primary necrotic cells (UL) and late apoptotic cells or 
secondary necrotic cells (UR) of HT-29 treatment with different concentrations of 2, 4', 
6-Trihydroxy-4-methoxybenzophenone for 24h, 48h and 72h.  
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 Therefore, the results indicate that apparent low levels of apoptosis on HT-
29 colon adenocarcinoma cells were induced by 2, 4', 6-trihydroxy-4-
methoxybenzophenone in a time- and dose-dependent manner.  
 
4.8.1.4. Cell cycle analysis  
One of the most important mechanisms in anti-cancer drug treatment is cell cycle 
arrest, which is measured by DNA content levels. DNA (deoxyribonucleic acid) plays an 
essential role in cell reproduction, cell life and cell death. It also carries genetic 
information for all living organisms and consists of two sets of chromosomes (Call et al., 
2008; Dickson & Schwartz, 2009).When 2N DNA is present in the G0 and G1 phase of 
each cell cycle, the G2 and M phase in the cell cycles are presented by 4N DNA which 
has a double 2N number of chromosomes, while the S-phase synthesizes DNA replication 
by using flow cytometry analysis. 
The HT-29 cells were treated with 2, 4', 6-trihydroxy-4-methoxybenzophenone 
for 24h, 48h and 72h. Treated and untreated cells were harvested with accutase and 
phosphate buffer saline, centrifuged and stained with propidium iodide. The HT-29 cells 
were then analysed by flow cytometry using CellQuest Pro software and their distribution 
in different phases of the cell cycle is shown in Figure 4.65. The resulting data were 
tabulated using the trial version of the ModFit L.V 4.0 software in order to represent a 
percentage of each cell cycle phase (G0/G1, S and G2/M), as shown in Figure 4.66.  
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Figure 4.65: HT-29 cell treated with the IC50 value (30 µg/mL) concentrations of 2, 4', 
6-Trihydroxy-4-methoxybenzophenone for 24h, 48h and 72h, and analyzed by flow 
cytometry after staining with PI was conducted.  Percentages of the diploid cells (DNA 
content) at G0/G1, S, and G2/M phases of HT-29 cells were determined after 24h, 48h 
and 72h incubation periods. 
 
 
Figure 4.66: Histogram showing quantitative percentage of diploid cells (DNA content) 
in each cell cycle phase without treatment and with treatment. All results were statistical 
significant difference in the cell cycle phases between treated cells and untreated cells 
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Treatment with the 2, 4', 6-trihydroxy-4-methoxybenzophenone (at IC50 value of 
30 µg/ mL) resulted in cell cycle arrest in the G0/G1 phase in a time-dependent manner. 
Standard deviation was calculated for the treated and untreated cells. The significance of 
the difference between the treated and untreated cells in each cell cycle phase, namely 
G0/G1, S and G2/M, was determined by Student's t-test and the p-value using SPSS version 
16.0 was <0.05.   
After incubation for 24h, 48h and 72h, the percentage of the diploid cells in the 
G0/G1 phase progressively increased to 70.69%, 79.98% and 88.21% and, the cell 
percentage in the G2/M and S phase were 13.61%, 3.17% and 3.20% and 15.70%, 16.85% 
and 8.60% respectively (Figure 4.67). The aneuploid cells in the G0/G1 and S phases were 
not stable because of abnormal chromosome problems in the centrioles where extra or 
missing chromosomes occurred.  
Every diploid cell has two sets of chromosomes (2N) which occur in the G0/G1 
phase of each cell cycle and tetraploid cells have double the normal 2N number of 
chromosomes (4N), which occur in the G2/M phase of each cell cycle. However, 
aneuploidy, which refers to an abnormal number of chromosomes, was observed as a 
significant difference between the G0/G1 and G2/M phases in the flow cytometry analysis. 
It was observed that the number of diploid cells and tetraploid cells in the G0/G1 and S 
phase of each cell cycle were heavily reliant on one another. 
Thus, the result shown here indicate that 2, 4', 6-trihydroxy-4-
methoxybenzophenone at 30 µg/mL  induced cell death in HT-29 cells during G0/G1 
arrest and the inhibition of cell growth could be a result of the induction of necrosis and 
apoptosis, which may be resolved by cell cycle arrest, that  may consequently result in 
programmed cell death.  
134 
 
4.8.2. 1-(2, 6-Dihydroxy-4-methoxyphenyl)-2-(4-hydroxyphenyl) ethanone  
4.8.2.1. Inverted and phase contrast microscopic examination 
Morphological changes in the HT-29 cell line that is treated with the 1-(2, 6-
dihydroxy-4-methoxyphenyl)-2-(4-hydroxyphenyl) ethanone were observed under an 
inverted and phase contrast microscope (Leica, Germany). The cells indicated the highest 
effects after treatment with DMHE for 48h. Microscopic observations revealed that more 
than 50% of the cells showed membrane blebbing, ballooning, chromatin condensation, 
and the formation of apoptotic bodies as shown in Figure 4.67 and Figure 4.68. Therefore, 
we have proven that HT-29 cells that are treated with the compound displayed significant 
morphological changes of apoptotic bodies during direct observation in inverted and 
phase-contrast microscopic examinations.
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Figure 4.67: Treatment with 1-(2, 6-dihydroxy-4-methoxyphenyl)-2-(4-hydroxyphenyl) 
ethanone  for 24h, 48h and 72h induces morphological changes typical of apoptosis in 
HT-29 colon cancer cells. Control or treated cells were observed under inverted 
microscope and photographed. 
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Figure 4.68: Treatment with 1-(2, 6-dihydroxy-4-methoxyphenyl)-2-(4-hydroxyphenyl) 
ethanone  for 24h, 48h and 72h induces morphological changes typical of apoptosis in 
HT-29 colon cancer cells. Control or treated cells were observed under phase contrast 
microscope and photographed. 
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4.8.2.2. Fluorescence microscopic examination 
Morphological changes of individual HT-29 cells in the cell population were 
observed by fluorescence microscopy. The AO/PI (acridine orange and propidium iodide) 
procedure was found to stain the DNA within the nuclei. My results showed that viable 
cells displayed bright green nuclei, early apoptotic cells exhibited orange nuclei, and 
necrotic cells or dead cells displayed red nuclei as is shown in Figure 4.69. Thus, the 
morphological analysis of AO/PI stained HT-29 cells indicate significant morphological 
changes. Therefore, the morphological analysis of AO/PI stained HT-29 cells indicate 
significant morphological changes.  
 
Figure 4.69: Treatment with IC50 value of 1-(2, 6-dihydroxy-4-methoxyphenyl)-2-(4-
hydroxyphenyl) ethanone for 48h induces morphological changes typical of apoptosis in 
HT-29 colon cancer cells. After being stained with acridine orange and propidium 
iodide, treated cells were observed under fluorescence microscopy and cells appeared 
under the imagez of live cells (green colour), necrotic cells orange colour) and apoptotic 
cells or death cells (red colour). All images used different filters without using overlay. 
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4.8.2.3. Annexin V staining assay 
Apoptosis is a type of programmed cell death, used by multicellular organism to 
purge extraneous cells. It differs from necrosis in that it lasts a lifetime and is actually 
beneficial to the body, while necrosis is itself, a form of cell death caused by acute cellular 
damage (Potten & James, 2004). Double staining with annexin V-FITC (fluorescein-
isothiocyanate) and a propidium iodide solution can help to distinguish necrotic cells, live 
cells, early apoptotic cells and late apoptotic cells or dead cells. Flow cytometry results 
of double staining done with Annexin V-FITC and propidium iodide solution can be 
interpreted as follows: the upper left quadrant (UL)—primary necrotic cells, the upper 
right (UR)—late apoptotic or secondary necrotic cells, the lower left quadrant (LL) -
viable or live cells and the lower right quadrant (LR)- cells were undergoing apoptosis 
(Figure 4.70). All data were expressed as the mean ± SD (standard deviation). The 
standard deviation was calculated for the treated and untreated cells. The SPSS program 
(version 16.0) found a significant difference between the treated and untreated cells (p 
<0.05). 
 
Control32.48% 
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Figure 4.70: Effects of 1-(2, 6-dihydroxy-4-methoxyphenyl)-2-(4-hydroxyphenyl) 
ethanone on the induction of apoptosis in HT-29 cells. The cells were treated with 
different concentration of compound (25, 50 and 75 µg/mL )  in a time dependent 
manner (24h, 48h and 72h), labelled with FITC annexin V and PI. Viable cells (LL); 
Early apoptotic cells (LR); Late apoptotic cells or dead cells (UR); Necrosis (UL). 
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Figure 4.71: Histogram representation of the quantitative percentage of viable cells 
(LL), early apoptotic cells (LR), necrotic cells (UL) and late apoptotic cells (UR) of 
HT-29 treatment done with different concentration of 1-(2, 6-dihydroxy-4-
methoxyphenyl)-2-(4-hydroxyphenyl) ethanone (DMHE) for 24h, 48h and 72h. 
The results showed that for untreated HT-29 cells, 92.28% of the cells were viable, 
2.66% in early apoptosis, 1.85% of the cells were necrotic cells and 3.21% of the cells 
were in late apoptosis or were dead cells. In HT-29 cells treated with 25 μg/mL, 50 μg/mL 
and 75 μg/mL of DMHE, the percentage of viable cells decreased to 78.39%, 74.16% and 
68.54%, the percentage of necrotic cells were 2.85%, 2.88% and 20.72%, early apoptotic 
cells decreased to 2.66%, 2.00% and 0.48%, and dead or late apoptotic cells were 16.10%, 
20.96% and 10.26% respectively (for 24h incubation). After 48h incubation, the live cells 
decreased to 76.66%, 73.60% and 66.23%, the necrotic cells were 8.60%, 6.96% and 
22.59%, the early apoptotic cells were 1.42%, 6.24% and 1.16%, and the dead or late 
apoptotic cells decreased to 13.32%, 13.24% and 10.02%. After 72h of incubation, the 
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live cells decreased to 74.87%, 70.82% and 30.37%, the necrotic cells were 3.33%, 
12.90% and 41.90%, the early apoptotic cells decreased to 3.17%, 2.12% and 1.02%, and 
the late apoptotic or dead cells were 18.64%, 14.15% and 27.26%. As shown in Figure 
4.70 and Table 4.30, the early apoptotic cells (LR) was almost absent. In this condition, 
it is difficult to ascertain whether the cells in UR are necrotic or late apoptotic cells. 
Table 30: Total cells percentage of viable cells (LL), early apoptotic cells (LR), necrotic 
dead cells (UL) and late apoptotic/secondary necrotic cells (UR) of HT-29 treatment 
with different concentration of compound for 24h, 48h and 72h. Most results showed 
that a statistical significant difference in a time dependent manner and in a dose 
dependent manner (* shown that statistical significant). 
 
Hour
s 
 
Concentratio
n (µg/mL) 
 
viable cells 
(LL) 
 
early 
apoptotic 
cells (LR) 
 
necrotic 
dead cells 
(UL) 
late 
apoptotic/secondar
y necrotic cells 
(UR) 
 Untreated 92.28±1.67* 2.66±0.11* 1.85±1.40* 3.21±0.92* 
 25 78.39±1.12* 2.66±0.17* 2.85±2.21 16.10±1.39* 
24 50 74.16±2.40* 2.00±0.33* 2.88±1.80* 20.96±2.89* 
 75 68.54±1.78* 0.48±1.33 20.72±1.65* 10.26±1.38 
 25 76.66±1.21* 1.42±0.89 8.60±1.01* 13.32±1.87* 
50 50 73.60±3.20* 6.24±1.67* 6.96±2.10* 13.24±1.39* 
 75 66.23±1.20* 1.16±0.83 22.59±2.09* 10.02±3.39* 
 25 74.87±0.81 3.17±0.17* 3.33±2.40* 18.64±2.85* 
72 50 70.82±3.10* 2.12±0.33* 12.90±1.24* 14.15±3.39* 
 75 30.37±1.98* 1.20±0.83* 41.17±1.30* 27.26±2.89* 
The results in this study suggest that although apoptosis may be one of the 
mechanisms by which 1-(2, 6-dihydroxy-4-methoxyphenyl)-2-(4-hydroxyphenyl) 
ethanone (DMHE) induces cell death, the primary mechanism involved may be necrosis. 
This effect was shown to be both dose- and time-dependent. All corresponding data are 
shown in Figure 4.70 and Figure 4.71. 
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4.8.2.4. Cell cycle analysis  
Cell cycle arrest and apoptosis are two important mechanisms involved in anti-
cancer drug treatment (Call et al., 2008; Dickson & Schwartz, 2009). The cell cycle plays 
an important role in cell fate, including cell replication, cell death, and cell function. The 
cell cycle consists of five stages: the first is the S phase, during which DNA replication 
occurs; the second is the G1 phase, which follows mitosis and during which the cell is 
sensitive to positive and negative cues from growth signaling networks; the third stage is 
the G2 phase, which is preceded by the S phase when the cell prepares for entry into 
mitosis; the next stage is mitosis or M phase, during which the cell divides into two 
daughter cells which have genetic material identical to each other and to the mother cell; 
and the final stage is the G0 phase, which is when cells have reversibly withdrawn from 
the cell division cycle in response to high cell density. 
Terminal differentiation or senescent out-of-cycle states are also possible, 
resulting in cells that are irreversibly withdrawn from the cell cycle. The synthesis of 
DNA and DNA staining increases during the S phase. The G2 phase is when 4n DNA is 
present just before mitosis and the M phase is when 4n DNA is present during mitosis 
itself. These phases are indistinguishable from one another by using just a DNA probe 
and a flow cytometer. 
All results showed that a statistical significant difference in the cell cycle phases 
between treated cells and untreated cells (negative control) in the G0/G1, S, and G2/S 
phases. Compared to the negative control, DMHE treatment for 24h, 48h and 72h induced 
an acceptable arrest of HT-29 cells in the G0/G1 phase of the cell cycle. Following 
treatment with DMHE for various time periods (24h, 48h and 72h), the HT29 cells were 
stained with PI (propidium iodide). The distribution of the cells in the various phases of 
the cell cycle was then analyzed with a flow cytometer and the percentage of cells in the 
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G0/G1 phase, the S phase and the G2/M phase were calculated by using Modfit software. 
The results are presented in Figure 4.75 and Figure 4.72. 
 
 
 
Figure 4.72: Effect of 1-(2, 6-dihydroxy-4-methoxyphenyl)-2-(4-hydroxyphenyl) 
ethanone (DMHE) on HT-29 cell cycle. Cells treated with compound (25μg/mL) for 
24h, 48h and 72h, and analyzed by flow cytometry after staining with PI. Percentages of 
the diploid cells (DNA content) at G0/G1, S, and G2/M phases of HT-29 cells were 
determined after 24h, 48h and 72h incubation periods. 
 
Untreated HT-29 cells 24h  
48h 72h 
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Figure 4.73: Effects of isolated bioactive 1-(2, 6-dihydroxy-4-methoxyphenyl)-2-(4-
hydroxyphenyl) ethanone compound on the HT-29 cell cycle. Cells treated with IC50 
value of concentrations of compound for 24h, 48h and 72h, and analysed by flow 
cytometry after staining with PI. Histogram showing quantitative percentage of DNA 
content in each cell cycle phase without treatment and with treatment. All results were 
statistical significant difference in the cell cycle phases between treated cells and 
untreated cells 
The results showed that after 24h, 48h and 72h of treatment with 25 µg/mL of 
DMHE, the percentage of cells in the G0/G1 phase significantly increased to 63.92%, 
68.36% and 73.06%, respectively. The percentage of cells in the G2/M phase increased to 
8.13%, 24.4% and 13.84% and the percentage of cells in the S phase also dramatically 
increased to 3.54%, 7.24% and 13.1%. When the cells were treated with 25 µg/mL of the 
compound, significant G0/G1 phase arrest was observed. 
HT29 cells treated with DMHE showed significant cell cycle arrest in the G0/G1 
phase in a time-dependent manner, compared to untreated cells. The standard deviation 
was calculated between the treated and untreated cells. In untreated cells, the percentage 
of DNA content was 56.00% at the G0/G1 phase, 26.19% at the S phase and 17.81% at the 
G2/M phase. My results suggest that DMHE induces cell death in HT-29 cells. The G0/G1 
arrest and inhibition of cell growth could be a result of the induction of necrosis or late 
apoptosis, which may be mediated by cell cycle arrest in the G0/G1 phase. 
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4.8.3.  (Z)-9, 17-Octadecadienal 
4.8.3.1. Inverted and phase contrast microscopic examination 
Apoptosis plays an important role in cancer prevention, and therapeutics can 
manipulate apoptosis to promote tumour cell death. All cell types are capable of 
undergoing apoptosis, a mechanism that eliminates excessive, damaged or unwanted cells 
from an organism without damaging surrounding cells. The human body is composed 
of nearly 1014 cells. Everyday billions of cells are produced by mitosis and a similar 
number die by apoptosis to maintain tissue homeostasis. Cell death appears to be 
developmentally fixed and programmed, which is why it is also called programmed 
cell death (PCD). 
The HT-29 cells were treated with 10 µg/mL of the compound for 48h and the 
morphological changes were examined using inverted and phase-contrast microscopy. In 
Figure 4.74, direct observation by inverted microscopy revealed numerous morphological 
changes such as membrane blebbing, cell shrinkage, chromatin condensation, and 
apoptotic nuclei and many cells were detached from the culture dish. Furthermore, treated 
cells were observed by phase contrast microscopy and then we found the presence of 
apoptotic bodies more clearly as shown in Figure 4.75. Therefore, these morphological 
studies proved that there are obvious apoptotic morphological changes of treated HT-29 
cells when examined under microscopic examination. 
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Figure 4.74: Treatment with compound for 24h, 48h and 72h induces morphological 
changes that is typical of apoptosis in HT29 colon cancer cells. Control or treated cells 
were observed under inverted microscope and photographed.  
 
  
  
Control 24 h 
48 h 72 h
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Figure 4.75: Treatment with compound for 24h, 48h and 72h induces morphological 
changes that is typical of apoptosis in HT29 colon cancer cells. Control or treated cells 
were observed under phase contrast microscope and photographed. 
 
 
 
 
 
 
 
 
 
 
 
 
Control 24 h
48 h 72 h
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4.8.3.2. Fluorescence microscopic examination 
Apoptotic morphological changes of individual HT-29 cells in the cell population 
were detected by fluorescence microscopy. After 48h exposure to 9, 17-octadecadienal at 
10µg/mL, the cells showed typical apoptotic changes in nuclei containing of DNA. Live 
cells, necrotic cells and dead cells were observed in HT-29 cells that were treated with 
the compound at 10 µg/mL for 48h. The results obtained from the acridine orange 
(AO)/propidium iodide (PI) double staining are shown in Figure 4.76. The acridine 
orange has taken up both the viable and dead cells, the fluorescent green has taken up the 
live cells and the fluorescent red has taken up the dead or late apoptotic cells. Moreover, 
propidium iodide has taken up the early apoptotic or necrotic cells. Therefore, we have 
shown that HT-29 cells had undergone remarkable morphological changes through AO/PI 
staining. 
 
Figure 4.76: Treatment with compound for 48h induces morphological changes that is 
typical of apoptosis in HT29 colon cancer cells. After staining was done with acridine 
orange and propidium iodide, treated cells were observed under fluorescence 
microscopy and the image of live cells (green colour), necrotic cells (orange colour) and 
apoptotic cells or dead cells (red colour) were captured. All images used different filters 
without using overlay. 
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4.8.3.3. Annexin V staining assay 
Double staining done with Annexin V-FITC and propidium iodide solution could 
distinguish between nercotic cells, live cells, early apoptotic cells and late apoptotic cells 
or dead cells. Using the Annexin V/PI double staining assay, the lower left (LL) quadrant 
for live cells, lower right (LR) quadrant which the late apoptotic necrotic cells in the upper 
right quadrant (UR) and the upper left quadrant (UL) for dead cells or primary necrotic 
cells (Figure 4.77). All data were expressed as the mean ± SD (standard deviation). The 
standard deviation was calculated for the treated and untreated cells. The SPSS program 
(version 16.0) found a significant difference between the treated and untreated cells (p < 
0.05).  
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Figure 4.77: Effects of 9, 17-octadecadienal on induction of apoptosis in HT29 cells. 
The cells were treated with different concentrations of compound (5, 10 and 25 µg/mL ) 
in a time dependent manner (24h, 48h and 72h), labelled with FITC Annexin V and PI. 
24 h 5 µg/mL 10µg/mL 25 µg/mL 
48 h 5 µg/mL 10 µg/mL 25 µg/mL 
72 h 
5 µg/mL 10 µg/mL 25 µg/mL 
Control 
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Viable cells = LL; Early apoptotic cells = LR; Late apoptotic cells or dead cells = UR; 
Necrotic cells = UL. 
 
 
Figure 4.78: Histogram representation of the quantitative percentage of viable cells 
(LL), early apoptotic cells (LR), necrotic dead cells (UL) and late apoptotic/secondary 
necrotic cells (UR) of HT-29 treatment with different concentration of compound for 
24h, 48h and 72h. 
 
 According to our data of the untreated cells, 92.28% of the cells were viable, 
1.85% of the cells were in early apoptosis and 3.21% of cells were in late apoptosis 
/secondary necrosis. In the HT-29 cells that were treated with 5µg/mL, 10µg/mL and 
25µg/mL of compound for 24h, the percentages of viable cells were 54.13%, 45.32% and 
37.90%, the percentages for primary necrotic cells were 34.25%, 28.85% and 31.18%, 
for the early apoptotic cells the percentages were 0.31%, 4.34% and 4.02% and the 
percentages for late apoptotic cells/ secondary necrotic cells were 21.49%, 21.49% and 
26.90%, respectively.  For the 48h incubation period, the live cells were 44.77%, 19.24% 
and 8.57%, the primary necrotic cells were 9.51%, 8.57% and 13.73%, the early apoptotic 
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cells were 6.49%, 10.06% and 4.88% and late apoptotic cells  / secondary necrotic cells 
were 39.23%, 62.13% and 72.82%, respectively. After the 72h incubation, the live cells 
were 66.60%, 57.00% and 14.11%, the primary necrotic cells were 18.85%, 3.63% and 
16.84%, the early apoptotic cells were 1.97%, 17.30% and 18.34% and the late apoptotic 
or secondary necrotic cells were 12.58%, 22.06% and 50.71%, respectively when the HT-
29 cells were treated with 5µg/mL, 10µg/mL and 25µg/mL of the compound. All these 
data are shown in Table 4.31, Figures 4.77 and Figure 4.78. 
Table 4.31: Total cells percentage of viable cells (LL), early apoptotic cells (LR), 
necrotic dead cells (UL) and late apoptotic/secondary necrotic cells (UR) of HT-29 
treatment with different concentration of 9, 17-octadecadienal for 24h, 48h and 72h. 
All most  results showed that a statistical significant difference in a time dependent 
manner and in a dose dependent manner (* shown that statistical significant). 
 
Hour
s 
 
Concentratio
n (µg/mL) 
 
viable cells 
(LL) 
 
early 
apoptotic 
cells (LR) 
 
necrotic dead 
cells (UL) 
late 
apoptotic/ 
secondary 
necrotic cells 
(UR) 
 Untreated 92.28±1.67* 2.66±0.11* 1.85±1.40* 3.21±0.92* 
 5 54.13±1.14* 0.31±0.33 34.25±2.61* 11.49±3.90* 
24 10 45.32±2.23 4.34±0.67* 28.85±2.16* 21.49±0.89* 
 25 37.90±1.20 4.02±1.88* 31.18±1.81* 26.90±1.19* 
 5 44.77±2.10* 6.49±1.67* 9.51±2.16* 39.23±1.79* 
48 10 19.24±1.56 10.06±3.67 8.57±0.86* 62.13±2.94 
 25 8.57±2.38 4.88±1.17* 13.73±3.58 72.82±3.49* 
 5 66.6±2.92* 1.97±0.33* 18.85±3.26* 12.58±4.90* 
72 10 57.00±1.99 17.30±0.72* 3.63±2.76* 22.06±3.40* 
 25 14.11±2.55* 18.34±0.77* 16.84±1.08* 50.71±2.39* 
 
153 
 
Therefore, the results show that cell death of the HT-29 colon adenocarcinoma 
cells upon treatment by 9, 17-octadecadienal occurred in a dose-dependent manner. It was 
also observed that the highest percentage of apoptotic cells (early and late) occurred 48hrs 
after treatment with 25 µg/mL of compound.  
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4.8.3.4. Cell cycle analysis  
It is estimated that 50 to 70 billion cells die each day due to apoptosis in human 
adults. In one year, the number of cell divisions and deaths that occur in a person's body 
is approximately equal to the person’s weight (Potten & James, 2004).  DNA or 
deoxyribonucleic acid is vital to the reproduction of cells, live cells and dead cell. DNA, 
made up of two sets of chromosomes is the molecule which carried genetic information 
of living organisms. Cells regenerate in order to replace dead or damaged cells or to grow. 
The cell cycle plays an essential role in the cell including cell replication, cell death, and 
cell function.  
During the flow cytometry analysis of the cell cycle, the most common categories 
of DNA binding dyes are the blue-excited dye propidium iodide, the UV-excited dyes 
4’,6-diamidino-2-phenylindole (DAPI) and Hoechst  33342 and 33258 dye. Each cell 
cycle consists of five stages: the G1 phase is preceded by mitosis and the level of DNA 
content is 2N; cells in the G0 phase are quiescent and do not participate in cell division; 
the S phase is where DNA replication and synthesis occurs; the G2 phase is when cells 
prepare for entry into mitosis, and the level of DNA content is 4N; the M phase or mitosis 
is when cell division involves the distribution of identical genetic material, DNA, into 
two daughter cells. Both G1 and G0 have 2N DNA and are indistinguishable from one 
another. To determine whether the inhibition of the compound on HT-29 cell proliferation 
involves cell cycle changes, we examined the cell cycle phase distribution of the treated 
cells by flow cytometry. The percentage of cells in the G0/G1, S and G2/M phase were 
calculated by using ModFit software and all data are represented in Figure 4.83.  
It was observed that the compound resulted in cell cycle arrest in the G0/G1 phase 
after treatment of 10 µg/mL of compound in a time-dependent manner, compared to the 
untreated cells. Standard deviation was calculated for the treated and untreated cells using 
Microsoft excel software. All significance of the difference between the treated and 
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untreated cells in each cell cycle phase was determined by Student’s t-test and the p value 
is ˂ 0.5. The results of statistical analysis of variance (SPSS 16.0) in differences between 
untreated cells and treated cells in each cell cycle phase.  The results of the flow cytometry 
analysis are presented in Figure 4.79 and Figure 4.80.  
 
 
 
  
Figure 4.79: HT-29 cells treated with the concentrations (10 µg/mL) of 9, 17-
octadecadienal for 24h, 48h and 72h, and analysed by flow cytometry after staining with 
PI. Percentages of diploid cells (DNA content) at G0/G1, S, and G2/M phases of HT-29 
cells were determined after 24h, 48h and 72h incubation periods. 
 
Untreated HT-29 cells 24h 
48h 72h 
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The untreated HT-29 cells showed that 56.00% of the cells were in the G1 phase 
whereas 17.81% and 26.19% were at the G2/M and S phase respectively. After 24h, 48h 
and 72h of treatment with 10 µg/mL of compound, the percentage of cells in the G0/G1 
phase increased to 61.70%, 69.48% and 77.26% respectively. Meanwhile, the percentage 
of cells in the G2/M phase were 14.75%, 5.26% and 16.98% and the percentage of cells 
in the S phase  were 23.55%, 24.75% and 5.77% in a time-dependent manner. 
 
Figure 4.80: HT-29 cells treated with IC50 value of concentrations of (Z)-9, 17-
Octadecadienal (m/z 264) for 24h, 48h and 72h, and analyzed by flow cytometry after 
staining with PI. Histogram showing quantitative percentage of DNA content in each 
cell cycle phase without treatment and with treatment. All results were statistical 
significant difference in the cell cycle phases between treated cells and untreated cells 
 
Therefore, 9, 17-Octadecadienal compound was able to induce a 77.7% of 
apoptotic cells death early and late apoptotic in HT-29 cells at 48h treatment at 25 µg/mL 
had resulted in cell cycle arrest at the G0/G1 phase.  
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4.9. General Discussion 
One of Indonesia’s famous herbal medicine plant is P. macrocarpa (Scheff.) 
Boerl which belongs to the Thymelaeceae family and it is especially well-known in 
Southeast Asia as an herbal medicine. P. macrocarpa is  used to address a variety of 
ailments such as cancer, diabetes mellitus, allergies, liver and heart diseases, kidney 
failure, blood diseases, high blood pressure, and stroke. It has also been used to treat 
various skin diseases including acne (Harmanto, 2002; Jemal et al., 2007). 
In this study, P. macrocarpa seeds and fruits were exhaustively soaked in 70% 
aqueous methanol and then fractionated with hexane, chloroform, ethyl acetate and water. 
After this, the methanol extracts and fractions were evaluated for cytotoxic activity in 
selected human cancer cell lines, namely the cervical epithelial carcinoma cell (Ca Ski), 
the hormone-dependent breast carcinoma cell (MCF-7), the epithelial colon carcinoma 
cell (HT-29), the epithelial lung carcinoma cell (A549), the ovarian carcinoma cell 
(SKOV-3), the hormone-independent breast carcinoma cell (MDA-MB231) as well as 
non-cancer human cells, namely the normal fibroblast cell line (MRC-5) using the MTT 
cell proliferation assay. The MTT assay is a sensitive and reliable colorimetric assay and 
it uses quantitative measurements to calculate the viability, proliferation and activation of 
cells and this method is commonly applied to screen anticancer agents (Petty et al., 1995). 
The methanol extract and its fractions (hexane, chloroform, ethyl acetate and 
water) in  P. macrocarpa fruits  were found to have cytotoxic effects on some cancer cell 
lines (MCF-7, HT-29, MDA-MB 231 and SKOV-3) but no cytotoxic effect on the cervical 
carcinoma cell line (Ca Ski) and the non-cancer human fibroblast cell line (MRC-5) 
according to  dose- and time-dependent manner. Some researchers have also noted that 
the edible fruits of P. macrocarpa  are very useful in treating individuals with 
hypertension, diabetes, cancer and/or diuretic problems because of their  high antioxidant, 
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antimicrobial, anti-inflammatory, and cytotoxic properties, as well as other bioactivities 
present in their compounds.  
In studying the  P. macrocarpa seeds,  results also revealed that their methanol 
extract and its fractions had highly cytotoxic effects on all selected cancer cell lines 
(MCF-7, HT-29, MDA-MB231, Ca Ski, and SKOV-3) and mild cytotoxicity effects on 
the normal human fibroblast breast cell line (MRC-5). The seed of P. macrocarpa is the 
most poisonous part of the plant, with significantly higher toxicity levels than the stem, 
roots or leaves but researchers have also reported that the seeds have cytotoxic activity, 
antimicrobial and other bioactivities. 
After investigating the seeds of the P. macrocarpa for cytotoxic activity, it was of 
interest to identify the bioactive and chemical compounds of the ethyl acetate fraction of 
the P. macrocarpa seeds and fruits. The hexane and ethyl acetate fraction were the refines 
subjected to column chromatography which led to the isolation and identification of some 
compounds done by nuclear magnetic resource (NMR), thin layer chromatography (TLC) 
and gas chromatography-mass spectrometry (GC-MS) analyses. 
Six compounds were identified from the hexane extract of the P. macrocarpa 
seeds by using GC-MS and they are namely methyl myristate, methyl stearate, oleic acid, 
linoleic acid, methyl linoleate, palmitic acid and other minor components. The chloroform 
fraction of the P. macrocarpa seeds showed presence of methyl myristate, palmitic acid, 
methyl oleate, 6-octadecenoic acid, (z) - and 9, 17-octadecadienal, (z)-. The bioactive 
fraction of the ethyl acetate fraction was subjected to column chromatography separation 
and this fraction yielded palmitic acid, methyl palmitate, β-sitosterol and (z) 9, 17-
octadecadienal using gas choromatography-mass spectrometery (GC-MS) analysis.  
In the hexane fraction of the P. macrocarpa fruit, the chemical compounds methyl 
myristate, palmitic acid, β-sitosterol, methyl oleate, oleic acid, methyl linoleate and other 
minor components were identified. Of the chloroform fraction of the P. macrocarpa fruit, 
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three chemical components were identified namely methyl myristate, metyl oleate, β-
sitosterol and other minor components by using GC-MS analysis. The bioactive ethyl 
acetate fraction of the P. macrocarpa fruit was  subjected to the column chromatography 
and this fraction produced palmitic acid, methyl palmitate, methyl oleate, oleic acid, 
methyl myristate, methyl linoleate, β-sitosterol, stigmast-4-en-3-one, flamenol, phenol 
2,4',6-trihydroxy-4-methoxybenzophenone (or) (2,6-dihydroxy-4-methoxyphenyl)(4-
hydroxyphenyl) methanone and 1-(2, 6-dihydroxy-4-methoxyphenyl)-2-(4-
hydroxyphenyl) ethanone and other  unidentified compounds. These two compounds,  
identified by using GC-MS and NMR analyses,  from fruits of P. macrocarpa  and 9, 17-
octadienal (z) from seeds of P. macrocarpa  were investigated for cytotoxic effects on 
the human colon carcinoma cell lines (HT-29) and the normal human fibroblast cell line 
(MRC-5) in a time- and dose-dependent manner. 
HT-29 and MRC-5 cell lines were treated with various concentrations of the first 
compound, 2, 4', 6-trihydroxy-4-methoxybenzophenone for 24h, 48h and 72h 
respectively to inhibit cell proliferation by using the MTT assay. 2, 4', 6-trihydroxy-4-
methoxybenzophenone has mild cytotoxic activity on normal cells but has anticancer 
effects in cancer cells (HT-29). The compound was found to induce apoptosis in HT-29 
cells and we observed the morphological changes under microscopic examination such 
as cell shrinkage, membrane blebbing, DNA fragmentation and apoptotic nuclei by using 
an inverted, phase contrast and fluorescence microscope with acridine orange and 
propidium iodide double staining.  
 The percentage of pro-apoptotic  HT-29 cells were determined by flow cytometry 
analysis by using Annexin V-FITC staining. During the cell cycle analysis, the percentage 
of HT-29 cells treated with the 2, 4', 6-trihydroxy-4-methoxybenzophenone was found to 
be arrested at the G0/G1 phase in a time-dependent manner and S phase accumulations 
were found to have sharply declined. All these data indicate that the mechanism of cell 
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cycle arrest in the S phase was related to apoptosis protein, which plays a vital role in 
regulating the mitochondria-dependent pathway of apoptosis.  
For the second compound, 1-(2, 6-dihydroxy-4-methoxyphenyl)-2-(4-
hydroxyphenyl) ethanone was also tested on the human colon adenocarcinoma cell line 
(HT-29) and the normal human fibroblast cell line (MRC-5) by using the MTT cell 
proliferation assay. In this study, we found that the MTT assay significantly decreased 
cell proliferation in the HT-29 cell line in a dose- and time-dependent manner. We also 
observed morphological features of the apoptotic bodies such as cell death, cell shrinkage, 
membrane blebbing, nuclear condensation and DNA fragmentation under inverted, phase 
and fluorescence microscopy.  
To the best of my knowledge, the bioactive 1-(2, 6-dihydroxy-4-methoxyphenyl)-
2-(4-hydroxyphenyl) ethanone induced in HT-29 cells, which were analyzed with the 
Annexin V-FITC/propidium iodide staining assay by using the flow cytometry technique 
and the percentage of early apoptotic, late apoptotic cells, necrotic cells and live cells 
were observed in a time-dependent and dose-dependent manner. During the cell cycle 
analysis, the IC50 values of concentration of the 1-(2, 6-dihydroxy-4-methoxyphenyl)-2-
(4-hydroxyphenyl) ethanone induced an apparent low level of apoptosis and G0/G1 arrest 
in HT-29 cells in a time-dependent manner.  
The third compound, the bioactive 9, 17-octadecadienal was tested on the human 
colon carcinoma cell line (HT-29) and the normal human fibroblast cell line (MRC-5) by 
using the MTT cell proliferation assay. The result of the MTT assay showed that 9, 17-
octadecadienal exhibited cytotoxic effect of the HT-29 cells but had no cytotoxic effect 
on MRC-5 cells line in a dose- and time- dependent manner.  
Next, the morphological features of the apoptotic bodies such as cell shrinkage, 
cell death, membrane blebbing, nuclear condensation and DNA fragmentation were 
observed under an inverted, phase and fluorescence microscope. It is also confirmed that 
161 
 
various concentrations of the 9, 17-octadecadienal induced HT-29 cells that were stained 
with Annexin V-FITC/propidium iodide when using the flow cytometry analysis. The 
results revealed low percentage of early apoptotic, late apoptotic or dead cells, necrotic 
cells and live cells. Furthermore, the cell cycle analysis showed that 9, 17-ctadecadienal 
at a concentration of 10 µg/mL was able to induce G0/G1 arrest in HT-29 cells in a time 
dependent-manner.Therefore, it can be concluded that that 9, 17-octadecadienal induced 
apoptotic cell death of HT-29 cells. 
In sum, the results showed that these three compounds and 2,4',6-trihydroxy-4-
methoxybenzophenone and 1-(2, 6-dihydroxy-4-methoxyphenyl)-2-(4-
hydroxyphenyl)ethanone, were found to have a cytotoxic effect on the human colon 
carcinoma cell lines (HT-29) in a time- and dose-dependent manner but mild cytotoxic 
effect on normal fibroblast cells (MRC-5).  More studies on the mechanism of cell death 
induced by the above compounds need to be conducted before a conclusion can be derived 
regarding its potential use as anti-cancer agents.
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CHAPTER 5 
CONCLUSION 
5.1.  Conclusion 
Results demonstrate that 9, 17-octadecadienal (Z)-, 2, 4’, 6-trihydroxy-4-
methoxybenzophenone and 1-(2, 6-dihydroxy-4-methoxyphenyl)-2-(4-hydroxyphenyl) 
ethanone induce cytotoxic effect on HT-29 cells by using MTT cells proliferation assay 
in vitro experiment. In the treatment with compounds in HT-29 cells for time dependent 
manner, morphological studies of apoptotic bodies were observed under microscopic 
examinations (phase contrast microscopy, inverted microscopy and fluorescence 
microscopy). It can be clearly seen that apoptotic bodies such as cell death, cell shrinkage, 
membrane blebbing, and nuclear condensation and DNA fragmentation were present. In 
the annexin V-FITC/PI staining assay, HT-29 cells treated with different concentration 
of compounds provide results which demonstrate clear percentages of late apoptotic cells, 
early apoptotic cells, necrotic cells and live cells. 
Apoptosis depends on cell growth and cell proliferation which are mainly 
regulated by cell cycle events. Investigation on the effect of these compounds on cell 
cycle arrest prove that treatment with compounds help to examine the cells cycle 
checkpoints which were arrested in the G0/G1 phase in HT-29 cells when using flow 
cytometry analysis. These data provide further investigation of the protein regulatory for 
good understanding of the anti-cancer mechanism action of these may compounds. 
Therefore, this study revealed that these three compounds have the potential to be used 
as a therapeutic drug in treating patients with colon cancer in the future.  
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5.2. Future work 
These finding suggest that these three compounds possess cytotoxic effect and 
low level of apoptotic ability on HT-29 cells but mild cytotoxic activity on normal human 
cells. These results provide the basis knowledge of targeted chemotherapeutic drugs in 
cancer research. However, these three compounds still need to be further investigated in 
target apoptotic studies in vivo experiment with animals and also to be further tested on 
patients with human colon cancer cells for clinical trials in further chemotherapeutic 
approaches.
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